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IF 
 
If you can keep your head when all about you 
Are losing theirs and blaming it on you, 
If you can trust yourself when all men doubt you, 
But make allowance for their doubting too; 
If you can wait and not be tired by waiting, 
Or being lied about, don’t deal with lies, 
Or being hated don’t give way to hating, 
And yet don’t look too good, nor talk too wise: 
 
If you can dream --- and not make dreams your master; 
If you can think --- and not make thoughts your aim, 
If you can meet with Triumph and Disaster 
And treat those two impostors just the same; 
If you can bear to hear the truth you’ve spoken 
Twisted by knaves to make a trap of fools, 
Or watch the things you gave your life to, broken, 
And stoop and build ’em up with worn-out tools: 
 
If you can make one heap of all your winnings 
And risk it on one turn of pitch – and – toss, 
And lose, and start again at your beginnings 
And never breathe a word about your loss; 
If you can force your heart and nerve and sinew 
To serve your turn long after they are gone, 
And so hold on when there is nothing in you 
Except the Will which says to them: “Hold on!” 
 
If you can talk with crowds and keep your virtue, 
Or walk with Kings --- nor lose the common touch, 
If neither foes nor loving friends can hurt you, 
If all men count with you, but none too much; 
If you can fill the unforgiving minute 
With sixty seconds’ worth of distance run, 
Yours is the Earth and everything that’s in it, 
And --- which is more --- you’ll be a Man, my son! 
 
By Rudyard Kipling from Rewards and Fairies, 1910 
 
Aan mijn ouders 
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1.1 Conceptual schemes in pressure ulcer development 
 
The two widely used concepts for the development of pressure ulcer (PU) emphasise that 
the two critical factors are pressure1- and shear forces [2, 3] and the viability of the skin 
tissues. If no pressure is applied to the skin tissues, patients with the most severely 
compromised viability of these tissues do not develop a PU. However, if pressure is exerted 
to the skin tissues in this patient group, and particularly to skin over bony prominences, PU 
will rapidly develop. The role of the exerted pressure, the different measurement techniques 
and the viability of the skin tissues in the development of PUs are highlighted in this 
introduction.   
 
Consequences of pressure in human body 
A patient lying on a bed for a long time exerts forces on the mattress. In turn, the mattress 
exerts forces on the body of the patient. The actual stress exerted on different parts of the 
body depends on a number of factors such as: 
• The actual sites of contact between the patient and the mattress 
• The stress situation in the adjoining sites of the body 
• The direction of the sites of contact compared with the gravitational force 
• The material properties of the site (hard bone or soft tissue) of the body that is in 
contact with the mattress  
• The material properties of the sites of the body surrounding this site 
• The material properties of the mattress 
 
Precise information on the actual stress on the body and its consequences may be 
the key to a fundamental explanation on “stress ulcer” development. Some investigators 
suspect that the deformation resulting from the stress on the body is an important parameter 
determining the actual damage caused by prolonged lying. The Technical University in 
Eindhoven has recently conducted several studies on methods to measure deformation [4, 5]. 
Complicating factors are the inability to measure the continuously changing stress on body 
sites directly and the translation of available measurements into an adequate description of 
stress on body sites. 
Therefore, we have to rely on incomplete information in our efforts to describe 
and prevent development of “stress ulcers”. In order to be able to combine the efforts of the 
scientific community in this field, it is necessary to accurately describe the parameters we 
measure. Although the term stress would be more appropriate as explained, we further 
adhere to the term pressure in order to conform with the medical tradition. 
In this chapter a series of measurements on the stress exerted on a measuring 
                                                
1 Physicists generally define pressure as the force exerted over a unit/area accordingly to Newton’s first and 
second laws [1]. Stress as expressed in tractions and the collection of tractions, however, would be a more 
appropriate term. Here for conventional reasons, we use the phrase pressure. 
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device that was located between the individual and a mattress are described. This 
measurement is referred to as the “interface pressure” (IP).  
  
Clinical characteristics of the skin after pressure application 
The first visible sign after pressure has been applied is a local non-specific erythema of the 
skin. This is often mentioned in the literature as Reactive Hyperemia (RH). Reactive 
Hyperemia is defined as “a characteristic bright flush of the skin associated with an 
increased volume of the pulse on the release of an obstruction to the circulation” [6]. The 
maximum flow occurs immediately after the obstruction is removed. If the erythema 
disappears under the locally applied pressure (for example through pressure applied by a 
finger or by using a transparent disc) this is called “blanching’’ hyperemia indicating an 
intact microcirculation [7]. If the redness does not disappear it is called “non-blanching” 
hyperemia, indicating a microcirculatory disruption.  
The “blanching” and “non-blanching” hyperemia is the result of RH [8] and can be 
identified at two levels. The first is a vasodilatory response as a reaction to a complete 
standstill of arterial blood flow and is visualized by a “non-blanching hyperemia”. This 
occurs mainly in the deeper tissue structures such as the muscles. There is also a more 
superficial response as a result of a reduction of blood flow prominently in the dermal 
tissues and noted as “blanching” hyperemia [7]. The occurrence of RH is a natural reflex 
vasodilatation of the dermal blood vessels for temporarily increasing the blood flow and 
therefore the oxygen supply and nutrition to specific ischemic parts of the dermal tissues [9]. 
This reaction is locally organized and independent of the central nervous control [6]. 
However, the intensity of the reaction may differ per patient [10].  
At the stage of “blanching” hyperemia the blood vessels are already slightly 
damaged because of ischemia, which creates a local aseptic inflammatory reaction and 
causes redness that disappears under pressure (made visible through a transparent disc). If 
the exerted pressure on the dermal tissue continues, the “blanching” hyperemia will change 
into “non-blanching hyperemia” because the damaged blood vessels start leaking and 
thrombi are formed [11].  
Lewis and Grant [6] reported that the duration of the RH response continued for 
half the time the blood vessels were occluded by the exerted pressure and that this fraction 
augmented with an increasing period of the occlusion. This was supported by Kosiak [12]. 
He also mentioned that the protective response of RH decreased before dermal tissue 
damage was noted indicating that the absence of redness did not guarantee that no PU will 
develop in the near future. 
The exact role of the RH remains uncertain. Lewis and Grant [6] found evidence 
that the RH was initiated in order to pay off the metabolic debt accumulated during the 
occlusion. Other investigators reported that no “debt” was paid off upon gradual restoration 
of the blood flow but that the function of the hyperemia was to re-establish the resting 
metabolic state of the dermal tissues as quickly as possible [13].  
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If prevention is not initiated early enough, the exerted pressure will cause splitting 
of the cutis and the space is filled with fluid resulting in the formation of a blister. When 
dermal tissue remains under pressure the epidermis will break and extended damage is 
caused to the underlying tissues. Under the influence of bacteria and their waste products 
more subcutaneous tissue will be destroyed creating necrotic tissue which spreads to the 
deeper layers of fat and muscle tissue culminating in a PU. At this stage the borders of the 
PU are not yet undermined. The following stage is characterized by an aseptic 
inflammatory process in the deeper layers of the tissues and particularly by the necrosis of 
fat tissue. Bacteria invade and cause the formation of abscesses that break through to 
various sides of the ulcer creating cavities undermining the borders of the ulcer. Enzymatic 
breakdown of tissues by matrix metalloproteinases enhances this process [14]. 
 
Etiology of Pressure Ulcers 
Clinical workers often view the development of a PU as a black box where the applied 
pressure to the dermal tissues results in a PU without exactly knowing what has happened 
at the cellular level in these tissues. As mentioned earlier, the primary cause of a PU is 
based on the exerted pressure and shear forces on the patient’s dermal tissues whereby the 
supply of oxygen is reduced or cut-off causing necrosis of these tissues [15].  During the last 
forty years, a number of theories have been formulated which describe the possible 
pathophysiologic processes involved and ensuing histopathologic events. These theories 
are:  
1. Theories based on localized ischemia [16-19] 
2. Theories based on impaired interstitial fluid flow and lymphatic drainage [20-23] 
3. Theories based on reperfusion injury [24, 25] 
4. Theories based on sustained deformation of cells [26, 27]. 
 
Classification of Pressure ulcers 
In the past various investigators have studied the process of PU development and searched 
for a visual description of the critical stages (the outside shows what is going on in the 
inside). This enables clinicians to place the actual observations in the perspective of the 
overall process in the development of a PU without the need for a histological description. 
Such a classification system indicates the severity, the necessary care and the prognosis of 
the actual observation [28]. Yarkony et al. [29] described three main purposes of such a 
system: 
1. To improve uniform communication between clinicians on the severity of the PU 
2. To evaluate various treatment regimes for PUs 
3. To improve the accuracy of medical and nursing records for clinical care and research.  
 
Haalboom [30] supported this concept and stated the following requirements for 
such a classification system. 
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1. The classification system should be such that it can be used at the bedside 
2. Its use should be uniform  
3. It should have a high inter-observer reliability 
4. There should be a logical correlation between the classification, the severity of the PU 
and the prognosis 
5. Its use should be international 
6. There should be a relationship between the classification and preventive or treatment 
policies. 
 
Various PU classification systems have been developed over the years. In the 
United Kingdom alone 14 classification systems have been used [31]. One of the first 
classification systems based on histological / anatomical findings was created by Shea [32]. 
An overview of this classification is shown in Table I. 
 
Table I.     Classification of pressure ulcers according to Shea [32] 
Stage 1  Limited to epidermis, exposing dermis 
Stage 2  Full-thickness of dermis to junction of subcutaneous fat 
Stage 3  Fat obliterated, limited by deep fascia undermining the skin 
Stage 4  Bone at the base of the ulceration 
Stage 5  Closed large cavity through a small sinus. 
 
The classification systems also changed, when the etiology of PU development 
became clearer. In the 1980s of the twentieth century, the Torrance system [33] was 
developed. The uniqueness of this classification system is the inclusion of blanching 
erythema as one of the stages in the development of a PU. Most other systems do not 
qualify blanching erythema as a PU stage as this is in principle reversible. Nevertheless the 
presence of blanching erythema may be seen as a pre-ulcer stage as this is the first visible 
sign that indicates that exerted pressure diminishes the blood flow in the dermal tissues. 
Including this stage in the classification system enhances the awareness of the clinical staff 
that in the particular patient there is a potential risk of developing a PU at the specific 
location [29]. Considering blanching erythema as stage 1 also suggests it is not normal as 
most other classification systems classify this stage as stage 0, the same as if there was no 
visible erythema at all.  
Yarkony et al. [29] divided this stage further and related it to the duration of the 
blanching erythema (see Table II). In their classification system, stage 1 was divided into 
stages 1a and 1b where stage 1a is applicable when the erythema is present for between 30 
minutes and 24 hours and stage 1b is applicable if erythema is present for longer than 24 
hours. Their classification system thus included the influence of time in relation to the 
tissue damage. Since it is difficult for clinicians to keep track of the exact onset of the 
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erythema and whether it was present for longer than 24 hours, it is difficult to chart because 
various nurses and doctors take care of the patients.  
 
Table II.     Classification of pressure ulcers according to Yarkony & Kirk [29[ 
Stage 1  a. Red areas lasting between 30 minutes and 24 hours 
  b. Red areas lasting longer than 24 hours 
Stage 2  Epidermis and / or dermis ulcerated with no subcutaneous fat observed 
Stage 3  Subcutaneous fat observed, no muscle observed 
Stage 4  Muscle / fascia observed, but no bone observed 
Stage 5  Bone observed, but no involvement of joint space 
Stage 6  Involvement of joint space. 
 
This classification was criticized by Witkowski and Parish [34] who stated that 
blanching or non-blanching was more important than the duration. The argument that was 
put forward was that only reactive vasodilatation was involved if erythema persisted for 
less than 30 minutes. This was in contrast to erythema that persisted for longer than 30 
minutes whereby edema in the upper portions of the dermis and vascular dilatation were 
present. They also stated that erythema that persisted for longer than 24 hours was always 
non-blanchable and showed all of the earlier mentioned histological changes in addition to 
inflammation of blood vessels with erythrocyte extravasation.  
 
 
1.2 Measurement of pressure 
 
Measuring the pressure between humans and their supporting material started within the 
realm of healthcare system [35].  Various pressure measurement techniques were developed, 
when it became apparent that the type of supporting material that was used for patients in a 
wheelchair mattered in relation to the risk of developing PUs.  
If the type of mattress influenced the prevalence of PU in wheelchair patients it 
must also influence the prevalence in hospitalized patients and specifically in those patients 
who were immobile or unable to change their body position. Therefore, research in this area 
was undertaken in high risk patients with spinal cord injuries who were assigned to 
standard hospital mattresses and special pressure reducing mattresses.  
As it is estimated that one quarter of all the work in industrial countries is sedentary 
[36], pressure measurements also caught the attention of industrial designers and the allied 
industry that designed and manufactured chairs. Seat pressure measurements were carried 
out in several types of industries in which seating comfort was an important issue [37] 
because comfortable seating influenced the productivity of the employee, whereas 
uncomfortable seats worsened the pre-existing medical conditions such as back aches.  
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During the last century investigators started to develop instruments that were able 
to indicate the pressure that was applied to areas of dermal tissues which were susceptible 
for the development PU. Kosiak et al. [38]  measured the pressure exerted on the dermal 
tissues in the pelvic area of 11 adults who set on various surfaces. They used 12 rubber 
butterfly type valves of 2 cm long and 1 cm wide that were attached to a non-distensible 
closed system into which a steady flow of air was maintained from a pressure source of 
approximately 600 mmHg. The pressure at which equilibrium was reached between the 
inflow of air into the system and escape of air through the test valve was accepted as the 
pressure applied externally on the valve. This in turn gave an indication of the pressure that 
was applied to the skin of the volunteer. The instrument could only measure the pressure of 
up to 300 mmHg accurately. If the pressure exceeded 300 mmHg, the value was obtained 
by extrapolation as it was assumed that the error in this pressure range was similar to that 
from 0-300 mmHg. 
The measurements by Kosiak and his team were carried out with the volunteer in 
an upright sitting position. Therefore, two valves were always positioned under the ischial 
tuberosities as it was expected that these were the two locations that exerted the highest 
pressure. Pressures were measured in volunteers sitting on 6 different surfaces (wooden 
office chair, flat board, 1 and 2 inch foam, and a padded and unpadded alternating 
mattress).  The main conclusion was that the use of alternating mattresses provided the 
largest reduction in the exerted pressure, specifically in the buttock area, which was within 
the range of the capillary blood pressure (32 mmHg = 4.3 kPa) [38].  
Since this was one of the first instruments with which one could actually measure 
and quantify (mmHg) the effect on the tissues when pressure was exerted by the body on 
the mattress, this method may be considered as the first method for evaluating 
commercially manufactured mattresses. The instrument consisted of various tubes, 
recorders and transducers and therefore, was complicated to use. It could only be 
effectively operated in a laboratory setting. This limited the use of such an instrument for 
measuring IP in a clinical setting.  
Lindan, Greenway and Piazza [39] were the first who developed a measuring device 
which could create a total body pressure map of the pressures exerted on the human body 
supported on a mattress. They used the “bed of springs and nails” which consisted of a 
piece of plywood with holes 1.4 cm apart for sitting measurements and 2 cm apart for lying 
measurements. In each hole a 7.5 cm nail was placed whereby in a supine position 1000 
nails created a “discontinuing surface” that supported the subject. Around each nail two 
types of steel springs with different resistance were used. The resistance of the “bed of 
springs and nails” could be changed by changing the spacing of the nails or changing the 
resistance of the springs. The force that was necessary to compress the spring 1 cm (range 
1.9 kPa (14.9 mmHg) -8.2 kPa (61.8 mmHg)) was calculated for each nail in combination 
with the two types of springs and two spacing distances.  The subjects were placed on the 
“bed of springs and nails”. The number of nails that were displaced was measured by hand 
with an accuracy of within 0.5 mm. After the compression of each nail was known, the 
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points of identical compression were connected and isobars were drawn which created a 
“pressure map” of the body that graphically showed the high and the low pressure areas. In 
doing so they came to the following conclusions: 
• Placing subjects in a prone position created more, but smaller high pressure areas, 
and also large low pressure areas compared with subjects in a supine position. 
• Softer mattresses resulted in lowering the maximum pressures by increasing the 
area of lower pressures 
• The effect of ischial cut-outs increased the areas of maximum pressures because 
the total pressure is distributed over a smaller area 
• Obese subjects had larger areas with lower pressure compared with under-weight 
subjects who had small areas of high pressure.  
 
This investigation may be considered as a breakthrough because it demonstrated 
that a mattress with different resistance clearly influenced the pressure that was exerted on 
the dermal tissues by the human body. It also emphasized that different body shapes created 
different “pressure maps” and therefore, underwrote the uniqueness of each human being. 
The consequence of this research was that human beings may react very differently in terms 
of “pressure mapping” to a standard mattress. This instrument can only be used in a 
laboratory setting considering its size and the technique for investigating the pressure 
distribution on the human body. The assessment of the pressure distribution in actual 
hospitalized patients is difficult to perform with such an instrument in view of the 
discomfort caused to the patients during the whole measurement.  
Following these two investigations, a large number of instruments were developed 
over the last three decades which can be used to measure the pressure between cutaneous 
tissue and the mattress. Bush [40] as one of the first, measured the pressure between the 
dermal tissue and the seat with an electronic sensor at the site of the ischial tuberosities.  
Others followed quickly [41-44]. The main problems with these early types of electronic 
measuring devices were that they were unreliable in terms of validity and reproducibility 
[35]. This is probably the reason that other types of sensors based on other technologies were 
developed and refined so that measurements became more reproducible. 
 
Electro-pneumatic sensors 
The next generation of sensors that were developed were the so-called electro-pneumatic 
sensors [45]. Basically these consisted of an inflatable sac inside which electrical contacts 
strips are positioned cross diagonally. The working principle is as follows. The sensor is 
placed between the body and the mattress at the site of interest. Air is slowly pumped into 
the sensor to the level at which the electrical contact between both strips breaks. The 
pressure recorded at that moment is considered to be the pressure exerted on the sensor by 
the body on the mattress under study. Another example of an electro-pneumatic measuring 
device is the Pressure Evaluation Pad designed by Garber, Krouskop and Carter  [46]. 
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Pneumatic sensors 
Bader [47] developed a pneumatic sensor which has been commercially available as the 
Talley Pressure Monitor (TPM). This sensor consists of air cells that are connected to a 
high pressure pump. The sensors are placed between the body and the mattress at the site of 
interest. The working of a pneumatic sensor is as follows. The pump will try to inflate the 
sensor by increasing the inflation pressure just above the pressure applied to the sensor by 
the body on the mattress. At the moment this is actual, a sudden drop in the pressure 
increase is recorded. The pressure at the moment the increase in pressure stops is the 
applied interface pressure [35].  
Another much used pneumatic sensor, the Texas Interface Pressure Evaluator was 
developed by Krouskop [22]. The working of this system is as follows. The sensor is placed 
between the body and the mattress at the site of interest. The sensor is over-inflated, then a 
relief valve opens whereby the air pressure in the pad is slowly reduced. When the pressure 
exerted by the body on the sensor exceeds the pressure keeping the relief valve open, the 
valve closes and the corresponding pressure is displayed. This sensor was used in a number 
of investigations in which the pressure reducing capacity of mattresses was evaluated [48, 49]. 
Later, a mini-version was manufactured and used in various investigations [29, 50-52]. 
Another type of sensor that was used in studies on this subject was a 100 ml fluid 
filled intravenous bag connected to the bedside hemodynamic monitor [53]. The 
investigators stated that it was small enough (4½ x 3½ x ½ inch) so that it was unlikely that 
it would act as a secondary flotation device. They measured the pressure between the 
mattress and the sacrum and the heel of 57 intensive care patients. Using the device as an 
intravenous fluid bag connected to the hemodynamic monitoring system may be interesting 
as data are recorded continuously.  
 
Electronic sensors 
In the 1980s of the last century, there was renewed interest for using electronic sensors for 
measuring the pressure at the interface of the body and the mattress. This was probably the 
result of an improved developing technology that made it possible to overcome earlier 
problems in terms of validity and reproducibility. Two main types of electronic sensors 
with different working principles have been described in the literature. Both principles are 
discussed.  
 
a. Capacitive sensors 
Bethaves, [54] described the working principle of a capacitive sensor based on the fact that it 
consists of “electrical elements that store energy in the form of an electrical field. This 
energy is supplied to the capacitor by a power supply and can be transformed into a useful 
reading with the appropriate circuitry”. Most capacitors consist of two metal plates that are 
oppositely charged. The amount of electrical charge that can be stored by the capacitor 
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depends on the size of the metal plates, and the distance between them (apart from the di-
electric constant of the free space and the used material).  If used for measuring pressure, in 
most cases, the change in the distance between the plates is used to calculate the exerted 
pressure [54].  The errors are extremely small because the capacitive sensor does not depend 
on the conductivity of its plates and the dimensions of the plates are not dependent on the 
temperature [55]. In relation to the measured pressure, a capacitive sensor measures the 
average pressure over the sensor area. This makes the size of the sensor an important 
characteristic. The larger the sensors the smaller are the areas of high pressure that are 
detectable. Examples of companies that manufacture measuring systems with capacitive 
sensors are Novel, with the Pliance® sensor and Crown Therapeutics with the Xsensor® 
sensor.  
 
b. Resistive sensors 
The working principle of this sensor is based on the change in the resistance of a special 
piezo-resistive layer when a force is applied [56]. This resistive layer contains strain gauges 
or force-sensing resistors that can map the applied force and translate this into a pressure 
reading. The pressure reading does not change as long as the same pressure is exerted on 
the sensor. It will only change when the applied force is changed or removed. Since the 
piezo-resistive sensor changes only its resistance when deformed, extremely small 
displacements can be measured [54].  Care must be taken because temperature and humidity 
affect the sensor reading.[54, 56]. It is important to know is that resistive sensors measure the 
peak pressure over the sensor area for measuring the pressure at the interface of the body 
and mattress. Examples of companies that manufacture resistive sensor technology are 
Vista Medical, with the Force Sensor Array® (FSA) and Clinseat with the Tekscan® 
sensors.  
 
A comparison of capacitive and resistive sensors 
Ashruf [56] stated that most suppliers (and probably users) favor the piezo-resistive sensor 
because it is fairly straightforward, fast, relatively simple and has a low sensitivity to 
electromagnetic fields. This is in contrast to capacitive sensors which are technologically 
more complex. Ashruf [56] further stated that some experts preferred the capacitive system 
as they found the disadvantages of the resistive sensors (non-linearity, influence of 
temperature, humidity and poor stability) more relevant than the more complicated 
electronics. The problem of non-linearity of resistive sensors was investigated by Ferguson-
Pell and Cardi [57]. The resistive sensors FSA® and Tekscan® had a linear response (r > 
0.99) to increasing pressure (0-160 mmHg in steps of 20 mmHg). Both types of sensors 
clearly have their pros and cons. Both types of sensors may be used for measuring the 
pressure at the interface of body and the mattress provided that the investigators are aware 
of the limitations of each type of the sensor. 
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Important sensor properties 
Independent of the type of sensor that is used for measuring the pressure, there are a 
number of factors that need to be taken into account. 
Hysteresis is the phenomenon that becomes manifest when the output of a sensor 
responds differently to an increasing load when compared with a decreasing load. 
Hysteresis is calculated as the maximum difference in measured average pressure as a 
percentage of the applied pressure at the point of the maximum difference [54]. Creep or 
instability is another source of error when the measured pressure does not remain at the 
same level over time when a constant load is applied to the sensor [54]. 
Ferguson-Pell and Cardi [57] investigated the hysteresis and the creep of the FSA®, 
Tekscan® and Talley Pressure Monitor III (TPM). During the investigation they observed 
high hysteresis for the FSA®  (18.7%) and Tekscan® (21.7%) sensors. Creep was also 
reported to be high for both sensor systems. Tekscan® had an instability of 17.9% after 2 
minutes and 26% after 10 minutes with a load of 50 mmHg. For a 100 mmHg load, this was 
7.5% and 13.5% at an interval of 2 and 5 minutes, respectively. The FSA® sensor produced 
a creep of 3.3% and 4.6% instability at 50 mmHg. For the 100 mmHg this was reduced to 
2.2 % and 7.6%, respectively. 
Since then, the technology has improved and the software programming has 
advanced. A more recent evaluation of the three pressure mapping systems (Xsensor®, 
FSA® and Tekscan®) was carried out by Ferguson-Pell et al. [58, 59]. They observed a 
hysteresis of less than 5% for the FSA® and the Xsensor® with a reproducibility of less 
than 4% when tested at 100 and 150 mmHg. The Tekscan® showed a significantly higher 
hysteresis (17.3% at 100 mmHg). The stability (1.8%) of the FSA® was also better at 100 
mmHg than that of the Tekscan®, which remained at 20%. The stability of the Xsensor® 
was 2.8%. The possible explanation for this, according the investigators, was the fact that 
calibration was carried out with the large air bladder of the FSA® calibration rig. When the 
whole procedure was carried out with a smaller air bladder, the Tekscan® sensor showed a 
much better performance. Unfortunately, they did not present the results of this 
investigation.  
Another important sensor property when measuring the pressure at the interface of 
the body and the mattress is the flexibility of the sensor [60]. Inflexible sensors cause a 
“hammock” effect by preventing the body from sinking in the mattress, thus not following 
the contour of the body at a specific location. Under these circumstances, the sensor is 
“carrying” the body and not the mattress. The thickness of the sensor also influences the 
reliability of the pressure reading. Thick sensors can act as a ”pebble in your shoe” creating 
an “unrealistic” high pressure compared with that in the absence of that sensor. In this 
respect, Ferguson- Pell [60] advised a maximum sensor thickness of 0.5 mm. The maximum 
diameter together with the thickness of the sensor is also important. Large inflated sensors  
may act as an additional mattress and change the interface between the body and the 
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mattress [61]. Ferguson-Pell [60] suggested a diameter of 14 mm for the sensors for measuring 
the peak pressure at specific sites. 
Generally speaking, placing a sensor at the interface of the body and the mattress 
always affects the pressure measurement [62, 63]. The aim is to minimize this influence. 
Reddy and Cochran [20] investigated the influence of the actual sensor at the level of the 
interface pressure. They used 4 sensors (2 electro-pneumatic, 2 piezo-resistive) and placed 
them between two square blocks of soft material in which the top one (polyvinyl chloride) 
represented the body and the bottom one the cushion material. A known pressure was 
applied to the tip of the square blocks. The result was that all sensors produced significantly 
higher readings compared with the pressure that was applied to the blocks. They repeated 
the experiment and measured the interface pressure with the 4 sensors under the human 
thigh and compared this with the subcutaneous pressure measured with a wick catheter in 
the thigh at the same site. They observed that the interface measurements with the two 
pneumatic sensors correlated the best with the subcutaneously measured pressure.  
The TPM III was used for measuring the exerted pressure in the studies described 
in this thesis. This decision was mainly motivated by the fact that Hobson [64] and Goossens 
et al. [65] used the device successfully for measuring the interface pressure in patients 
confined to a wheelchair. Last but not least, the equipment was readily available at the 
hospital. As the sensors were meant for use in a clinical environment, hygiene and easy 
positioning of the sensors in patients were also aspects that worked well in the TPM III. 
The fact that it ran on batteries instead off the main electrical circuit of 220 volt made the 
transfer to the operating rooms possible in order to carry out the measurements there. 
 
Analysis of the interface pressure (IP) measurements 
There are various ways to analyze the measured IP. Much depends on whether the collected 
measurements are needed to assess a current clinical case or for research purposes in which 
case statistical analysis was required. In this thesis, the IP generated on the dermal tissues 
of patients while lying on hospital mattresses was measured. Such measurements are used 
in many other situations for clinical and research purposes, but the methods of analysis are 
often not discussed.  
The maximum IP as the primary outcome parameter in this area of research is used 
in many studies. This use is based on the assumption that the maximum IP is ultimately 
responsible for the development of a PU. Measurements are often carried out at predefined 
body sites such as the sacrum, the heels etc. as these sites are particularly vulnerable for 
developing PUs. In doing so, the maximum IP that is measured reflects the pressure at that 
particular body site and not the whole body.  
The IP measurements at these sites are carried out using a single sensor or a sensor 
array. Using a single sensor may have the disadvantage of not being completely sure of 
measuring at the target site that generates the maximum pressure. Therefore, describing 
where and how the sensor is positioned becomes important for reproducible measurements. 
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Most investigators carry out a number of measurements varying from three to eight using 
single sensors. Repositioning the sensors between the measurements was sometimes carried 
out [53, 66-68]. In most cases an average of several measurements was used for statistical 
analysis [53, 66-73].  
The disadvantage of a single sensor may be overcome by using an array of sensors 
that covers the target area. Two main types of IP measuring devices namely the Mini Texas 
Interface Pressure Evaluator (Mini TIPE) and the TPM (version MKII) are frequently 
mentioned in the literature. The Mini TIPE is a 5.5 x 5.5 inch bladder with 16 inflatable 
sections containing electro-pneumatic sensors. The TPM MKII has 12 sensors with a 
diameter of 20 mm distributed over an area of 105 x 140 mm and positioned in an array of 
3x4 sensors. Positioning the array over the area of interest makes measuring the maximum 
pressure at the particular site more reliable. The method of analysing these values becomes 
important because during a single measurement 16 and 12 IP values are retrospectively 
recorded (frame). Averaging the values disguises the maximum IP at the site of interest [50, 
51]. Using only the maximum value out of each frame seems to be the best way for selecting 
the point of maximum IP at the site of interest. A complicating factor in this is that often in 
one volunteer / patient a number of frames are generated within a specific time. This results 
in each sensor having more than one IP value recorded during the time of measurement. 
Analyzing the obtained IP values may be carried out according to the different strategies. 
The simplest way is to take the maximum measured IP value of each frame and use 
the average values for analysis [74]. It is possible that the maximum IP is measured by 
different sensors of the sensor array over the different frames because of the movement of 
the volunteer or the patient. The maximum IP value may also be influenced by unreliable 
sensor measurements due to connection / measurement errors and thus in the end influence 
the average maximum IP values of the frames. Theoretically, the site of interest cannot 
change if the volunteer or the patient and sensor array do not move significantly. Therefore, 
changes in the location of the sensor that measures the maximum IP in an array over the 
different frames may be regarded as variation in the sensitivity of the sensor.  In view of 
this, the most reliable way to locate the sensor with the maximum IP pressure is as follows: 
1. Calculate the mean, maximum and standard deviation of the IP values measured by 
each separate sensor in the array over the number of measured frames 
2. Delete the measurements of the sensors, which measured the maximum IP for that 
particular measuring device over each frame 
3. Locate the sensor with the maximum mean IP (if there are two sensors with the same 
mean IP value, choose the one with the lowest standard deviation) 
The maximum mean IP for each site of interest over which an array is positioned is thus 
established. 
Another method for measuring the IP is with a pressure mapping array [75, 76]. This 
is a mat, like the FSA®, containing a large number of electronic pressure sensors. The IP 
measured with a pressure mapping array is not associated with a specific body site, but 
provides an overview of the measured IP over a large area of the body. The maximum IP 
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that is measured is used for the analysis irrespective of the site of interest.  
Other ways to analyze the measured IP is by calculating the mean pressure at the 
site of interest. More complex methods that were studied involved the calculation of the 
tissue deformation index [77], various pressure indexes [62, 78], the pressure impulse [79] and 
the pressure relief index [80]. The pressure relief index is often used for comparing different 
mattresses that operate according an alternating working principle.  
 
 
1.3 Risk assessment for developing a PU 
 
The tolerance of dermal tissues to withstand the adverse effects of the exerted pressure 
ultimately determines the speed with which a PU develops. The “incubation period” (the 
period between the moment pressure is exerted on the tissues and the moment the PU grade 
I is visible) in patients in whom the dermal tissues are healthier is longer than that in 
patients whose dermal tissues are more susceptible under the same pressure. Risk 
assessment tools have been developed specifically in order to assess the tolerance of the 
dermal tissues for the development of a PU. These tools consist of a large number of factors 
that are subdivided into levels of severity, if present, increases the risk of developing a PU. 
The purpose of the risk assessment tools is to determine the level of risk a patient has for 
developing a PU at any time during hospitalization [81].   
Gosnell [82] reported 126 items that were already identified as risk factors in 
different risk assessment scales. However, it is impractical to create a risk assessment tool 
consisting of all 126 items. The first PU risk assessment tool was developed by Norton, 
Mclaren and Exton-Smith [83]. This tool consisted of 5 items that were subdivided into 4 
levels of severity. Many other risk assessment tools have been developed since then. 
Currently, more than 40 PU risk assessment tools are described in the literature [84]. 
Therefore, we can choose a tool in which the majority of the risk factors are included in 
relation to the population of interest.  
In the literature, these tools are regarded as diagnostic tests and are evaluated 
accordingly. Basically, diagnostic tests provide the result of an investigation and the correct 
diagnoses based on necropsy, biopsy or surgical inspection [85]. A medical example in this 
area is the ability of a liver scan to predict liver pathology compared with a liver biopsy. 
The ability of a scan to detect pathological changes is evaluated by calculating the 
sensitivity (the proportion of true positives that are correctly identified by the tool) and the 
specificity (the proportion of true negatives that are correctly identified by the tool). Based 
on these data the predictive value of both the proportions can be calculated.  
The difference between a PU risk assessment tool and a liver scan is that the latter 
visualises the abnormality that is present without any invasive intervention. Using a PU risk 
assessment tool one can assess the risk of developing a PU in the (near) future. Rightly so, 
Halfens [86] stated that measuring the risk of developing a PU is not the same as the actual 
development of a PU. Using the diagnostic test approach for evaluating the reliability of PU 
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risk assessment tools, every preventive measure taken during the time of hospitalization is 
bypassed. Physicians and nurses always wishfully thought to try and prevent PU 
development by starting preventive measures, especially in patients at risk (according to the 
risk assessment tool) for developing PUs. Thus, the quality of care during the “incubation 
period” may ultimately prevent the PU from developing, although the instrument 
“predicted” the development of a PU. In relation to this, De Laat [81] suggested that a low 
specificity in combination with a high sensitivity possibly indicates that adequate 
preventive measures have been taken. 
As more awareness develops among researchers that risk assessment tools are 
recommended, and should be used, it is essential that these become a part of a more general 
PU prevention program and their findings should be combined with the clinical judgement 
of the nurse [86]. Otherwise, using a risk assessment tool for predicting the development of a 
PU may only be compared with flipping a coin [87]. 
Which other method may be used if using a diagnostic test approach is not the best 
method to evaluate the value of a PU risk assessment tool? Halfens [86] suggested to 
calculate the odds-ratios for each risk score. This would provide the nurses with the 
percentage-wise insight into the risk a patient has for developing a PU. Since the number of 
risk factors will change over time, calculating the odds-ratios does not provide the insight if 
the daily risk for developing a PU increases or decreases over time. As time is an important 
variable in the development of PUs, it would be essential to know the risk the patients have 
for developing a PU upon hospital admission. This may be achieved by using actuarial 
statistical methods like the Kaplan-Meier curves. In order to do so, daily risk assessment 
should be carried out in all patients during a prolonged period. Next to the risk assessment, 
information on the development of a PU and the type and the frequency of preventive 
interventions should also be collected. When the data of between 400 and  500 patients are 
collected (based on an expected prevalence of 25% and confidence interval of 4% or less) 
survival curves may inform the nurses and the physicians on the risk a patient faces for 
developing a PU at any given moment during hospitalization. 
 
Type of PU risk assessment tools  
The majority of the risk assessment tools were not designed with any particular patient 
group in mind. The three most used and tested tools are the Norton [83], the Braden [88] and 
the Waterlow  [89]. All three tools have been tested in different patient groups with varying 
results. 
The patients in the intensive care unit are at increased risk for developing PUs. In a 
Dutch prevalence study, a total of 850 intensive care patients (423 in 1998 and 427 in 1999) 
were assessed. Patients from surgical, medical, cardiac and pediatric intensive care units 
were included. The prevalence of PU in that study was 28.7 %. If the stage I PUs were 
excluded, the prevalence was 18.2 % indicating that one in every  5 patients  had signs of 
damaged dermal tissue [90].  Other studies reported similar results.  Carlson, Kemp and 
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Shott [91] measured  a prevalence of 12.5% in a general intensive care unit with a mixed 
patient group. Marchette, Arnell and Redick [92] reported a prevalence of 40 % in a surgical 
intensive care unit and Fife et al. [93] reported a prevalence of 12.4 %  in a neurological 
intensive care unit. 
 
Specific risk factors in intensive care patients  
A literature review by De Laat [81], highlighted several specific risk factors in intensive care 
patients. The healthcare status of the patient [94] and the APACHE score [91, 95, 96] are 
important parameters upon admission in the intensive care unit. Patients who have a 
compromised health in combination with a high APACHE score are more at risk for 
developing a PU.  
The use of specific groups of medication increases the risk for developing a PU. In 
particular treatment with sympathomimetics [97, 98] and sedatives [91, 94] increases the risk for 
developing a PU. Nutritional status of the intensive care patients is another important 
factor. Since a number of  intensive care patients are in a catabolic state, it is imperative 
that the patients’ anabolic state is restored via an effective feeding regime [92, 95].   
At the level of preventive interventions, it is not always possible to implement the 
PU preventive measures such as turning the patient because of respiratory and 
hemodynamic instability. Therefore, it is essential to use pressure-reducing mattresses. The 
time interval between ordering and installing a pressure-reducing mattress may be critical 
because most of the mattresses are rented. It must be also said that some patients are so 
critical that even changing the type of mattress is not an option. Other important risk factors 
that have been identified in this group of patients through other research are the presence of 
infection [90], the presence of moisture [90], the impaired mobility [90], old age [90, 99], 
prolonged hospitalization  [90], emergency admission [99], number of days without nutrition 
[99] and a low Body Mass Index [93]. 
 
Risk assessment instruments for patients in the intensive care unit 
Solars [100] reported that not all PU risk scales are suitable for patients in the intensive care 
unit. It is essential that such scales should include some of the most important risk factors 
that are mentioned in the paragraph. A number of risk assessment tools for intensive care 
patients are reported in the literature. Jackson and Cubin developed the original[98] and  the 
revised version [101] of  the pressure area risk calculator.  
 Barret [102] suggested that the Waterlow risk assessment tool could best be used for 
patients in the intensive care unit as it included a number of specific risk factors. 
Waterlow’s  idea was not to create a cut-off point with her tool, but to let it function as a 
clinical warning device [103]. The disadvantage of working with a cut-off point is that the 
difference between the high and the low risks is just one point [97, 103]. Therefore, she created 
risk groups based on the number of points calculated with the tool. Three groups were 
identified as low risk, moderate risk and high risk. Since the quality of the basic hospital 
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mattress and the standard prevention strategies for PUs affect the range of the Waterlow 
risk assessment tool namely low, moderate and high risk, the outcome in assessing the 
value of such a tool may vary between hospitals. This was also acknowledged by Braden et 
al. [88]. Therefore, the usefulness of the tool may vary between hospitals and even intensive 
care units. Personally, it acknowledges the opinion that using a risk assessment scale for 
predicting the development of a PU may only be seen as effective if used in combination 
with the clinical judgment of the nurse and  appropriate PU preventive strategies are 
implemented [81, 86]. Taking this into account, we used the Waterlow risk assessment scale in 
the studies described here because it includes most of the factors that are relevant for 
intensive care patients (see Appendix 1). 
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Abstract 
The development of pressure sores is associated with negative patient outcome. Patients in an 
intensive care unit (ICU) are particularly prone to develop pressure sores caused by severe 
illness and being immobile for long periods. A method to prevent the development of pressure 
sores is to use the Waterlow pressure sore risk calculator as a warning device, followed by 
appropriate action.  
A prevalence study on pressure sores was conducted in the ICU, where the following 
variables were noted for each patient admitted: pressure sore stage on the sacrum or the 
buttocks, the Waterlow pressure sore risk score, and the number and the kind of preventive 
measures taken by the nursing staff. 
 The results show that the prevalence of pressure sore varies greatly over the study 
period, that a relationship exists between the pressure sore stage and the risk of developing a 
pressure sore and that nurses are more motivated to take pressure sore precautions based on 
the visible damage due to pressure than by the warning provided by the presence of specific 
risk factors.  
 It is concluded that point prevalence measurement does not give reliable information 
about the pressure sore problem in general in an ICU and that daily measurement of the risk 
of developing pressure sores with the Waterlow pressure sore risk calculator helps nurses to 
indicate specific risk factors and assists them with decisions on the frequency and method of 
pressure sore precautions to be taken. 
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Introduction 
 
Haalboom and Bakker [1] estimated that in The Netherlands on average 6-10% of all 
hospitalized patients suffer from pressure ulcer (PU) problems and that the calculated yearly 
costs of prevention and treating pressure ulcers (PUs) amounted to D.Fl 700,000,000. The 
development of PUs is associated with negative patient effects such as pain, depression, loss 
of function and independence, increased incidence of infection, sepsis, additional surgical 
procedures, all resulting in a prolonged hospital stay [2]. The most vulnerable categories are: 1) 
patients with spinal cord injuries; 2) geriatric patients; 3) hospitalized patients, especially 
those who have undergone orthopedic surgery; and 4) patients who need to be admitted to the 
intensive care unit (ICU) [3]. The last patient group especially has a high risk of developing 
PUs, as ICU patients are often immobile for long periods of time and have an elevated Acute 
Physiology And Chronic Health Evaluation (APACHE) score indicating an increased severity 
of illness [3]. Bergstrom et al. [4] documented that 40% of ICU patients develop PUs. A point 
prevalence study performed in the University hospital of Amsterdam, The Netherlands 
showed that 43% of adult intensive care patients had a PU problem [5].  The workload of the 
nursing staff is increased by 50% once a patient has developed a PU[6], so prevention of PUs 
is of primary importance to the patient and has a secondary economic benefit for the health 
system.  Prevention is the domain of nursing staff [7]. This involves promoting patient care 
that prevents physical, psychological and social deterioration of the patient’s current health 
status. Therefore, planning care that prevents the development of PUs falls directly under the 
responsibility of the nursing staff. 
 The development of a PU is a product of time and pressure in combination with a 
number of predisposing intrinsic and extrinsic factors [6]. Kosiak [8] found that PUs develop 
between 1-5 days after pressure is applied to the skin with a severity depending on the force 
and duration of the applied pressure. In order to prevent PUs it is important that at least one of 
these components is reduced or eliminated. The factors of time and pressure are effectively 
influenced by turning the patient regularly on one side for a short time (< 5 minutes) or 
nursing the patient for longer time on alternate sides or by using special pressure relieving 
mattresses.  
 The influence of the intrinsic and extrinsic factors on the development of PUs is 
more difficult to assess. Over the last 30 years several instruments have been developed in 
order to measure the influence of intrinsic and extrinsic factors on the development of PUs [9], 
of which the Norton Pressure Sore Risk Scale is most well known [10]. For intensive care 
patients this scale is not applicable because it over-predicts the risk of developing an ulcer [11]. 
Barrat [6] suggested that the Waterlow Pressure Sore Risk Scale  [12] (see Appendix 1) is 
suitable for patients in an ICU because it incorporates special risk factors related to this 
patient group. So far no studies have been published in which the Waterlow scale has been 
evaluated for intensive care patients.  
 Therefore, a study was designed to investigate the general size of the PU problem in 
an ICU, the relationship between the Waterlow scale score and the PU stage in ICU patients, 
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and at what different PU stages various PU precautions are taken by the nursing staff.  
 
 
Materials and Methods 
 
An indication of the average situation concerning the development of PUs in an ICU can best 
be performed by a period prevalence study. One investigator screened every possible working 
day all patients between 08:00 and 10:00 o'clock each morning in the surgical ICU during a 
period of 5 months. Each screened patient had been admitted before midnight the previous 
day.  
 The ICU is divided into a short-stay unit and a long-stay unit. The short-stay unit has 
5 beds (mostly postoperative and trauma patients). The average length of stay per patient in 
this unit is 4.5 days. The long-stay unit has 4 beds occupied by patients with severe infections 
needing ventilatory support for more than 5 days. The average length of stay per patient in 
this unit is 12.8 days.  
The following variables were noted:  
a) The risk of developing a PU, scored using the Waterlow scale [12] (see Appendix 1);  
b) The total number of preventive nursing measures used, such as the number of times 
the patient was turned (every 2 to 3 hours for less than 5 minutes), nursed on 
alternate sides (nursed for at least 30 minutes on alternate sides), or mobilized out of 
bed into a chair for at least 30 minutes;  
c) The type of mattress used;  
d) The stage of the PU on the sacral area or the buttocks, classified according to a scale 
used by the Dutch National Pressure Ulcer Advisory Panel [1] (see Appendix 2 for 
the definition). 
  
 In this study, a patient was classified as having a PU when stage II was diagnosed. 
The calculation of the patient's risk of developing a PU was made on the basis of the risk 
factors that were present at some time during the 24 hours before screening. The number of 
points scored was unknown to the intensive care nurses. We specified five risk categories of 
the Waterlow scale in order to make sure that throughout the whole study the same criteria 
were used. In the category Incontinence, fecal incontinence was defined as having two or 
more defecations in bed within 24 hours. Mobility always scored 5 points because intensive 
care patients spend the majority of time in bed. In the category Tissue Malnutrition, cardiac 
failure was scored when the patient was receiving a catecholamine medication. In the 
category Neurological Deficit, paraplegia was scored when paralyzing drugs such as 
Pancuroniumbromide or Vecuroniumbromide were administered to the patient. This item was 
also scored when patients had leg fractures and were therefore immobilized. Major Surgery 
was only scored when it took place within the previous 24 hours.  
 The total number of nursing precautions taken for PUs was calculated on the basis of 
24 hours periods. When a patient remained in the ICU for less than 24 hours the frequency of 
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the PU precautions was extrapolated for 24 hours. The type of mattress that was used was 
noted as a low-air loss type mattress/bed or no special mattress.  
 Statistical analysis was performed with the Pearson Product-moment correlation to 
investigate a relationship between the measured variables and the PU stage. The statistical 
difference between the measured variables was analyzed with the student t-test for two 
independent groups. The level of significance was set at p < 0.05.  
 
 
Results 
 
On 80 days during a period of 18 weeks, all variables were measured for all intensive care 
patients in both the short-stay and the long-stay unit. All measurements were performed (583 
times in total) in 130 patients. On average all measurements were performed 4.5 times in each 
admitted patient in the ICU. Both units on average were screened every two days, so that 
patients who stayed for longer than two days were often screened more than once. Table I lists 
the descriptive data for both units.  
Table I.     Descriptive data for the short-stay and long-stay units during the study 
period (± SD). 
Descriptive data of sample Short-stay unit Long-stay Unit 
Number of measurements 317 266 
Number of patients 109 21 
Age 61.6 (± 16.1) 59.9 (± 17.7) 
Average measurements per patient 2.9  (± 3.1) 12.7 (± 8.9) 
Average Waterlow scale score 17.5 (± 5.9) 16.2 (± 4.7) 
Average number of PU precaution interventions 5.5 (± 1.6) 5.4 (± 1.6) 
 
 Figure 1 gives an overview of the PU prevalence in each week during the five 
months study period in which measurements were done in both units. 
Table II gives the prevalence of the number of days the various PU stages were seen on each 
of the units and the mean Waterlow scale score for the patient with these sores. In the short-
stay unit 13.6% of the measurements (43 patient days) showed a PU stage ≥ II. In the long-
stay unit this was 42.1% (112 patient days). There was a significant correlation between the 
Waterlow scale score and the PU stage in both units (short-stay: r = 0.15; long-stay: r = 0.43). 
In the short stay-unit the mean risk scores of the various PU stages were not always 
statistically related. The difference of the Waterlow scale score between stages 0 and III was 
significant (p = < 0.001). It was noteworthy that stages II and IV were occasionally seen 
during the study. In the long-stay unit a significant difference was found between all 
Waterlow scale scores of the different PU stages except pressure stage II (2 measurements). 
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Figure 1. Prevalence of PUs in the short- and long-stay surgical intensive care units 
 
Table II      An overview of the number of measurements for each PU stage with the 
mean PU risk score (± SD) on the short- and long-stay units. 
PU stage Number of 
measurements 
(short-stay) 
Waterlow scale 
score  
(short-stay) 
Number of 
measurements 
(long-stay) 
Waterlow scale 
score 
(long-stay) 
Grade 0 233 16.5 (± 5.8) 
(+) 
139 14.3 (± 3.8) 
(*)(**)(***) 
Grade 1 41 18.4 (± 6.1) 15 16.1 (± 4.0) 
(****) 
Grade 2 8 13.9 (± 4.8) 
(++) 
2 21.5 (± 5.5) 
(*) 
Grade 2 33 20.2 (± 6.1) 
(+) (++) 
68 18.1 (± 5.1) 
(**) 
Grade 4 2 14.5 (± 2.5) 42 19.1 (± 3.9) 
(***)(****) 
(+) p = 0.001; (++) p = 0.012(*); p = 0.009; (**) p = 0.000; (***) p = 0.000; (****) p = 0.015 
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 The frequency and the sort of PU precautions is shown in Figure 2. No distinction 
was made between the data collected in the short- or the long-stay units as these PU 
precautions were carried out by the same nursing staff who worked in both units. The 
statistically significant differences between the PU stages and the frequency of the PU 
precautions taken are shown in Table III. There was a significant negative correlation (r = - 
0.30) between the PU stage and turning the patient every 2 - 3 hours and a positive correlation 
between the PU stage and turning on alternate sides (r = 0.28). A significant positive 
correlation (r = 0.53) was also found between the total number of precautions and the number 
of times of nursing on alternate sides. This indicates that the increase in the total number of 
precautions taken was mostly caused by an increase in the number of times a patient was 
nursed on alternate sides.  
 In both units special beds were only used when a patient was diagnosed as having a 
PU of stage III or IV and it was impossible to nurse the patient on alternate sides. The 
correlation between the PU stage and the use of a special bed was statistically significant (r = 
0.60).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Mean frequency of precautions taken at various PU stages 
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Table III.     An overview of the statistically significant differences (p < 0.05) 
between the frequencies of the PU precautions taken by the nursing staff at the 
various PU stages. (Turning = Turning the patient every three hours; NAS = 
Nursing the patient on Alternate Sides; MOB = Mobilizing the patient Out of Bed) 
 Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 
Stage 0   NAS Turning 
NAS 
Turning 
NAS 
Stage 1   MOB Turning Turning 
NAS 
Stage 2 NAS MOB  
 
 MOB 
Stage 3 Turning 
NAS 
Turning   MOB 
Stage 4 Turning 
NAS 
Turning 
NAS 
MOB MOB  
 
Discussion 
 
A method of measuring the occurrence of PUs in an ICU is to perform a prevalence study [13]. 
Prevalence can be defined as: “The number of cases in a population at a particular point in 
time (point prevalence) or during a specific period (period prevalence)” [14]. There is limited 
knowledge on the prevalence of PUs in intensive care patients. The reason why prevalence 
studies have not been carried out in this category of patients may have to do with the opinion 
that PUs are an indication of "bad nursing" [15]. A point prevalence study may not be the 
optimum method of PU research in an ICU unit because of the limited number of beds (8-15 
beds) and it is a transition unit. The percentage of patients who have a PU problem at one 
moment in time does not therefore reflect the general extent of the problem. With people 
moving in and out every day, the percentage of patients with a PU varies from day to day. Our 
results show (Figure 1) that the percentage of PUs varies significantly over the weeks. 
Variation in prevalence was also found by Dealey [15] during three different point prevalence 
studies. In order to achieve an accurate indication of the occurrence of PUs, it would be better 
to perform frequent point prevalence surveys (for example one day a week) or a period 
prevalence study over a longer period in these units.  
 The prevalence of PUs > grade I in the short-stay unit was lower than that in the 
long-stay unit. The prevalence (13.6%) in the short-stay unit, in terms of percentage of 
measurements which revealed a PU ≥ stage II, may be influenced by the fact that patients on 
the average stayed for only 4.5 days before returning to the ward. The long-stay unit had a 
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prevalence of (42.1%). Patients in this unit on average stayed for 12.8 days. These results 
indicated that the risk of developing a PU increases when patients have to stay longer in the 
ICU. 
 Whether the Waterlow scale can be effectively used to measure the risk that the 
patients have of developing a PU cannot be stated definitely. Waterlow [12] suggested that the 
total Waterlow scale score may consist of all Waterlow scale criteria that are present in the 
patient. This can cause a large variation in the number of scoring points in each patient 
between the measurement days. To overcome this in this study the procedure was changed so 
that out of each category only one criterion was selected and if two or more criteria were 
applicable the one with the highest score was chosen. To date there have been a limited 
number of studies in which the Waterlow scale was compared with the PU risk scales such as 
the Norton Pressure Sore Risk Scale. Hamilton [16] cited three studies, but none of these were 
performed in an ICU. The studies showed that generally the Waterlow scale was highly 
sensitive in predicting the risk of PUs compared with the Norton Pressure Sore Risk Scale ,[16] 
but often at the expense of gross over-prediction [17]. At present no results are available for the 
sensitivity and the specificity of the Waterlow scale used in an intensive care setting.  
 To our knowledge there have been no studies that mentioned the number and the 
type of PU precautions that are carried out in the evaluation of a PU risk scale. This is 
important because PU precautions influence the development of PUs and influence the 
accuracy of the used PU risk scale [15]. In this study PU prevention precautions were carried 
out every 4 - 5 hours. When PUs developed to a more visible stage (> stage I), the nursing 
staff increased the frequency of nursing the patients on alternate sides without increasing the 
total number of precautions. This suggested that the nurses were motivated to carry out a 
more effective PU precaution (nursing on alternate sides) on the basis of visible PU than on 
the basis of the number of PU risk factors that are present in the patient when PU stage is less 
visible. This feature can be explained by the nature of work carried out by the intensive care 
nurses. In general, they act on what they see or monitor. No intensive care nurse will 
administer a dopamine infusion as a preventive intervention. The beginning of a PU is often 
an invisible process in the tissues of the risk areas. Daily monitoring of intrinsic and extrinsic 
factors by intensive care nurses with the Waterlow scale may help them to identify patients 
who are at risk of developing PUs. Further study is needed to determine if combining specific 
Waterlow scale scores with a special kind and frequency of preventive measures may prevent 
PUs.  
 In general, the results of this study provide enough reason for daily registration of the 
PU stage, measuring the risk of PUs with the Waterlow scale and recording daily the number 
and the type of PU precautions taken by the nursing staff. The Waterlow scale score may be 
used to plan the frequency of PU preventive measures to be taken by the nursing staff. A 
further validation study of the Waterlow scale is merited, on the basis of the results of this 
study.  
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Abstract 
 
Objective: To investigate the prevalence of PU in intensive care units (ICU) in 4 European 
countries. Secondly, to investigate which organizational and clinical strategies are used in 
those countries to prevent the development of PU in intensive care patients. 
 
Method: A questionnaire was distributed among the ICUs in Denmark, Italy, Germany and 
The Netherlands. Part 1 of the questionnaire was devoted to questions on the organization 
in relation to the development of PU. Part 2 of the questionnaire was devoted to questions 
on the risk, the presence and the prevention strategies followed for each patient in the ICU. 
 
Results: A total of 299 patients in 44 ICUs were investigated. A special protocol in relation 
to preventing the development of PU was used in 71% of the ICUs and 41% had a specialist 
nurse, who was appointed for this task, working within the unit. Forty-three percent of the 
units used the Norton scale to assess the risk of PU development. Twenty-seven percent of 
the units used no risk assessment scale, but used their own clinical judgment in assessing 
the risk of PU development in patients. The commonly observed risk factors were a 
decreased mobility and activity, an increased sensitivity and the use of vasoactive 
medication. 
Twenty-seven percent of the 299 patients had a stage II or higher PU. This varied 
between the countries from 4%-49%. Eighty percent of the patients who ran a high risk of 
developing a PU used a special support mattress. In one country, 36% of the patients with a 
PU used no special support mattress.  
 
Discussion: The development of a PU is a complication that occurred frequently in the 
ICUs that participated in this study. The prevalence of PUs varied considerably between the 
countries and the various ICUs. The PU prevention strategies also varied between the 
countries and the participating ICUs. Standardization in using risk assessment scales, 
preventive interventions and the use of a special mattress is strongly recommended. The 
European PU Advisory Panel (EPUAP) in collaboration with the European Federation of 
Critical Care Nursing associations (EFCCNa) and the European Society of Intensive Care 
Medicine (ESICM) may all play in important role in developing and implementing such a 
protocol in the ICUs in Europe. 
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Introduction 
 
Preventing the development of a pressure ulcer (PU) is an important aspect of the care 
provided by nurses and physicians. Besides being a very painful and uncomfortable 
complication, pressure ulcers (PUs) also affect nursing by increasing the workload per 
patient by 50% [1]. Furthermore, it is a very costly healthcare problem. In the Netherlands 
alone, it is estimated that approximately 350 million Euros are spent each year on the 
prevention and the treatment of PUs [2]. In another study, the cost of treating a PU per 
patient was calculated to be between 5,500 and 45,000 Euros [3]. Although prevention is 
‘treating’ something that is not yet there, it is still the best and the cheapest option 
compared with the costs of treating a PU [4]. 
In general, there are three groups of patients who run a particularly high risk of 
developing a PU. Besides patients with spinal cord injuries or geriatric patients, patients in 
an intensive care unit (ICU) are particularly prone to developing PUs. Jiricka et al. [5] 
reported that 25% of patients developed a PU of higher than stage II during their stay in the 
ICU. If PUs of stage I were included, the percentage of patients who developed a PU 
increased to 56% [5]. In a more recent study, Fifi et al. [6] reported that the incidence of PUs 
(stage II or higher) was 12.4% in patients in the ICU. In another study, the incidence of PUs 
(stage II or higher) was noted to be 7.9% among 594 surgical ICU patients [7]. These results 
demonstrate the large differences in the incidence between different ICUs. This may be 
caused not only by the fact that different groups of patients were included in those studies, 
but also due to the differences in the care of the patients. This last issue is difficult to 
discuss among nurses because in the past, the development of PUs was often associated 
with poor basic patient care [8]. Nowadays, however, the problem of PUs in most 
institutions is regarded as a multifactorial, multidisciplinary problem that requires a 
multidisciplinary approach for solution. The influence of the European PU Advisory Panel 
(EPUAP) may have contributed to this change in perception as this organization includes 
physicians, nurses, technicians and scientists.  
 
PU risk assessment scales 
There is a variety of PU risk assessment scales, which are used in ICU patients to quantify 
the level of risk (low, medium, high and extremely high). These may help ICU nurses in an 
early identification of patients needing preventive intervention to stop the development or 
worsening of a PU. Different risk assessment scales have been used by different 
investigators. For example, the Braden risk assessment scale was used by Fifi et al. [6], 
Carlson et al. [9] and Jiricka et al. [5], where as Weststrate et al. [7] used the Waterlow risk 
assessment scale, and Jackson [10] used the Jackson/Cubbin pressure area risk calculator. It 
is important to realize that these assessment scales are not predictive instruments, as they 
are unable to predict the development of a PU, irrespective of what the intensive care nurse 
does to prevent it. Instead, these scales provide a clinical indication of the risk a patient has 
of developing a PU if no preventive interventions are implemented [11].  
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Risk factors 
Several studies have identified risk factors for PUs, which are particularly associated with 
ICU patients. Batson et al. [12] identified four highly significant, critical care-related factors: 
noradrenaline infusions, adrenaline infusions, restrictive movement (due to traction, post-
operative pain, intra-aortic balloon pump and hemofiltration), patients who were too 
unstable to turn. In another study, extracorporeal circulation and time on the operating table 
were reported to be significant factors [13], whereas sensory perception of the patient was a 
critical factor in one study [9]. From three national prevalence studies done in the 
Netherlands, Bours et al.[14] observed that the most significant risk factors were: age, day 
since admission, malnutrition, and the three Braden subscales, moisture, sensory perception 
and mobility. Thus, specific risk factors may be identified, though different studies 
emphasized different factors. 
 
Pressure-relieving mattresses 
In the area of critical care, the use of pressure-relieving mattresses is an essential 
component for the prevention of PUs. Patients in ICU can develop a PU within hours 
because of the above mentioned risk factors. The availability and the readiness of special 
support surfaces that relieve pressure and therefore stimulate skin perfusion are essential. 
Having to wait for another 12–24 hours for a special mattress may be detrimental to the 
skin of the intensive care patient [9]. 
 
Prevalence of PUs 
From a European perspective, O’Dea [15] investigated the prevalence of PUs in four 
countries (The Netherlands, Italy, Germany and the U.K.); prevalence ranged from 7–18%. 
At present, there are no studies in which the difference in the prevalence of PU in ICUs in 
different countries has been investigated. As European nations become more integrated and 
work together more closely, knowledge of PU prevention strategies used by the various 
ICUs in Europe may be exchanged to identify the most successful strategies. The 
prevalence of PUs in intensive care patients in ICUs in four European countries and factors 
that could possibly influence the results were investigated in this study. 
 
 
Materials and Methods 
 
A questionnaire, specially developed for this study, was distributed to ICUs in Denmark, 
Germany, Italy and The Netherlands. Part 1 of the questionnaire consisted of questions on 
the organization of the ICU in relation to PU prevention (Table I). Part 2 consisted of 
questions on the risk, the presence and the prevention strategies for each patient in the ICU 
(Table I). 
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Table I.     Study questionnaire provided to ICUs 
Part 1: Questions answered by the nurse manager on organizational issues in relation to 
prevention of PUs in the ICU 
 
1. Presence of a specialized nurse in the unit or in the hospital for advise regarding 
assessment of the risk of PU development and its prevention 
2. Name of PU risk assessment scale 
3. Frequency of PU risk assessment 
4. Presence of a hospital PU prevention and treatment protocol in the unit 
 
Part 2: Patient observations answered by the ICU nurse in relation to PU prevention 
 
1. Demographic data 
2. Risk of PU development according to the PU risk scale used (high, medium or low) 
3. Surgery in the previous 24 hours or more than 24 hours ago 
4. Use of vasoactive medication in the previous 24 hours 
5. Mobility (immobile, changes position sometimes, changes position frequently) 
6. Activity (inactive, on chair, active) 
7. Sensitivity (no reaction to stimuli, limited reaction, normal reaction) 
8. Presence of incontinence and edema 
9. Type of nursing interventions taken to prevent PU development 
10. Type of surface upon which the patient is lying. 
 
 
The nurse managers of the different ICUs were approached by national 
representatives of KCI Medical (Houten, The Netherlands), and asked to participate in the 
study. If participation was agreed, the KCI representative explained the questionnaire to the 
nurse manager and the nursing team. The management of the ICU was asked to choose a 
day in the subsequent week to complete a questionnaire for each patient present on that day 
in the unit at 8.00 a.m. Part 1 of the questionnaire was filled in by the nurse manager and 
part 2 was filled in by the ICU nurse looking after the patient at the time of assessment. 
After completion, of the questionnaire was checked and signed by the nurse manager for 
authenticity and sent to the Dutch office of KCI Medical, where the information was 
entered into a Microsoft Access database. Once all the data had been entered, the data entry 
was checked for accuracy and the data file with the original data was sent to the 
investigators who analyzed the data using the statistical software program SPSS 9.0. 
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Results 
 
Participating ICUs 
A total of 299 patients in 44 ICUs were evaluated between March and June 2000. The 
distribution of the ICUs in the participating countries is shown in Table II. The majority of 
them were general ICUs (n = 29) and coronary care units (n = 8). The remaining ICUs were 
medical (n = 1), neurological (n = 2), surgical (n = 3) and cardiothoracic (n = 1). The 
average number of beds in each ICU was 8.7 (range between 3 and 18). Of all the ICUs, 
71% used a hospital PU prevention and treatment protocol and 61% had a nurse who was 
specialized in the prevention and the treatment of PUs at the hospital. Forty-one percent of 
the units actually had a specialist PU nurse working in the unit. In relation to the use of a 
PU risk assessment scale, the Norton risk assessment scale was used in 43.2%, the 
Waterlow scale in 6.8%, the Braden in 4.5% and the Dutch CBO scale in 4.5% of the ICUs. 
In 27.3% of the ICUs the nurses used their own clinical judgement instead of an existing 
scale to evaluate the patients’ risk of developing a PU. In 9.1% of the ICUs, the nurses used 
their local scale, while 4.5% of the ICUs used another nameless scale. In 25% of the ICUs 
own risk assessment scale was used during every shift and 36% of the ICUs did this daily. 
A risk assessment scale was used by 34% of the ICUs once a week, whereas in 5% of the 
ICU no risk assessment was carried out. 
 
Table II.     Number (No) of participating Intensive care units (ICUs,) total number of 
patients and pressure ulcer (PU) prevalence data per country 
Country No. of participating ICUs No. of patients No. of patients with a PU 
Denmark 3 24 1 
Italy 25 150 21 
Germany 11 99 49 
The Netherlands 5 26 10 
Total 44 299 81 
 
Patients 
A total of 299 patients participated in the study. An overview of the number of patients with 
a PU is shown in Table II, and the demographic data for all patients in the study are shown 
in Table III.  
Of the total number of patients, 27% had a PU of stage II or higher. The 
prevalence of PUs varied between countries; it was 4% in Denmark, 14% in Italy, 49% in 
Germany, and 38% in The Netherlands. At the moment of observation, intensive care 
nurses were asked to classify their patient as having a high, medium or low risk for 
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developing a PU, according to the risk assessment scale used in their ICU. Overall, 150 
Table III.     Demographic data of participating patients (± SD) 
 Female Male 
Age (years) 62 (± 20) 59 (± 18) 
Height (m) 1.63 (± 0.13) 1.74 (± 0.13) 
Weight (kg) 67 (± 22) 76 (± 18) 
Days in ICU 11 (± 23) 17 (± 30) 
 
patients were identified as being at high risk of developing a PU, of whom 31% already had 
a PU. Of the patients (n = 88), with a medium risk of developing a PU 27% already had a 
PU. Of the patients (n = 29) at low risk of developing a PU, 3% had a PU. In Germany, 
among high-risk patients with no PUs, 63% were being given preventive treatment with a 
special mattress; in the other countries in the study, this figure was 85%. The risk level for 
PUs per country is shown in Table IV. 
 
Table IV.     A breakdown of the number of patients (n), their levels of risk (high, 
medium, low) and the percentage of patients in each risk level who had a pressure 
ulcer (PU) (n-PU (%) per country 
 Denmark Germany Italy The Netherlands 
Level of risk n n-PU 
%) 
n n-PU (%) n n-PU 
(%) 
n n-PU (%) 
High 16 1(6) 37 21(57) 79 15(19) 18 10(56) 
Medium 6 0 43 21(49) 34 3(9) 5 0 
Low 1 0 6 1(17) 19 0 3 0 
Missing data 1 0 13 6(46) 18 3(17) 0 0 
Total of patients 24  99  150  26  
 
Risk factors 
The following risk factors for developing a PU were observed in this study: mobility, 
activity, sensitivity, vasoactive medication, incontinence, edema, surgery less than 24 hours 
ago and surgery more than 24 hours ago. The frequency with which these factors were 
present in all patients and specifically in those patients who had developed a PU are shown 
in Table V.  
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Table V.     Number of patients without a pressure ulcer (n-PU), but with a specific 
risk factor at the time of assessment (n-total) compared to the number of patients with 
a PU in whom a specific risk factor is present. 
 Denmark Germany Italy The Netherlands 
Risk factor n-
total 
n-PU n-total n-PU n-total n-PU n-total n-PU 
Immobility 13 1 63 39 77 13 20 7 
Inactive 16 1 67 39 113 16 24 8 
Limited (or no reaction) 14 1 83 43 90 14 19 6 
Vasoactive medication 10 1 53 29 76 10 10 4 
Incontinence 12 1 73 42 94 15 6 2 
Edema 8 1 1 1 27 7 12 7 
Surgery < 24 hours 7 1 20 9 32 0 5 2 
Surgery > 24 hours  17 1 55 28 73 16 14 5 
 
Support mattress 
According to the risk level of developing a PU, the results indicated that a special support 
mattress was used by 80% of the high risk patients, 64% of the medium risk patients and 
54% of the low risk patients. The frequency of choice for each type of commonly used 
support mattresses for patients with and without a PU is shown in Table VI. 
 
Table VI.     Number of patients (with or without a pressure ulcer (PU)) using each 
mattress type at the time of assessment, and the number of patients with a PU ( ) 
using each type of mattress 
Type of mattress Denmark Germany Italy The Netherlands 
Hospital mattress 6 39 (14) 31 (1) 3 
Foam mattress 3 22 (13) 6 (1) - 
Air mattress - - 5 (2) 7 (4) 
Water mattress 8 - 23 (1) - 
Alternating mattress - 10 (5) 14 (2) 4 
Low-air-loss mattress - 24 (16) 44 (9) 10 (5) 
Rotation bed - - 11 (5) 2 (1) 
Other 7 (1) 4 (1) 16 - 
Total no. of patients 24 (1) 99 (49) 150 (21) 26 (10) 
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Discussion 
 
The number of ICUs that participated in the study in each country varied significantly. An 
explanation for this variance may be that some ICUs that were approached refused to 
participate because of the additional work involved in collecting the data or because they 
did not want to make their prevalence data public. Whatever the reason, the only way to 
improve the standard care in this area is to share the information on the prevalence and the 
incidence for the PU prevention and treatment protocols. The importance of this was seen 
in a number of articles that discussed different methods for improving the care of patients at 
risk of PU development [16-19]. 
 
Need for standardization 
The variety of risk assessment scales implies that there is no general consensus among the 
intensive care nursing organizations on which risk assessment scale to use for intensive care 
patients. Barrett suggested using the Waterlow scale for the assessment of risk of PU 
development in intensive care patients [1]. At present, only Weststrate et al. [7] have 
evaluated the Waterlow scale in  this patient group. Other investigators found various cut-
off levels when they validated the Braden PU risk assessment scale for intensive care 
patients [5, 6]. Braden and Bergstrom [20] suggested that often these differences may be 
related to the influence of external factors such as staffing ratios. However, regardless of 
which risk assessment scale is chosen, the scale needs to be validated based on the patients 
and working conditions in the ICU. Besides validation, standardization in using a particular 
PU risk assessment scale for ICU patients would make comparison and analysis possible 
between the different PU prevention programs used in different ICUs.  
 
Frequency of risk assessment 
The frequency of assessment depends on the type of patients. The more rapid the changes 
are likely to occur in a patient’s condition, the more frequently the risk assessment should 
be carried out. For ICUs, it was recommended that risk assessment should be carried out 
once every 24 hours [20]. This is endorsed by the fact that the majority of patients, regardless 
of whether they already had a PU, could be classified as being at high risk of developing a 
PU (Table IV). Despite this finding, 34% of the ICUs only assessed the patients’ risk once a 
week. This period is far too long as nursing awareness lags behind the actual status of most 
patients, and in some cases, PUs can develop in only a few hours. It is striking that there 
was a large amount of missing data concerning the calculated risk levels for Germany and 
Italy. It is possible that the risk assessment scale used for these patients did not discriminate 
between different risk levels.  
 
Risk factors 
Immobility, inactivity, impaired sensitivity, vasoactive medication and incontinence were 
observed to be the most important risk factors for the development of a PU in this study. 
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Impaired sensitivity was also found by Carlson et al. [9]. In other studies, these risk factors 
including inactivity and the use of vasoactive medication[12], immobility [21], and 
incontinence[22] were noted to be important for a PU development. 
 
Prevalence rates 
The PU prevalence rates (stage II or higher) for the various countries varied significantly. 
The highest figure of prevalence was 49% in ICUs in Germany. In an earlier study, O’Dea 
[15] reported that Germany had a PU prevalence of 4%  among hospital patients, but this 
study was conducted in general patients and not only in intensive care patients. The 
prevalence of PU in ICUs in Europe has not been compared thus far. Prevalence studies are 
difficult to compare with incidence studies because they include every patient with a new 
PU within a specific time frame [23]. Prevalence studies take a ‘snapshot’ at one moment in 
time. Another reason why comparison is difficult is that some studies include stage I (non-
blanching erythema) as being a PU, although this stage is reversible. In our study, we 
excluded this stage because it was shown that nurses do not always know the difference 
between blanching and non-blanching erythema. At PU stages II, III and IV, the skin is 
broken and so they are easier to classify accurately [24] than stage I.  
 
Type of support mattress 
The use of support mattresses is interesting. The largest number of different types of 
mattresses was used in Italy, whereas it was the smallest in Germany. Besides the low-air-
loss and alternating mattress, the water mattress was frequently used. Compared with a 
standard mattress, Cullum et al. [25] reported that the water mattress prevented the 
development of a PU more effectively, but there was no significant difference between a 
water mattress and an alternating mattress. Furthermore, there was no evidence that low-
air-loss mattresses are more effective than alternating mattresses in preventing PUs, 
although these was only limited evidence for a reduced incidence of PUs in ICU patients 
with low-air-loss mattresses. In order to decide which kind of mattress (low air-loss or 
alternating) is more effective in preventing PUs in intensive care patients, ICUs should 
standardize the type of mattresses used to one of these two alternatives. Italy and The 
Netherlands were the only countries where rotation beds are used. Primarily, rotation beds 
have been used in (ventilated) patients to prevent further pulmonary complications [26]. 
However, rotation beds have a secondary effect in preventing the development of a PU. The 
original, primary reason for using such expensive beds was not given in that study. 
It was found that Germany had the highest proportion of at-risk patients (high and 
medium). The finding that care providers waited too long before installing a special 
mattress for high and medium risk patients may be the reason why Germany had the highest 
prevalence of PUs in ICUs in this study. As the average ‘incubation period’ of a PU is 4 
days [27]. It is critical that some sort of pressure relief is installed as soon as a patient has an 
increased risk (medium or high) of developing PUs. Compared to other countries, Germany 
had the lowest proportion of high-risk patients using a special mattress. 
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Conclusions 
 
It is evident that the prevalence of PUs in intensive care patients in different ICUs varies 
between the different European countries, and in relation to risk assessment scales and type 
of mattresses used. Protocols provide professional guidance regarding procedures to follow 
when a PU is likely to occur in a patient. Apparently some protocols are more effective than 
others in preventing PUs. In order to prevent the development of PUs in intensive care 
patients in ICUs in Europe, it is essential that protocols for the prevention are standardized 
for ICU patients. The EPUAP can play an important role in developing such a protocol 
because they have an extensive network of clinical healthcare professionals. For successful 
implementation of such a protocol, collaboration with other European professional societies 
such as the European Federation of Critical Care Nursing associations (EFCCNa) and the 
European Society of Intensive Care Medicine (ESICM) is critical. Together with monthly 
prevalence studies at each ICU, successful strategies can be developed and further 
implemented in all ICUs in Europe. 
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Abstract 
 
Objective: Evaluation of whether the Waterlow pressure ulcer risk (PUR) scale (see 
Appendix 1) has prognostic significance for intensive care patients. 
 
Design: A prospective study. 
 
Setting: The surgical intensive care unit (SICU) of the Erasmus MC, University Medical 
Center, Rotterdam. 
 
Patients: A total of 594 patients who had been admitted to the SICU during the year 1994 
were investigated.  
 
Methods and Results: Each patient was assessed daily with respect to their Waterlow PUR 
score and the development of pressure ulcers (PUs) in the sacral region. Actuarial statistical 
methods were used to analyze the predictive value of the risk score. When a patient had a 
Waterlow scale score > 25 on admission, the risk of developing a PU was significantly 
increased compared with patients with a Waterlow PUR score < 25. After admission, the 
daily Waterlow PUR scores obtained were significantly associated with the risk of 
developing a PU. For each additional point this risk increased by 23% (95% confidence 
interval 17% - 28%). 
 
Conclusions: The Waterlow scale provides the medical and nursing staff with reliable 
information on the risk patients run to develop a PU at an early stage. 
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Introduction 
 
Both time and pressure [1, 2] in combination with several predisposing intrinsic and extrinsic 
factors are responsible for patients developing pressure ulcers (PUs) [3]. Generally, PUs are 
related to a negative patient outcome associated with pain, depression, loss of function and 
independence, increased incidence of infection, sepsis and additional surgical interventions 
which all result in a prolonged hospital stay [4]. Those particularly prone to develop PUs 
are: 1) patients with spinal cord injuries; 2) geriatric patients; 3) patients who have 
undergone major orthopedic surgery; and 4) patients who are to be admitted to the intensive 
care unit (ICU) [5].  
 Pressure ulcers not only affect the patients but also increase the nursing workload 
by 50% once a patient has developed a PU [3]. The yearly costs of prevention and treatment 
of PUs in The Netherlands is estimated to be 350 million Euros [6]. Therefore, prevention of 
PUs is not only beneficial to the patient, but also has a secondary economical benefit for the 
health system.  
 On average 6-10% of all hospitalized patients in The Netherlands suffer from a PU 
[6]. In order to determine which patient has an increased risk of developing a PU, PU risk 
scales have been developed to measure the influence of intrinsic factors on the development 
of PUs [7]. Several of those scales have been used over the last 30 years. The Norton Scale 
is probably the most known [8]. 
 The working of these scales is based on the summation of a specific number of 
points for each intrinsic factor that is present in the patient indicating the level of the risk a 
patient has of developing a PU. Most scales make use of a threshold score. When a patient 
reaches this threshold then the development of a PU is likely in the near future. Waterlow 
stressed that scales are not designed to predict the inevitable development of PUs, but 
should mainly serve as a clinical warning device [9]. The primary purpose of such a scale is 
to provide the physicians and the nurses with information which indicates the risk a patient 
has of developing a PU [10]. This information may be helpful in deciding which appropriate 
preventive measures need to be taken.  
 A scale widely used in the United Kingdom is the Waterlow Pressure Sore Risk 
Scale (Waterlow scale) (Appendix I) [9]. This scale contains a number of intrinsic factors, 
which makes it suitable for a variety of clinical settings [11]. In the Waterlow scale, the risk 
of developing PUs varies across a gradient of "no risk" to "very high risk" and uses 
categories to identify these risks. Hunt [12] suggested that for the clinical use of a scale this 
may be a more suitable approach than using a single threshold score to identify patients at 
risk. 
 On the basis of an earlier study [13] and the indication that the Waterlow scale is 
suitable in a variety of clinical settings, we designed a study to evaluate whether the 
Waterlow scale was of clinical value when used in the special group of intensive care 
patients.  
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Patients and Methods 
 
A prospective study was performed in all patients who were admitted to the surgical 
intensive care unit (SICU) of the University Hospital Rotterdam in 1994. They were 
assessed with respect to their PU risk score and the development of PUs in the sacral 
region. Patients were excluded from the study if their stay in the ICU was less than 24 
hours or had a stage II PU on admission (n = 31) or used a special mattress on admission 
other than the standard hospital mattress (n = 34). The PU risk scale developed by 
Waterlow was used to measure the risk of PUs [11]. This scale uses risk categories in order 
to determine the risk patients have of developing a PU. It has been suggested that the 
Waterlow scale is one of the most appropriate instruments for use in intensive care patients 
[3].  
 The various elements in the sections of the Waterlow scale score (Appendix 1) 
were assessed daily by the nurses night staff for the previous 24 hours and registered in the 
hospital information system. The nurses were unaware of the actual score or any previous 
score. The highest score was recorded from each section of the Waterlow scale. Some of 
the elements of the Waterlow scale sections were redefined to prevent dual explanation. In 
the section Mobility, all patients scored 5 points. In the section Tissue Malnutrition, cardiac 
failure was scored when the patient used catecholamines. In the section Neurological 
deficit, paraplegia was scored when the patient was on muscle relaxants. This item was also 
scored when patients had leg fracture and were thus immobilized. Lesions of the skin were 
staged according to the staging of PUs developed by the European PU Advisory Panel. 
Stage 0: normal skin; Stage I: non-blanchable erythema of skin; Stage II: formation of 
blisters; Stage III: superficial (sub)cutaneous necrosis; Stage IV: deep subcutaneous 
necrosis. (see Appendix II). From stage II onwards skin lesions were considered to be PUs. 
 If the condition of the patient allowed, the following precautions to prevent the 
development of PUs were carried out by the nurses: Turning the patient every three hours 
for a short time (< 5 minutes) onto one side nursing the patient for at least 1 hour 
continuously on alternate sides and mobilizing the patient out of bed in order to stand for a 
few minutes next to the bed or sit for 15 minutes in a chair.  
 These measures were performed according to the hospital protocol. Barcodes were 
used for registration. Each element of the Waterlow scale was linked with a barcode. Each 
computer that was connected to the hospital information system had a light pencil which 
could read the barcodes connected to it. On the average, it took a nurse between 30 and 60 
seconds to record a scale score for one patient. The advantage of this registration method 
was that all information was stored in a central computer by the nurse who carried out the 
scoring. In order to analyze the information, it was transferred to a personal computer. 
For statistical analysis continuous outcomes between groups were compared using 
the Mann-Whitney test and percentages were compared using the Chi-square test. The risk 
of developing PUs increased with length of stay in the ICU. To adjust the number of days 
the patients had been admitted to the ICU, actuarial methods (Kaplan -Meier curves, 
Chapter  4 
65 
logrank-tests) were used to evaluate and compare the risk of developing PUs. To asses the 
current value of the Waterlow scale score and the rate of developing a PU, Cox-regression, 
with the daily Waterlow scale score as time dependent covariate was used [14]. The limit of 
significance was considered to be p = .05 or less (two sided). 
 
 
Results 
 
After the exclusion criteria were applied, 594 of the in total 686 admitted patients were 
included in this study. The studied group consisted of 389 men and 205 women with a 
mean age of 58.8 years (range 9 to 96 years). The mean stay in the ICU was 6.3 days (range 
2 to 183 days). Of all patients, 47 (7.9 %) of the 594 patients developed a PU. The 
characteristics of patients who did and did not develop PUs are given in Table I.  All 
characteristics, except age differed significantly between the groups. The number of 
patients with various Waterlow scale score characteristics present on admission is given in 
Table II. 
 
 
Table I.     Baseline characteristics of all included patients. Data are given as 
median  (interquartile ranges) or percentages. 
 
PU: no 
(N = 547) 
PU: yes 
(N = 47) 
Level of 
significance 
Age (years) 62.7 (48.8 – 70.9) 68.9 (54.6 – 75.9) Not significant 
Male/Female 67% / 33% 49% / 51% p = 0.001 
Duration of stay in the ICU 
(days) 
3 (2 – 5) 19 (8 –  33) p < 0.001 
Waterlow scale score at baseline 17 (14 – 21) 20 (16 – 26) p = 0.001 
Turning patient (< 5 min)/24 hrs 2.5 (1.5 – 3.5) 4.2 (3.7 - 5.0) p < 0.001 
Nursing patient on alternate 
sides/24 hrs 
0.3 (0.0 – 0.3) 0.6 (0.0 – 0.7) p = 0.003 
Mobilizing patient out of bed/24 
hrs 
0.4 (0.0 – 0.7) 0.1 (0.0 – 0.1) p < 0.001 
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Table II.     The Waterlow scale. The * column gives the number of patients 
having the characteristics on the day of ICU admission  
 
Build/weight for height * Sex /Age * 
Average  471 Male 389 
Above average 71 Female  205 
Obese  27 0 - 14  5 
Below average  25 14-49  148 
Continence  50-64  164 
Completely catheterised  550 65-74  175 
Occasional incontinence  9 75-80  68 
Catheter and fecal incontinence  31 81 +  5 
Incontinent for feces and urine  4 Appetite  
Skin type visual risk areas  Average  91 
Healthy  521 Poor  27 
Tissue paper, dry, clammy, ede-
matous  
59 NGa tubes and fluids only  51 
Discolored  12 NBMb/anorexia   425 
Broken spot  2 Tissue Malnutrition  
Mobility  Terminal cachexia 0 
Fully mobile  0 Cardiac failure or peripheral 
vascular disease  
145 
Restless or fidgety 0 Anemia 54 
Apathic  0 Smoking ND 
Restricted  0 Neurological deficit  
Inert/traction  0 Diabetes, MSc, CVAd; 
Motor/sensory paraplegia 
72 
Chairbound/complete bedrest  594 Major surgery/trauma  
Medication  Orthopedic: below the waist;or 
spinal cord; operation time  > 2 
hours  
364 
Cytotoxics, high doses steroids, anti-
inflammatory drugs 
114   
a= nasogastric tube; b= nil by mouth; c= multiple sclerosis; d= central vascular accident 
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 The risk of patients developing a PU according to the number of days they were in 
the ICU is shown in Figure 1 (upper panel). If ICU stay lasted 30 days, this risk would have 
increased to 60%. Patients were grouped according to baseline Waterlow scale score: < 15 
points (n =  165); 15 – 19 points (n = 213); 20 – 24 points (n = 140); � 25 points (n = 76). 
In these groups the numbers of patients developing a PU during their stay in the ICU were 
9, 13, 10 and 15 respectively. The lower panel in Figure 1 shows that when patients have a 
score � 25 on admission, the risk of developing a PU during their stay is significantly 
increased compared with those patients with a score < 25.  
Figure 1. Upper panel: Cumulative percentage (actuarial) of patients developing a PU according to days of ICU 
stay. Numbers along the curve denote the numbers of patients at risk of developing a PU on the indicated days.
Lower panel: Cumulative percentage (actuarial) of patients developing PUs along time. Patients are grouped 
according to Waterlow scale at admission to the ICU. Curve A: < 15 points (n = 165); curve B: 15-19 points (n = 
213); curve C: 20-24 points (n = 140); curve D: � 25 points (n=76). Difference between curve D and curves A, B 
and C: all p < 0.001. 
 The longitudinally obtained Waterlow scale scores are shown in Figure 2. At each 
day of ICU stay, the range which covers 95% of the Waterlow scale scores for those 
patients who did not develop a PU at or before that day, is shown. It can be seen that 
patients who developed a PU on a particular day tended to have higher Waterlow scale 
scores compared with those who did not develop a PU on the same day. Cox-regression 
revealed that the rate of development of PUs increases linearly with an increasing Waterlow 
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scale score. For each additional point of the Waterlow scale score this rate increased by 
23% (p < 0.001, 95% confidence limits: 17% - 28%). Relating both the current score and 
the score on the previous day to the rate of development of PUs, it appeared that the score 
on the previous day did not significantly improve the predictive value of the current score. 
Further analyses showed that as long as the Waterlow scale score continuously remained 
below 15 in the ICU (total: 166 patient days) none of the patients developed a PU.  
Figure 2. Graph of the Waterlow scale score versus the number of days after entry into study.  Solid lines (n = 47) 
represent data of patients who developed a PU. The right end of each solid line represents the score value on the 
day of the occurrence of the PU. The left end shows the score value on the preceding day. The vertical dotted lines 
represent the 5-95 percentile range of the Waterlow scale score for those patients who are still at risk for 
developing a PU at each day, except those who already developed a PU on that day. 
Figure 3 shows the actual risk of developing a PU according to whether or not patients have 
a Waterlow scale score, which exceeded a specific threshold. Curve I demonstrates the risk 
for patients if the Waterlow scale score remained below 20. Curve II shows the risk for 
those had a score between 20 and 25, and curve III shows the risk for patients with a 
Waterlow scale score exceeding 25. The risk increases considerably with increasing cut-off 
level. When patients have exceeded the score of 25, the risk of developing a PU within a 
period of 10 days is 50%. 
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Figure 3. The risk (actuarial) of developing a pressure sore (PU)  
Curve I: As long as patients continuously show a Waterlow scale score below 20 points after admission. 
Curve II: After the first occurrence of at least 20 points but less than 25 points. The time axis represents the 
number of days patients continuously remained within this range. 
Curve III: After the first occurrence of at least 25 points. The number of patients at day 0 for curves I, II and III 
are 378, 206 and 116 respectively. 
Discussion
The most important result of our study is that it produced a PU risk assessment model, 
which can be used as a reliable warning device for intensive care patients in daily practice. 
When the Waterlow scale was developed four risk categories were suggested: No risk (<10 
pnt), at risk (�10 - �14 pnt), high risk (� 15 - �19 pnt) and extra high risk (� 20 pnt) [11].
These risk categories were global and never quantified through research. When we 
quantified the risk categories in our study, on the one hand, we found that as long as the 
patients had a score below 15, they developed no PUs during their stay in the ICU. This 
finding is in contrast to the suggested risk of that category. On the other hand, when 
patients developed a score � 25, the risk of developing a PU during their ICU stay was 
extremely high. This finding has prompted us to place patients having a Waterlow scale 
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score ≥ 25 points for more than 2-3 days on a special bed or mattress that reduces the 
pressure on the skin.  
 Without considering the length of stay in the ICU we found a PU incidence of 
7.9%. Other studies reported incidences varying between 13% and 56% [4, 15-17]. On the  
average between 6% and 10% of the patients admitted in Dutch hospitals develop a PU [6]. 
The moderate risk for the total group of ICU patients in our study is mainly due to the fact 
that most patients had only a short stay in the ICU. At 30 days the risk of developing a PU 
in our study increased to about 60% (Figure 1, top panel). As a result of this study, far more 
attention to PU prevention is given to patients with a prolonged stay in ICU. 
 Our results indicated that the scale score over the last 24 hours is the best indicator 
for the development of a PU in the next 24 hours. As the physical condition of ICU patients 
can change dramatically in a very short period, the risk of developing a PU is influenced 
likewise [17]. This study showed that it is important to assess this risk every day, that both 
the nurses and the physicians must have access to this information and that the day staff 
compares the score in the morning with the scores of the previous days in relation to the 
patient’s present condition. Following this, the kind and frequency of preventive measures 
should be adjusted if necessary. Due to respiratory and hemodynamic instability, patients in 
the ICU often do not tolerate being nursed on alternate sides or even being turned. In these 
cases the only other way to reduce pressure on the affected areas is to use a special 
mattress. 
 Most categories that are incorporated in the Waterlow scale have a confirmed 
influence on the development of PUs. The combination of these categories and the 
weighing of the various category items were based on a study of relevant literature and a 
discussion with other healthcare professionals. This process was confirmed in a clinical 
study in which 650 patients from different types of wards participated [9]. The scale was 
designed as an instrument to warn care providers about the risk level in patients and not to 
predict whether or not the patient will inevitably develop a PU [18]. The use of this 
evaluation method is therefore different from other scales that calculate the sensitivity and 
the specificity of a threshold score above which a patient will develop a PU. No 
quantitative risk evaluations of the Waterlow scale score regarding the development of PUs 
are available and so far only global evaluations have been made: two in a geriatric patient 
population [19, 20] and one in a community setting [21]. In both the studies, it was reported that 
the Waterlow scale was highly sensitive but the specificity was very low (10% -14%) 
indicating that it over-predicted those at risk of developing a PU [22]. By using actuarial 
statistical methods, as in our study, the results not only indicate a new score range in the 
various risk categories, but also provides insight on the course of the risk in due time. This 
is a valuable contribution because care providers can then determine at which risk level 
financially more expensive PU precautions have to be taken [11, 16].  
 In our study, patients who developed a PU, had a longer ICU stay compared with 
those who did not develop a PU. This was also reported by Jiricka, et al. [4]. Patients who 
developed a PU in our study also had a significantly higher Waterlow scale score on 
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admission. Again other investigators did find the same results, although they used the scale 
developed by Braden [23, 24]. This indicated that the longer a patient stays in an ICU, with an 
increased risk score on admission, the higher the risk he or she has of developing a PU 
despite the fact whether or not the risk score is decreasing. This supports the view that 
when a patient a stays in the ICU, more attention should be given to PU prevention.  
 Patients who developed a PU in our study received significantly more frequent 
short turning episodes (< 5 minutes) and were nursed significantly more on alternate sides. 
These precautions did not prevent the development of PUs. Since nurses were blinded to 
the total PU risk score of each patient they relied on the clinical assessment of the patients’ 
skin as an indicator whether or not to initiate preventive precautions as was also found in an 
earlier study [13]. The results of this study showed that initiating PU preventive precautions 
on the basis of the patients’ skin assessment does not prevent the development of PUs, but 
often only confines the area of damage.  
 The following limitations and drawbacks need to be considered. A possible reason 
why not all patients with an increased risk developed a PU is because the nurses increased 
the number of preventive measures at a very early stage. The influence of such 
interventions in combination with the use of a risk scale is often overlooked in other studies 
evaluating the effectiveness of these scales. Furthermore, different kinds and timing of 
interventions influence the time span between measuring an increased risk of developing a 
PU and the appearance of PU. It is therefore difficult to generalize the results of this study 
to other patient settings due to probable different levels of nurse alertness in taking 
measures against PUs.  
 The results of this study now serve as a model for the management of PU 
prevention in our ICU. The method of evaluation can be used for quantitative risk 
evaluations of any pressure risk model. This study demonstrates that evaluating pressure 
risk models by means of actuarial statistical methods provides the user with much valuable 
information on the development of PUs. 
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Abstract 
 
Background: Although pressure is a critical factor in the development of a pressure ulcer 
(PU), clinical studies addressing the value of this parameter in a patient population are 
unavailable.  
 
Objectives: To examine the “between day” reproducibility of the Tissue Interface Pressure 
(TIP) measurements at the sacrum and the buttocks, measured at an interval of at least 24 
hours in bed rest patients.  
 
Methods: A descriptive, longitudinal study in 76 surgical patients. The TIP was measured 
using the Talley Pressure Monitor III (TPM III). 
 
Results: The main outcome was the Intra-Class Correlation coefficient (ICC) between two 
Peak Interface Pressures (PIP) measured with a time interval of at least 24 hours. The ICC 
Coefficients for assessing the “between day” reproducibility were low (the sacrum: 0.23, 
the right buttock: 0.13 and the left buttock: 0.15).  
 
Conclusion: The TIP measurements at the sacrum and the buttocks vary significantly over 
days in a clinical population. Measurement of TIP under more standardized conditions may 
shed further light on this issue. 
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Introduction 
 
After 45 years of intensive research, the development of pressure ulcers (PUs) is still 
poorly understood and imposes a significant burden on the health care budget. Prevalence 
studies in the Netherlands showed that about 22% of the patients in hospitals and nursing 
homes demonstrated evidence of the negative effects of pressure on the skin. Ten percent 
of these patients progress to develop a wound necessitating treatment by the medical and 
the nursing staff [1]. If these figures are translated into financial burden, approximately 350 
million Euros are spent annually in the Netherlands in order to prevent or treat PUs. 
Although prevention is not “free”, it is still the best option for the patient [2]. 
The phrase “pressure ulcer” suggests that pressure is an essential component in its 
development.  This was first quantified by Kosiak [3] who observed that the magnitude and 
the duration of pressure on the skin are the primary components starting a cascade of 
patho-physiological and biochemical changes, which ultimately lead to the development of 
an ulcer. It is generally accepted that the exerted pressure on the skin inhibits satisfactory 
tissue perfusion, jeopardizing adequate nutrition and oxygenation at cellular level [4]. A PU 
will develop rapidly or slowly depending on which other risk factors are present [5]. If we 
assume that the exerted pressure on the skin by the support surface (Tissue Interface 
Pressure, TIP) is the primary cause of PU development, then this parameter may be used to 
predict PU development. Currently PU risk assessment scales are used for this purpose. 
However, research has shown that these are not optimum [6]  
The reliability of the TIP is assessed by establishing the reproducibility. The 
European Pressure Ulcer Advisory Panel (EPUAP) defined the reproducibility as follows: 
“The variation in analysis outcomes when a calculation is performed on pressure data 
derived from a test subject who has repositioned several times”. Thus, a low reproducibility 
implies a large variation in TIP measurements making the parameter less reliable for 
predicting PU development [7]. Generally three methods of establishing the reproducibility 
of the TIP are cited in the literature. 
The first method is to repeat the measurement without removing the pressure 
sensor or repositioning the patient. In his study Hobson [8] investigated the pressure 
distribution differences affected by deformity and/or alterations in 8 different body 
positions within and between non-disabled and patients with a spinal cord injury. The 
sensors to measure the pressure were fixed to the seat surface so that the distance between 
them was the same in all patients. Successive pressure measurements were taken in one 
position without reseating the subjects in order to verify  the repeatability and the 
variability [8]. The practical value of such a procedure for the reproducibility is minimal 
because the measurement was made under the same conditions so that it can be regarded as 
more or less continuous measurement that was interrupted for a short period. 
 The second method is to remove and replace the sensor between two or more 
consecutive measurements on the same day in the same subject [9-13]. It is important that not 
only the sensor is repositioned, but also that the patient or the volunteer is removed from 
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the support surface so that it can regain its initial thickness [13]. In a number of studies only 
the sensor was repositioned [10, 11].  
 The third method is to increase the time interval and repeat the measurement on 
the following or another day with the same subject on the same support surface. This 
procedure was not undertaken frequently because it is time-consuming and often 
impractical for the volunteers because of the long time period [14]. An example of such a 
study is that by Allen et al. who repeated IP measurements with an interval of at least 24 
hours [10, 11].  
 TIP measurements may be relevant in the guidelines for the clinical practice. 
Therefore, the TIP measurement must be reproducible, especially taking into account the 
frequently changing circumstances that may affect such measurements. The majority of 
studies to date, in which the TIP was measured on various support surfaces and in different 
body positions were carried out in healthy volunteers.  However, it has not yet been 
established that a study on measuring the TIP in the healthy volunteers mimics the situation 
in the patients [15]. It is more likely that the patients choose the most comfortable position 
during a period of bed rest, especially after surgery. Moreover, this position is not always 
the same for the whole day because prolonged exerted pressure on the skin forces the 
patient to change position. We cannot assume that such changes do not influence the 
reproducibility of the TIP measurement. 
 To our knowledge, no study has yet been undertaken in which TIP measurements 
were repeated on different days in hospitalized patients in order to determine the 
reproducibility of the TIP measurement and to assess the influence of extraneous variables 
such as body mass, position of backrest, use of incontinence pads and the wearing of 
pyjamas and underwear on this reproducibility. Therefore, we undertook a clinical study in 
which we addressed the “between day” reproducibility of the TIP measurements at the 
sacrum and the buttocks in patients who were confined to bed for at least 4 days.  
 
 
Materials and Methods 
 
Patients 
Patients were selected from the general surgical and medical units of our hospital from 
September 2000 to July 2001. In total 76 patients participated in the study. The inclusion 
and the exclusion criteria for patients who participated in the investigation are shown in 
Table I. Data were collected after the patient had signed the informed consent form. In 
elective surgical patients, the first day of bed rest was defined as the day they underwent 
surgery. The study was approved by the local Medical Ethics Committee of the Erasmus 
MC, University Medical Center. 
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Table I.     Inclusion and exclusion criteria for patients participating in the study. 
Inclusion criteria Exclusion criteria 
Bed rest for at least 4 days after inclusion An existing pressure ulcer >grade 1[31] 
Using a standard hospital mattress Using a special bed frame 
Caucasian > 48 hours of bed rest before inclusion 
Age => 18 years Body Mass > 125 kg 
Signed informed consent  
 
Pressure measurement technique 
The TIP was measured with the Talley Pressure Monitor 3 (TPM III). It is  a device 
developed at the Oxford Orthopedic Engineering Centre, Nuffield Orthopedic Centre, 
Oxford, England [16]. Currently Talley Group Ltda markets this device. Different versions of 
the TPM were used extensively by several researchers for measuring the Interface Pressure 
(IP) in patients [8, 17, 18]. The TPM III consists of three basic components: a sensor array, a 
pneumatic monitor and a calibrating jig. It is able to connect to 8 arrays, each array 
containing 12 sensors (sensor 20 mm in diameter). The general working of the TPM was 
described in detail by Hobson (1992) [8]. Calibration data published by the developers 
showed a maximum deviation from linearity of 3 percent over the optimum range of 0-33.3 
kPa [16]. We used the TPM III with 3 arrays, each containing 12 sensors (3 x 4) (see 
Appendix 3) and calibrated it weekly during the study.  
 
Positioning the arrays 
The arrays were positioned under the sacrum and the right and the left buttocks of the 
patient. The three arrays were positioned as follows: the sensor array at the sacrum was 
positioned first. The patient was asked to lift the buttocks and the sensor array was 
manually positioned by the investigator over the sacral area by positioning the sacrum as 
close as possible to the center of the sensor array. The second array was placed under the 
left buttock. To do so the patient was asked to pull up the left knee as much as possible 
towards the chin and to turn approximately 300 to the right side, without moving the right 
buttock over the mattress. The investigator positioned the sensor array manually over the 
buttock such that the ischial tuberosity was felt as close as possible to the center of the 
matrix. The same procedure was repeated for positioning the array under the right buttock.  
In order to obtain the most accurate clinical data, the arrays were placed between 
the patient and the bed sheet over the standard hospital mattress (Tempur Pedic)b. This 14 
cm mattress is made of a 4 cm top layer of visco-elastic polyurethane and a 10 cm bottom 
layer of cold foam. The whole mattress has a washable cover around it consisting of a 
semi-permeable layer of 80% cotton and 20% polyester.  
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If patients wore pyjamas or other underwear, the arrays were placed over this, thus 
not in direct contact with the skin. If the patient wore an incontinence pad, the array was 
placed between the mattress (with a sheet) and the pad. Information on what the patient 
was wearing at the time of measurement was recorded on the measurement data form. The 
patients were then instructed to put the backrest of their bed in the most comfortable 
position with their head on a pillow, their hands along side their body and their legs 
uncrossed and stretched out. The first ten minutes of the measurement were used to check 
if any of the sensors produced values that indicated a false measurement due to bending or 
malfunctioning of the sensor. In total 36 sensors measured the pressure between the patient 
and the mattress: 12 in the sacral area, 12 in the area under the right buttock and 12 in the 
area under the left buttock. The patient was asked to stay in the same position and lie as 
still as possible for ten minutes when measuring the TIP. During this period the actual TIP 
was measured continuously. The TPM III starts to measure the TIP at the sacrum followed 
by the left and the right buttocks. Then the cycle starts again. Each cycle is called a frame. 
Each measurement consisted of at least 11 frames. When the measurement procedure was 
finished, the sensor arrays were removed and cleaned. A second measurement procedure 
was carried out between 1 and 5 days later depending on the patient’s clinical condition. 
The data were transported and statistically analyzed in SPSS (version 11.1).  
 
Method of analyzing the interface pressure 
The measured TIP was analyzed on the basis of the calculated Peak mean of the TIP (PIP) 
for each sensor. As the pressure between the patient and the mattress has a continuous 
character, the PIP probably has the highest impact on the patient’s skin. The sensor with 
highest mean TIP in the array over the 11 measured frames was considered to be the PIP. 
All readings of a particular sensor were excluded if one or more readings were 32.8 kPa or 
higher. Apparently this is the highest readout of the TPM III and therefore, the accuracy is 
uncertain.  
 
Statistical analysis 
In order to analyze the reproducibility of the measurements, scatterplots were constructed 
for measurements of the PIPs for the sacrum and both the buttocks. To analyze the 
systematic statistical differences between the means of the two PIP values, the paired 
sample T-test was used. To analyze the differences of the mean PIP between the various 
sites (the sacrum, the left and the right buttock) within each measurement the paired sample 
T-test was used. The reproducibility was quantified by calculation of Intra-Class 
Correlation Coefficients (ICC). The reproducibility was considered satisfactory if the ICC 
of the two measurements was at least 0.8. 
To evaluate the reproducibility of the measurement technique itself, the data from 
each measurement period was divided in half and was treated as if it were two separate 
measurements. The mean values of both (sub) measurements were compared with one 
another and the ICC was calculated once again. 
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Changes in the PIP between the first and the second measurements were evaluated 
with regard to the effects of body mass, height, Body Surface Area (BSA) and Body Mass 
Index (BMI), using the Spearman correlation test. The same was done with regard to the 
effect of change in backrest and Fowler’s position.  Changes in the use of incontinent pads, 
pyjamas and underwear were evaluated with regard to the change in PIP using ANOVA. 
Multivariate analysis of the effects of these factors on the change of PIP was done using 
multiple regression. The level of significance was set at p < 0.05 for all the statistical tests.  
 
 
Results 
 
In the period September 2000 to July 2001, 76 patients were included in the study (44 
males and 32 females).  An overview of the demographic characteristics of the patients is 
shown in Table II.  
 
Table II.     Mean values of demographic characteristics of participating patients 
 Patients (n=76) Range 
Age (years) 59 30-95 
Mass (kilograms) 76 33-114 
Height (cm) 173 152-197 
Body Mass Index [32] 25 10-39 
Body Surface Area (cm3) 1.88 1.4-2.4 
 
The reliability of the measurement technique proved to be high. Comparing the mean of the 
first half of each individual measurement with the second half, the ICC for the 
measurements at the sacrum, the right buttock and the left buttock were 0.80, 0.90 and 
0.88, respectively. 
An overview of the position of the bed frame and the mean PIP values measured 
at the sacrum and the buttocks of measurements 1 and 2 are shown in Table III.  The 
position of the bed rest could not be standardized as patients were asked to position 
themselves in the most comfortable position before each measurement. This position varied 
between the measurements as the most comfortable position of the patient changed 
frequently during their stay in the hospital. The mean interval between the two 
measurements was 4.3 (SD 2.9) days. 
There appeared to be no significant difference between the two mean PIP values at 
all the three sites for the two measurements. Within both measurements, the mean PIP 
values at the three sites differed significantly between the sacrum and the right buttock 
(measurement 1: p = 0.001; measurement 2: p = 0.008) and between the left and the right 
buttocks (p= 0.016) in the second measurement. 
The reproducibility of interface pressure measurements in patients at risk of developing a pressure 
ulcer 
82 
 
Table III.     An overview of the mean Peak Interface Pressure (PIP) at 
measurements 1 and 2 with significance levels. 
 Measurement 1 (sd) Measurement 2 (sd) Significance 
Backrest elevation 210, range 00-470 210, range 00-580 p = .960 
Fowler elevation 1.20, range 00-220 3.20, range 00-350 p = .102 
PIP-Sacrum 6.6 kPa (± 2.5) 6.0 kPa (± 2.7) p = .108 
PIP-right Buttock 5.4 kPa (± 2,6) 4.9 kPa (± 2.6) p = .214 
PIP-left Buttock 6.0 kPa (± 2.0) 5.6 kPa (± 1.6) p = .073 
 
In order to assess the “between day” reproducibility of the PIP visually, 
measurement 1 was plotted against measurement 2 in a scatter plot.  The PIP at the sacrum 
and both the buttocks is shown in Figure 1. The resulting ICCs for the sacrum, the right 
buttock and the left buttock were 0.23, 0.13 and 0.15, respectively. These results indicated 
a low “between day” reproducibility. 
In 17 patients the second measurement was on the next day (“between day” 
interval 1 day). The correlation between both the measurements in this group (group A) 
was compared with the correlation between both measurements of the remaining 59 
patients (group B). The ICCs for the sacrum was higher in group A compared with group B 
(0.36 versus 0.20). For the right buttock the values were 0.07 versus 0.17 and for the left 
buttock the values were 0.24 and 0.07. 
Comparing the absolute value of the change in PIP of measurement 1 with 
measurement 2, a statistically significant difference was observed between the PIP at the 
sacrum and the PIP at the left buttock (2.4 kPa versus 1.6 kPa; p< 0.001). The other three 
comparisons were not significantly different.  
The possible influence of extraneous variables was also analyzed. During the first 
measurement, the elevation of the backrest had a statistically significant positive correlation 
with the PIP at the sacrum and the right buttock. During the second measurement the PIP at 
all locations had a significant correlation with the elevation of the backrest. The level of the 
Fowler’s position had only a significant correlation with the measured PIP at the sacrum 
during the first measurement. There was a correlation between the change in backrest 
elevation and the change of PIP at the sacrum and the left buttock (r = 0.28, p = 0.014; r = 
0.27, p = 0.022, respectively). 
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Sacrum 
 
Right buttock 
 
  
Left buttock 
 
 
Figure I. The reproducibility of the PIP (Peak Interface Pressure) at the sacrum and the 
buttocks. The line in the figures represents the line of indentity 
 
Changes in wearing pyjamas, and underwear had no statistically significant 
influence on the changes in PIP for each of the three sites. A change in incontinence pad 
however, influenced the changes in PIP between the two measurements only at the left 
buttock (p = 0.045).  Using multiple regression it was noted that the effect of change in 
backrest differed between the groups who had and who had not changed the incontinence 
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pad (p = 0.029).In the group who had not changed incontinence pad, there was a significant 
positive correlation (r = 0.29, p = 0.019) between the change in the backrest and the change 
in the PIP at the sacrum. The patients who had changed (n = 12) incontinence pad showed 
a significant correlation at the left buttock (r = 0.76, p = 0.004) between the change in the 
PIP and the change in the backrest.  
Of the patients’ characteristics, only body mass showed a significantly positive 
correlation with the level of the PIP during both measurements at the left and the right 
buttocks (the right buttock measurement 1:r = 0.28, p = 0.014; measurement 2: r = 0.27, p 
= 0.017 ;  the left buttock measurement 1: r = 0.28, p = 0.016; measurement 2: r = 0.34, p = 
0.003). However, there was no statistically significant correlation between the body mass 
and the change in PIP over the two measurements.  
 
 
Discussion 
 
The main objective of this study was to determine the reproducibility of the TIP 
measurements in patients with the aim to establish whether this parameter could be used in 
clinical practice in a PU risk assessment model [19]. The results demonstrated that the 
“between day” reproducibility is very low and therefore, based on these results and this 
methodology, the TIP cannot be used as a parameter for this purpose. 
This absence of an adequate reproducibility can be caused by the fact that the patients were 
allowed to place the backrest of their bed in the, for them at that moment, the most 
comfortable position. As being comfortable can change over the observation period, none 
of the backrest positions were the same in one patient during the two measurements. This 
finding is supported by the fact that the results also indicated that the change in the backrest 
elevation was strongly correlated with the change in the PIP. The actuality that the repeated 
measurements were carried out at different intervals probably had less influence on the 
reproducibility of the PIP value in the group of patients in whom the measurement was 
repeated after 24 hours, a low ICC was already present. It is evident from the results of this 
study that when patients change their position in bed (even during bed rest) it causes in a 
significant variation in the PIP. 
Sugama et al. [20] developed a multi-pad pressure sensor which can be used to measure the 
TIP more easily in patients compared with the equipment we used in this study. Although 
the author admitted that there is no simple relationship between the exerted pressure and 
the pressure needed to constrict capillaries, after measuring the TIP at the sacrum in 79 
elderly Japanese patients, they suggested that maximum pressures varying from 5.3 kPa - 
6.6 kPa may be tolerated before a PU develops. The “between day” reproducibility of the 
measurement was not established and therefore, the value of the measured TIP for 
predicting PU development in clinical practice is debatable as it is unknown whether the 
measured TIP will vary over time. 
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Only a few other researchers have investigated the “between day” reproducibility 
of their measurements. Most of them were carried out in healthy volunteers.  To date the 
“between day” reproducibility of the TIP has not been investigated in any other clinical 
study.  Allen et al. [10] investigated the reproducibility of IP measurements in 6 healthy 
volunteers. Measurements were carried out four times a day over four consecutive days at 6 
body sites (occiput, scapula, elbow, sacrum, buttock and heel) in supine position without a 
pillow on a foam mattress. They noted an average difference of 5.4 mmHg (0.72 kPa) in 
the “between day” measurements and 4.8 mmHg (0.64 kPa) in the same day between repeat 
measurements. They evaluated the reproducibility by comparing the means and the mean 
SDs of the measured TIP at group level. However, the results provided no information on 
the reproducibility of the actual TIP measurements in the individual patient. Based on the 
findings of that study, the investigators conducted 2 additional studies in which TIP 
measurements were carried out over four consecutive days on various mattresses [11, 12]. 
Unfortunately, no data in relation to “between repeats” reproducibility and “between day” 
reproducibility was reported.  
In our study the highest PIP value was generally measured at the sacrum 
compared with the buttocks. No other clinical studies reported results suitable for 
comparison because in most studies the TIP was investigated at the sacrum, the trochanter 
and the heel and not at the buttocks[21]. Allen et al. [10, 11] and Ryan et al. [12] reported the 
opposite in healthy volunteers and measured the lowest TIP at the sacrum compared with 
the buttocks. Maklebust et al. [22] reported that healthy volunteers had good tone in the 
gluteal musculature. This tends to elevate the sacrum from the support surface on which the 
person is reclining resulting in low TIP readings at the sacrum. Another explanation may be 
the presence of the Hawthorne effect when measuring the TIP in healthy volunteers.  When 
participating in a study, they are informed on its purpose. This can subconsciously alter 
their weight distribution by pressing their shoulders more in the mattress which will alter 
the pressure exerted by the pelvic area on the mattress. This is less likely to occur in a 
clinical situation as in our study because of the frequently poor physical condition of the 
patients. This in turn determines the way these patients position themselves in bed. In most 
cases, the most comfortable position is determined by the absence of pain. 
The observation that the backrest elevation was significantly correlated with the 
level of the PIP at the sacrum and the buttocks was also reported in another study [23]. In 
contrast, we observed a positive correlation between the elevation of the backrest and the 
PIP at the sacrum and the right buttock. Defloor [24] reported no differences in the PIP 
measured in healthy volunteers on a polyethylene-urethane mattress with the backrest 
angles of 00, 300 and 600. The difference with our study is that Defloor et al [24] used a 
pressure mapping system and did not distinguish between the sites (the sacrum and the 
buttocks) where the pressures were measured.  Therefore, the movement of peak pressures 
from the sacrum towards the buttocks was not identified. 
The mean PIP values of measurements one and two did not differ significantly 
from each other. This observation supports the suggestion that TIP measurements may be 
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used for assessing the pressure-reducing capacity of a mattress in a varied patient 
population. Currently, this is carried out in healthy volunteers only [21, 25]. In a limited 
number of studies the TIP was measured in a patient population [26-29].  Working group 2 of 
the European Pressure Ulcer Advisory Panel has produced guidelines for assessing the 
pressure-reducing capacity of mattresses. They suggested to use mannequins as these can 
be easily adapted for different positions but in order to obtain reliable measurements these 
should be repositioned at least 6 times during 6 consecutive measurements [7]. Although 
this may be beneficial in producing a ranking of pressure-reducing capacity of various 
mattresses, a clinical evaluation with the, for example, top three mattresses must provide 
the ultimate evidence on the pressure-reducing capacity of the mattress. 
Considering the typical patient characteristics like body mass, length, height and 
indexes (BMI and BSA), we observed a significant positive correlation between the body 
mass of a patient and the PIP at the right and the left buttocks. This is in contrast to the 
results by Rojas & Reynolds [30], who noted no relationship between the body mass and the 
generated IP.  However, when the body mass of the patient was correlated to the change in 
the PIP, no significant correlation was noted indicating the limited value of this parameter. 
A significant limitation of this study was the large diversity of patients who 
participated in relation to mobility and activity; using a more homogeneous patient group 
might produce different results. Repeating the study in patients who do not or are unable to 
move for longer periods (particularly intensive care patients, patients with spinal cord 
injuries and neonates) without changing the position of the backrest and fixed moments of 
measurement (12 hours, 24 hours, 48 hours and 72 hours) may produce TIP values that are 
more reproducible.  
 
 
Conclusion 
 
It is evident from the results of this study that the PIP value is not reproducible in a diverse 
patient population considering their activity and mobility. This variation in PIP is mainly 
caused by the degree of the backrest elevation. As the majority of patients with bed rest 
vary their position regularly, the TIP will also vary. Research addressing the reproducibility 
of TIP measurements in patient groups with similar activity and mobility is needed to 
investigate whether the TIP value can be used as a parameter in a pressure ulcer risk 
assessment model. 
Analysis of the average PIP measured at the sacrum and the buttocks in patients 
indicated that this parameter may be used to evaluate the pressure-relieving characteristics 
of patient support surfaces.  
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Abstract 
 
The purpose of this study was to evaluate whether Tissue Interface Pressure (TIP) measured 
in healthy volunteers and in patients lying on the same type of mattress are equivalent. 
Therefore, TIP was measured at the sacrum and the buttocks in 28 patients and 30 healthy 
volunteers. In patients, the measurements were carried out in their preferred position at that 
moment and in healthy volunteers they were carried out in the three most used positions: 
supine, backrest elevated to 300 and backrest elevated to 300 with 220 Fowler’s position. 
The body mass of both groups was equally distributed and was between 50 and 125 kg. 
Measurements were carried out with the Talley Pressure Monitor III (TPM III) and the 
values were expressed in kPa. 
Results showed that the TIP values at the sacrum (7.3 kPa) and the left buttock 
(6.1 kPa) in patients were significantly higher than those measured in all three positions at 
the sacrum (4.0 kPa; 3.5 kPa; 2.5 kPa respectively for each position) and the left buttock 
(3.3 kPa; 4.0 kPa; 4.4 kPa, respectively for each position) in healthy volunteers (p <  0.05). 
When the maximum TIP values over the pelvic area of each patient and volunteer were 
compared, it became evident that averaging TIP pressures at site level may obscure high 
local TIP values. Again in patients the maximum TIP values were significantly higher 
compared with those in healthy volunteers (7.9 kPa vs 4.5 kPa, 5.1 kPa and 4.9 kPa, 
respectively for each position) (p< 0.01). In patients the maximum pressure measured at the 
buttocks and the sacrum was the same. In the healthy volunteers the site of maximum 
pressure depended on the position.  
The implications of these results are that evaluation of pressure distribution ability 
of a mattress is best carried out in patients instead of volunteers as is currently done. 
Measuring the TIP at the sacrum only is also not always revealing the maximum TIP 
exerted in a particular patient. 
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Introduction 
 
The development of a pressure ulcer (PU) in patients during their stay in hospital always 
has adverse consequences like pain, discomfort, prolonged hospital stay [1], increased risk 
of infection [2] and death [3]. For the nurses and the physicians it causes an increased 
workload [4, 5]. For the hospital organization it leads to increased costs [5-7]. Although 
prevention is not free, it is still cheaper compared with treating the accumulated burden of 
PU [8].  
The increased risk of developing a PU is often made visible through a PU risk 
assessment instrument [9]. Although recent research questions the validity of such an 
instrument in predicting PU development, it is still used widely and provides the nurses 
with practical insight into the patient’s risk of developing a PU [10]. 
The available conceptual schemes indicate that pressure and shear forces are the 
primary causes of PU development [11, 12]. As shear forces are currently difficult to measure 
clinically, over the years more attention has been paid to the influence of pressure. The 
most direct method to measure this parameter is by placing sensors just below the skin of 
the subject. As this invasive method is rather cumbersome, measuring the pressure (Tissue 
Interface Pressure (TIP)) at the interface of patient and the mattress was also shown to be 
reliable [13]. Since the human body is not flat, the TIP will vary depending on the site at 
which it is measured. The more protruding parts of the body, because they contain bony 
structures close under the skin such as the scapula, the sacrum, the buttock, the heel and the 
trochanter, will have higher TIP values compared with the flat parts of the body. The shape 
of the body can also change during a period of severe illness [14] or from being in the same 
position for a long time [15].  
Following this concept, the basis of all PU prevention strategies is lowering the 
TIP at the protruding sites of the body. The nurses can decide on the basis of the PU risk 
level and / or inspection of the skin, when and which type of PU prevention strategy is 
suitable, varying from repositioning patients regularly every two hours to using a special 
mattress [9]. Although repositioning the patient every two hours is often the first step in PU 
prevention, it is often difficult to maintain such a schedule on an around the clock basis 
certainly in intensive care patients [16]. In addition, Clark [17] questioned the effectiveness of 
repositioning patients every two hours as there is hardly any scientific evidence which 
endorses this time interval. On the one hand, Knox [18], based on skin temperature 
measurements, recommended to the turn patients every one and a half hour, or even every 
hour, when at the end of this time frame redness occurred. On the other hand, Meijer et al. 
[19] concluded from their investigations that frequent repositioning may even result in 
applying a pressure load to a specific site that has not fully recovered from an earlier 
pressure load, especially in patients who have co-morbidities such as diabetes [20]. Besides 
this, clinical practice showed that patients who need repositioning most, are often in such 
an unstable clinical condition that they are less likely to be turned at all [21]. From an 
economic point of view Xakellis et al. [8] found that the time involved in repositioning 
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patients every two hours was a more expensive intervention in the prevention of PU 
compared with the costs of using special pressure-reducing mattresses. Defloor [22] reported 
that PU could be effectively prevented by repositioning the patient every four hours instead 
of every two hours  if this was carried out in combination with the use of a polyurethane 
hospital mattress. All this indicates that the effectiveness of interventions such as 
repositioning strongly depends on the pressure-reducing ability of the mattress. 
Many manufacturers of mattresses, and investigators use healthy volunteers in 
order to evaluate the pressure-reducing ability of a mattress by measuring the TIP. 
Whittemore [23] reviewed 22 studies in which TIP was measured to assess the pressure-
reducing ability of a large range of mattresses. The TIP was measured in an actual patient 
population [24] (n=17) [25] (n=18) [26] (n=57) in only three of the 22 studies. In the other 19 
studies, an average of 19 volunteers per study (range 6-64) was tested.  
It is unknown whether a healthy volunteer can truly substitute a patient to evaluate 
the pressure-reducing ability of a mattress. Maklebust et al. [15] stated that healthy 
volunteers have good gluteal musculature tone, which tends to elevate the sacrum from the 
mattress. This results in a lower TIP being exerted on the skin at the sacrum, in contrast to 
patients who may be debilitated and lack good tone in the gluteal musculature.  Following 
this concept Berjian et al  [14] noted that the TIP at the sacrum and the trochanter in healthy 
volunteers was lower compared with cancer patients. Clark and Rowland [27] evaluated the 
TIP that was produced by healthy volunteers (mean age 19.8 years) and hospital patients 
(mean age 82.2 years) on a foam mattress and air mattress . They observed that hospital 
patients had a 41% higher TIP compared with the TIP that was produced by healthy 
volunteers on the same mattress.  
As two thirds of all PUs occur in the pelvic region, in most mattress evaluation 
studies the TIP was measured at the sacrum and the trochanter. [14, 15, 25, 26, 28-32]. Only a 
limited number of investigators measured the TIP also at the ischial tuberosities [31-33]. 
Measuring the TIP at the ischial tuberosities becomes more relevant when the backrest of 
the bed is elevated. As the human body has two ischial tuberosities (left & right) and both 
are not always equally loaded, from a balance point of view it is important to measure both 
sides in order to be certain to obtain the highest TIP value. These two measurements were 
not carried out routinely in all mattress studies [31-33].  It is evident that all human beings 
have different shapes, especially in the pelvic region. Some will have a more protruding 
sacrum and others more protruding ischial tuberosities, but most mattresses do not have 
other material support for the pelvic region. Therefore, it is questionable whether the 
measurement at one site can be extrapolated to others and also to contra lateral sites.  
Whether the TIP should be measured in patients or healthy volunteers for 
assessing the pressure-reducing ability of a mattress is still a matter of debate. The outcome 
of such an investigation may be important for both the clinical practice (users) and the 
manufacturers (suppliers). If such investigations show that TIP measurements in healthy 
volunteers can be used for assessing the pressure-reducing ability then, the manufacturers 
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should request independent standardization institutes to test the pressure-reducing ability of 
their mattresses or they should co-operate with clinicians. 
In order to analyse the relevance of the TIP, we designed a study in which we compared the 
TIP measured in a group of healthy volunteers with those in hospitalized patients on a 
standard hospital mattress. As the elevation of the backrest was shown to influence the 
measured TIP value [34], the effect of this extraneous variable was taken into account. The 
influence of the Body Mass Index (BMI) of the patient or the volunteers on the magnitude 
of the TIP was also investigated in the past [35]. Therefore, the influence of this factor was 
also taken into consideration.   
The following questions were formulated: 
1. Is there a statistically significant difference between the maximum TIP measured in 
patients and volunteers at the specific body sites (the sacrum and the right and the left 
buttocks)? 
2. Is there a statistically significant difference between the measured maximum TIP over 
the three sites (the sacrum, the right and the left buttock) between patients and 
volunteers?. 
3. Which factors (age, BMI, backrest elevation) influence the TIP significantly in patients 
and in volunteers? 
 
 
Materials and Methods 
 
Patients 
A convenient sample of 28 patients was selected for this study. All patients were admitted 
to the medical and surgical wards of the ErasmusMC, University Medical Center, 
Rotterdam, The Netherlands. Participants were selected and stratified according their body 
mass in one of the three categories (50kg - 74.9kg; 75kg - 99.9kg; 100kg - 125kg). The aim 
was to have at least 8-10 patients in each category. The category 100kg - 125kg had 8 
patients. The two other categories had each 10 patients. 
Participating healthy volunteers were recruited from within- and outside the 
center. Participants were selected and stratified according to their body mass in one of the 
three categories. Each category had 10 volunteers. 
Patients and healthy volunteers were positioned on a standard hospital mattress 
(Tempur Pedic®)1. This is a 14 cm thick mattress made of a 4 cm top layer of visco-elastic 
polyurethane and a 10 cm bottom layer of cold foam. The whole mattress has a washable 
cover around it consisting of a semi-permeable layer of 80% cotton and 20% polyester.  
The study was approved by the Medical Ethics Committee of the Erasmus MC, University 
Medical Center. 
 
                                                
1 Fagerdala, Sweden. Manufactured by Dan/Foam A-S, Denmark 
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Instruments 
The Talley Pressure Monitor III (TPM III)2 was used to measure TIP. The concept of this 
device was developed at the Oxford Orthopaedic Engineering Centre, Nuffield Orthopedic 
Centre, Oxford, United Kingdom. Four studies have been published using the TPM III for 
measuring TIP in patients as well as in and the volunteers  [36-39]. The TPM III consists of 
three basic components: a pneumatic transducer array, a monitor and calibrating equipment. 
It is able to connect to eight arrays, each containing 12 connected (array) or separate 
(single) sensors (sensor 20 mm in diameter). Calibration data published by the developers 
show a maximum deviation from linearity of 3 % over the optimum range of 0-33.33 kPa 
[40]. We used the TPM III with three single sensors similar to that in the volunteer group 
reported by several other investigators [31, 32, 39, 41-45].We used the TPM III with three arrays, 
each containing 12 connected sensors (3 x 4) (see appendix 3) because the patients found it 
more difficult to lie still during the measurements. This technique was also used by other 
investigators for evaluating mattresses [33, 37]. All sensors were calibrated weekly during the 
study. 
 
Procedure 
The arrays (AR) or single sensors (SS) were positioned under the sacrum and the right and 
the left buttocks of the patients and the volunteers. The position of the three AR/SS was 
standardized. The individual was asked to turn onto the left side. The sacrum was located 
by palpation and the AR/SS was held in place by the investigator’s hand while the patient 
or the volunteer was asked to turn back into the supine position. The next AR/SS was 
placed under the right buttock by asking the patient or volunteer to turn onto the left side 
while making certain that the AR/SS placed under the sacrum remained in place. The 
ischial tuberosity of the right buttock was located by palpation and the AR/SS was held in 
place by the investigator’s hand while the patient or volunteer was asked to turn back into 
the supine position. The same procedure was repeated for positioning an AR/SS under the 
left buttock. If patients wore pyjamas and / or underwear the AR were placed over this, thus 
not in direct contact with the skin. If the patient wore an incontinence pad, the AR was 
placed between the mattress (with a sheet) and the pad. Information on what the patient was 
wearing at the time of the measurement was recorded on the measurement data form. The 
patients were then instructed to put the backrest of their bed in the most comfortable 
position while lying with their head on a pillow, to put their hands along side their body and 
their legs uncrossed and stretched out.  Further it was stressed to keep body movements to a 
minimum during the time of measurement.  
The volunteers wore their own underwear and standard cotton hospital trousers. 
The measurements in the volunteer group were carried out in three supine positions. 
Position 1: backrest in 00, position 2: backrest in 300 and position 3: backrest in 300 with 220 
Fowler’s position. All volunteers had one pillow under their head during the measurements. 
                                                
2 Talley Group Ltd, Premier Way, Abbey Park Industrial Estate, Romsey, Hampshire SO519AQ, England, UK. 
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In order to obtain the most accurate clinical measurements, the arrays were placed between 
the patient and the bed sheet over the standard hospital mattress. 
The first ten minutes of the measurement were used to allow the measurement 
equipment and visco-elastic mattress to reach steady state. In the meantime it was checked 
if any of the sensors produced values that indicated a false measurement due to bending or 
malfunctioning. In the patient group it was not always possible to reposition the sensor as 
this involved turning the patient. This happened in four patients when the TIP was 
measured at the sacrum. These TIP values were excluded from analyses. 
In total 36/3 sensors measured the TIP between the patient/volunteers and the 
mattress: 12/1 sensor(s) in the sacral area, 12/1 sensor(s) in the area under the right buttock 
and 12/1 sensor(s) in the area under the left buttock. While measuring the TIP, the patient 
or the volunteer was asked to stay in the same position and lie as still as possible for ten 
minutes. During this period the actual TIP was measured continuously. These TIP 
measurements were performed in consecutive order starting in the sacral area and ending at 
the left buttock. The AR/SS were removed and cleaned when the measurement procedure 
was finished. 
As at least 10 measurement frames were performed within each procedure, the 
record file contained a list of 36 x 10 = 360 / 3 x 10 = 30 interface pressure values in kPa. 
The records were transported and statistically analyzed using SPSS (version 11.1).  
The mean TIP value and the standard deviation were calculated for all arrays and 
single sensors at each site from each measurement. In the patient group the sensor with the 
highest mean TIP value at each body site was entered into the database as the Peak mean 
Interface Pressure (PIP-Patient). As the volunteer group used single sensors for each site 
the mean TIP value was calculated for each sensor at each site and entered into the database 
as the PIP-Volunteer. 
  
Statistical methods 
Demographic values between the two groups were compared using the Fisher exact test or 
the unpaired T-test. Comparison of the patient values with the volunteer values at the 
separate sites was done by the unpaired T-test. Comparison of PIP within subject groups 
(patients and volunteers) between the three sites was done using repeated measurements 
ANOVA.  For the maximal PIP the same method was used within the volunteer group for 
the comparison between the three positions and to investigate the relations with BMI. The 
Fisher exact test was used for comparison of the difference in site of the maximum PIP 
between patients and volunteers. The correlation coefficients are Pearson’s. P < 0.05 (two-
sided) was considered the limit of significance. 
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Results 
 
An overview of the demographics of the patient and the volunteer groups is shown in Table 
I. The age distribution between the volunteers and the patients differed. Although the mean 
height of the patients and the volunteers differed significantly there was no statistically 
difference in the BMI as the body mass was used to stratify the patients and the volunteers. 
The average elevation of the backrest in the patient group was 20.80 including five patients 
in completely horizontal position (00 elevation). The mean Fowler’s elevation was 2.90 as 
only four patients used this position with a range of 170-220. The majority of the patients 
wore their underwear and pyjamas during the measurements. Only three patients wore 
incontinence pads during the measurement. The coefficient of variance for the mean TIP 
value of each sensor in the patient group was 5.2% and for the healthy volunteer group was 
3.5%. 
 
Table I.     Means (± SD) of demographic characteristics of the patients and the 
volunteers 
 Patients Volunteers Sign. 
N 28 30  
Male / Female 12/16 15/15 p =0.799 
Age in years 62.2 (±12.3) 32.4 (±11.7) p < 0.001 
Body mass in kg 82.6 (±17.3) 87.1 (±20.6 p = 0.378 
Height in cm 171.4 (±9.6) 177.9 (±10.8) p = 0.018 
BMI  28.1 (±5.4) 27.6 (±5.9) p= 0.740 
Elevation Backrest in degrees 20.8 (±14.8) 0 and 30 NT 
Elevation Fowler in degrees 2.9 (±7.3) 22 and 30 NT 
Presence of underwear 21 30 NT 
Presence of pyjamas 9 30 NT 
Presence of incontinence material 3 0 NT 
NT: not tested; BMI: Body Mass Index 
 
The mean PIP at the three sites in the patients and the volunteers are shown in 
Table II. Comparisons between sites within the patient group and within the three separate 
positions for the volunteer group are shown. The average PIP at the sacrum and the left 
buttock in the patients were significantly higher than those in all three positions in the 
volunteer group (p < 0.01). The average PIP in the patients at right buttocks was only 
significantly higher than the average PIP in the volunteers lying flat (00) (p < 0.05).  
Within the volunteer group the PIP at the sacrum only in the first position was not 
significantly different compared with that in the second position (p = 0.106). The PIP 
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measured on the right buttock in the second position was not significantly different from 
that in the third position (p = 0.373). Further, all PIP values in the three positions differed 
from each other (p < 0.05). 
 
Table II.     An overview of mean PIP, mean maximum PIP and the number of 
maximum PIP in patients and volunteers at three sites in different positions (± SD) 
Site Patients* Volunteer 
Position 1 
Volunteer 
Position 2 
Volunteer 
Position 3 
Sacrum (kPa) 7.3 (± 2.8)b,c, 4.0 (± 1.3)c 3.5 (± 1.6)b 2.5 (± 1.2)b,c 
Buttock right (kPa) 5.2 (± 1.6)a,c 4.0 (± 0.7)c 4.7 (± 1.2)a,c 4.8 (± 0.8)a,c 
Buttock left (kPa) 6.1 (± 1.7)a,b 3.3 (± 0.5)a,b 4.0 (± 0.5)b 4.4 (± 0.5)a,b 
Mean maximum PIP (kPa) 7.9 (± 2.4) 4.5 (±0.9) 5.1 (±1.1) 4.9 (±0.8) 
Maximum PIP sacrum (n) 19 15 6 1 
Maximum PIP buttocks (n) 9 15 24 29 
Note 1: * variable positions see text 
Note 2: significant differences within each group between the three sites is indicated as; a: p< 0.05 
versus sacrum, b: p< 0.05 versus buttock right, c: p< 0.05 versus buttock left) 
Note 3: Position 1: backrest 00; position 2: backrest 300; position 3: backrest 300 and Fowler 220 
 
As was hypothesized, if a PU will develop, it will do so at the site that endured the 
maximum PIP for the longest period. Therefore, the maximum PIP was selected in each 
patient and each volunteer for each position. The measured pressures in the three positions 
in the volunteer group were compared with the corresponding pressures measured in the 
patient group. The maximum PIP in patients differed significantly from the maximum PIP 
measured in volunteers for all three positions ( p < 0.01). In the volunteers, the maximum 
PIP in position 1 differed significantly from those in the second and the third positions (p < 
0.05). There was no significant difference between the maximum PIP in the second and the 
third positions. The maximum PIP in the majority of the patients (19/28) was at the sacrum. 
In the volunteers this varied according to the position. There were significantly more 
patients with maximum pressure at the sacrum compared with the second and the third 
positions in the volunteers (p < 0.01). 
There was a significantly positive correlation between the maximum PIP and 
backrest elevation in the patients (r = 0.66; p < 0.001). No significant correlation was noted 
between the maximum PIP and the BMI in the patients. In the volunteers, the BMI 
correlated with the maximum PIP (resp. r = 0.51 (p < 0.01); r = 0.33 (p < 0.05) and r =0 .59 
(p < 0.01) for the positions 1, 2 and 3 respectively). These three relations did not differ 
significantly (p = 0.80) from each other and the increase in PIP was 0.08 (± 0.02 sem, p < 
0.001) kPa per unit of BMI (kg/m2). 
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Discussion 
 
The most noteworthy finding of this study was that TIP values in the patients were higher 
than those in the volunteers. This was specifically the case for the TIP values at the sacrum 
and the left buttock. The maximum PIPs in the pelvic area in the patients were significantly 
higher than those in the volunteers. This supports the view that when healthy volunteers are 
used for assessing the pressure-reducing ability of a mattress lower TIP values will be 
generated compared with those in the patients.We found one study in the literature in which 
the TIP at the sacrum in patients with cancer and healthy volunteers on the same type of 
mattress with the same type of TIP measuring instrument were investigated [14]. The 
investigators observed no significant difference between the TIP measured at the sacrum in 
the patients and those measured in the healthy volunteers.  
A possible explanation for higher TIPs measured at the sacrum in the patients than 
the TIPs in the volunteer group was given by Maklebust et al. [15].  They reported that the 
reclining healthy volunteers showed a good gluteal musculature tone which caused the 
sacrum to elevate from the mattress whereby lower TIPs were generated.  This is in contrast 
to patients who often have prolonged periods of bedrest and are generally physically 
weakened, whereby good gluteal muscle tone is lacking which causes the sacrum to force 
itself into the mattress and generate higher TIP values at the sacrum. This view is further 
supported by the high number of patients in our study who had the highest maximum PIP at 
the sacrum compared with the lower number of maximum PIPs in the volunteers in the 
three positions.  
Maklebust et al.  [15] also reported that TIP measurements are best performed in 
patients, but they are often reluctant to participate. In our study, most of the patients were 
co-operative and had no problem participating in the study. The reason for this may be that 
the TIP was measured in the patient’s most comfortable position. For the patient this is also 
the most relevant position for assessing the pressure distributing capacity of a mattress. 
Furthermore, the high PIP measured at the sacrum compared with the PIP measured at the 
other sites may also be an explanation for the development of most PUs in the sacral area 
[46].  
Maklebust et al.  [15] further suggested that measuring the TIP in healthy volunteers 
at the trochanter will produce more reliable information on the pressure-reducing capacity 
of a mattress because this is a protruding part of the body that exerts  more pressure on the 
mattress. Measuring the TIP at the trochanter indicates that patients spend considerable 
time on a mattress in the 900 lateral position. As most PUs develop in the sacral area, there 
is no evidence that TIP measurements at the trochanter provide more reliable information 
on the pressure-reducing capacity of mattresses. In addition, Seiler et al. [47] recommended 
to position patients 300 laterally instead of 900 when positioning them on alternate sides to 
prevent the development of a PU. In this position the pressure is not exerted on the 
trochanter or the sacrum but on the soft tissue between the two sites. They reported that soft 
tissue may tolerate up to 3.5 times as much pressure compared with that on bony sites. 
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Recent research has shown that the lower TIP measured at 300 laterally compared with 900 
laterally also depended on the type of mattress [34]. Furthermore, placing the patients at 300 
laterally showed not to compromise the health status of hemodynamic and respiratory 
unstable patients,[48] which may worsen when they are positioned 900 laterally.  
Besides the sacrum, the TIP at the buttocks was investigated in three studies [31-33]. 
In all these 3 studies, higher TIPs at the buttocks than those measured at the sacrum were 
reported. In our study, a significantly high number (19) of the patients had a higher TIP at 
the sacrum compared with those at the buttocks. This is again an indication that the patients 
lacked good gluteal muscle tone which caused the sacrum to press more into the mattress. 
The PIP measurements at the right buttock in the volunteers appeared to generate the 
highest values compared with the values at the left buttock. This may be explained by the 
fact that the TPM III and the investigator were always standing on the right side of the 
patient. The volunteer possibly emphasized the right side by turning to the investigator and 
in doing so increased the pressure exerted on the right buttock unintentionally. It was not so 
that the patients found it more difficult to lie still during the measurement because the TPM 
III was placed on the different side of the patient’s bed. Moreover, because of their illness, 
patients probably pay more attention to their physical well being than to the investigator 
and his equipment.  
When the maximum PIP is analysed in each patient and each volunteer, the mean 
maximum PIP is higher than the mean PIP measured at each of the three sites separately. 
This indicates that by averaging the TIP for each site separately, the TIPs are artificially 
lowered. This provides a misleading impression on the interaction between the patient and 
the mattress. Besides, the study mattress has the same properties over its entire surface and 
is no different in the pelvic area and therefore, there is no reason for the higher pressure at 
the buttocks compared with the sacrum or vice versa. Thus, analysing the pressure-reducing 
capacity of the mid-section of a mattress is best carried out by evaluating the maximum PIP 
in the pelvic area (the sacrum and the buttocks).  
Besides the height, the age of the volunteers was significantly lower compared 
with that in the patients.  There appeared to be no relationship between the maximum PIP 
and the age. In contrast, Clark and Rowland [27] reported that elderly patients had a 
significantly higher TIP than the healthy young volunteers. Two important findings can 
possibly explain the difference with our investigation. The mean age of the elderly in the 
Clark and Rowland [27] study was higher than 80 years compared with 62.2 in our study. 
Next, the mean body mass of their elderly group was below 53.4 kg, whereas in our study 
this was 82.6 kg. Other investigators suggested that patients with a low BMI have less 
padding over bony prominences like the sacrum and therefore, generate a high TIP. There 
is no consensus in the literature on the influence of body mass or BMI on the TIP. Berjian 
et al [14] suggested that the patients with a low BMI exert higher TIPs. However, Rondorf-
Klym and Langemo [24] could not find a significant difference in the TIP measured between 
the elderly patients with and without an ideal body mass. The results of our study showed 
that in the patients, there was no relationship between the maximum PIP and the BMI. In 
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the volunteers there was generally a significant relationship between the BMI and the 
maximum PIP for all the three positions. As yet, the exact influence of the BMI on the TIP 
remains unclear.   
There was a strong correlation between the elevation of the backrest and the level 
of the maximum PIP in the patients. This relationship has also been reported by other 
investigators [26, 34, 49, 50]. This could not be evaluated in the volunteers as they were placed 
in three fixed positions. It was evident in the volunteers that when the backrest was elevated 
to 300 or in combination with 220 Fowler’s position, the PIP at the sacrum was decreased 
and the PIP at the buttocks was increased.  Specifically in position three (backrest 300 and 
220 Fowler’s position) there is a maximum lift of the sacrum area as the contact area 
increases when the legs also carry some of the weight of the pelvic area. 
Apart from human test subjects (patients and volunteers), a number of other non-
human test devices are mentioned in the literature that have been used to evaluate 
mattresses. These devices involve the use of indentors [51] and mannequins [50, 52]. The main 
advantage of using non- human test devices, is a high experimental reproducibility. This is 
not the case in patients because they are unable to act consistently over time [53]. Therefore, 
the European Pressure Ulcer Advisory Panel installed a working group which investigated 
which test device is the most appropriate for evaluating the pressure redistribution 
properties of mattresses relative to a standard surface [54]. They concluded that for the 
comparative ranking of the pressure-reducing capacity of a mattress, a human-like 
mannequin should be used.  Measuring the TIP using a human-like mannequin enables 
researchers to obtain a high experimental reproducibility in the measurements with the 
currently used TIP measurement instruments. The main purpose of this is to show the 
reliability of the measurement technique and produce specific mattress-related 
measurements. The mannequins are not yet commercially available. Therefore, the results 
cannot be generalized for all types of mannequins and do not reflect the clinical situation. 
Human beings move and can vary the pressure on the mattress influencing the TIP. The 
value of TIP measurements using a human-like mannequin for clinical purpose is limited.  
All human beings have different shapes, weight distributions and favor different body 
positions on a mattress. Therefore, clinicians are more interested in the pressure-reducing 
capacity of mattresses expressed as the TIP measured at the most protruding parts of the 
body such as the sacrum and the buttocks in patients.  
The results of this study clearly showed that the patients produce higher PIPs then 
the volunteers on the same mattress. This implies that the assessment of the pressure-
reducing capacity of a mattress used for patients is only possible if the TIP is measured 
with patients in a clinical setting. In such an assessment, it is the best to evaluate the 
maximum pressure at the three sites, (the sacrum and the left and the right buttocks) in the 
pelvic area of each patient.  
Further studies in this field should address the differences in PIP between the 
patients and the volunteers in population older than 70 years because of the generally 
increasing age of hospitalized patients. Clinical research should also address the question 
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whether the site with the maximum PIP is also the site at which pressure ulcers develop. In 
addition, the clinical implications of the discrepancy in the measurements of PIP between 
the patients and the volunteers should be investigated more thoroughly.  
In conclusion, this study may act as a model for the manufacturers of mattresses 
and encourage them to test their products in patient studies prior to marketing such 
products. Moreover, other factors such as safety features, patient comfort and product 
service requirements can also be investigated.  
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Abstract 
 
Patients undergoing surgery are at an increased risk for developing a pressure ulcer. 
Decreased mobility and an inability to feel or react to pain are the main causes of a high 
incidence of pressure ulcers. Standard operating table mattresses do not effectively reduce 
the exerted pressure on the skin. Therefore, specific pressure-reducing mattresses are 
additionally required on top of the standard table. In this investigation the pressure-reducing 
capacity of three commonly used mattresses (Action® 1.5 cm visco-elastic dry polymer 
mattress, Waffle® air mattress and the ROHO® air mattress) was evaluated during surgery. 
Moreover, the variation of the measured Tissue Interface Pressure (TIP) during surgery was 
also evaluated. Sixty-three patients undergoing surgery participated in the study. Each 
mattress was tested in 20-22 patients. 
The pressure-reducing capacity of a mattress was evaluated by measuring the TIP. 
Approximately every 15 minutes during surgery the TIP was measured for 5 minutes at the 
sacrum, the left ischial tuberosity and the right and left heel. The Peak mean TIP (PIP) out 
of each 5 minute measurement was the primary outcome variable.  
Comparing the course of the mean PIP for each mattress during surgery, the 
Action® mattress produced the highest PIPs for each anatomical site compared with the 
PIPs measured on the Waffle® and the ROHO® mattresses (p < 0.01).  A few patients on 
Waffle® and the ROHO® mattresses produced instable measurements, which were 
responsible for a variation coefficient of higher than 10%.  
The results showed that the ROHO® and the Waffle® mattresses generated the 
lowest TIP compared with those measured on the Action® mattress. However, the TIP 
measured at the sacrum and the heels exceeded the generally accepted diastolic blood 
pressure level in a number of patients. Therefore, the tested mattresses would not 
adequately prevent pressure ulcer development in patients during surgical procedures.  
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Introduction 
 
Patients undergoing surgery under anesthesia have an increased risk of developing a 
pressure ulcer (PU) varying from 12% - 66% [1-4]. Recent research in the Netherlands 
reported a  PU incidence of 21.2% in this group of patients [5]. Most investigators explained 
this high incidence because of the patient’s decreased mobility during the operation [6], 
inability to react to the pain caused by the pressure exerted on the skin [5] and the inability 
of the standard operating table mattresses (OTMs) to reduce the pressure effectively on the 
patient’s skin [2, 7-11]. This is further complicated by the fact that per-operatively induced 
PUs become visible after a period ranging from a few hours to 5 days [4, 12, 13]. This is 
frustrating for the physicians and the nurses in the clinical wards as they get the impression 
that their hard work in preventing PUs is ineffective. It is also a serious threat to the 
operating theatre personnel as they falsely assume that adequate measures were taken to 
prevent the development of PUs [8]. 
The development of a PU is the result of pressure and the length of time for which 
the pressure is applied to the skin of the patient [13]. High pressure for a short time can be as 
detrimental as low pressure for a prolonged period [14]. A complicating factor is that each 
patient has an individual threshold in relation to the damaging effect of the applied pressure 
[15, 16]. This difference in threshold is mainly caused by the variation in skin tolerance. Skin 
intolerance is a collective term for factors, when present, adversely affect the integrity of 
the skin under pressure, ergo a higher risk for PU development. Defloor [17] in his 
conceptual model, divided these factors into two groups. Group A consists of factors that 
influence the integrity of the skin in relation to the pressure. Group B consists of factors 
that influence the integrity of the skin in relation to the change in tissue oxygenation [17]. 
Examples of factors in group A are weight, age, dehydration status, protein and vitamin 
shortage, use of corticosteroids, and the presence of stress. Factors in group B are 
temperature, medication, protein, being a smoker, and illnesses that cause a decreased 
oxygen supply, a delay in reactive hyperemia and an increased vascular occlusion. 
It is evident from this conceptual model that during each surgical procedure the 
tolerance of the skin is adversely affected by one or more of these factors.  Some of these 
factors (medication, nutritional status, etc) are familiar to the nurses and the physicians 
before the operation. Others (influence of temperature, a decreased oxygen supply to the 
tissues and the use of inotropics) are unclear and probably occur or change during the 
surgery. In particular, an increased skin temperature at the interface of the patient’s body 
and the mattress is one of the leading contributors in the development of PUs following 
surgery [18, 19]. This is caused by the use of warming devices that are placed under the 
patient in order to minimize heat loss during surgery. These devices enhance the cell 
metabolism, thereby increasing the need for cellular oxygen, nutrients and the rate of waste 
removal. Since this area is also under pressure, blood vessels are compressed and do not 
function adequately to supply oxygen and remove waste products [20]. In order to prevent 
this from occurring, reducing the exerted pressure by the OTM becomes critical.  
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The performance of OTMs was investigated in a limited number of studies [8, 21-25] 
in contrast to mattresses for hospitalized patients [26].  Stability, firmness, pressure 
reduction, and the ability to distribute pressure evenly without “bottoming out” are 
mentioned in the literature as important characteristics of OTMs [21]. The pressure-reducing 
capacity of an OTM may be evaluated by measuring the Tissue Interface Pressure (TIP) at 
the body sites (the sacrum, the buttocks and the heels) where PUs usually develop [27].  
Campell [19] measured the TIP in patients on an OTM and investigated the 
difference in TIP values at the sacrum, the scapula, the thoracic spine and the heel in the 
pre-anesthesia-, post-anesthesia- and post-surgical phase. It was concluded that the sacral 
TIP values increased 35% in the post-surgical phase particularly compared with the pre-
anesthesia phase in patients who had undergone surgery for longer than 2.5 hours. This 
indicated that TIP values may also vary in patients during surgery [22].  It is therefore 
questionable whether volunteers can act as a true model for actual patients [22, 28], although 
this was done in two studies [8, 23]. 
Most studies, in which the pressure distribution capacity of OTMs was 
investigated, a set of  one or two measurements or a limited number (<=5) of measurements 
at short intervals were performed. If the TIP does change during surgery, it may be missed 
when an insufficient number of measurements are performed. Therefore, we designed a 
study in which the interface pressure was measured every 15 minutes in patients who were 
placed on three different OTMs during surgery. The two questions that were addressed in 
this study were: 
1. How does the TIP value vary in patients placed on one of the three special OTMs 
during surgery? 
2. What are the TIP values that are generated when patients were placed on one of the 
three special OTMs during surgery? 
 
 
Materials and Methods 
 
Routinely, an Action® 1.5 cm visco-elastic dry polymer mattress (Action® products, Inc, 
Hagerstown, Md, USA) on top of the standard operating theatre table is used during 
surgery. The two other types of mattresses that were used for this study were the Waffle® 
mattress (EHOB, Inc, Indianapolis, IN, USA) and the ROHO® mattress (The ROHO 
group, Belleville, IL, USA). The Waffle® is a static air mattress, which has a number of 
punched holes that allows the patient to sink into the mattress. The ROHO® mattress 
consists of flexible air cells that are pneumatically connected with each other. Each cell acts 
as a small piston in creating the same internal pressure for each cell. The mattress is 
covered with a lose fitting semi-permeable cover. Both mattresses have an air tube that can 
be connected to a pressure gauge and an air pump in order to add or release air, depending 
on the air pressure inside the mattress or the position of the patient.  
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The TIP was measured with the Talley Pressure Monitor III (TPM III) at the 
sacrum, the left buttock and both the heels during surgery in patients on each type of the 
mattress. The TIP at the right buttock was not measured as this interfered with the work of 
the surgeon. The TPM III consists of three basic components; a sensor array, a pneumatic 
monitor and a calibration jig. The general working of the TPM was described in detail by 
Hobson [29].  
The sensor array (Appendix 3) used for measuring the TIP at the sacrum and the 
left buttock had a 3x4 matrix configuration and single sensors were used for the heels (see 
Appendix 3). The sensor array consists of twelve 20 mm diameter cells mounted on 28 mm 
centers. This matrix provides an effective measurement area of approximately 8,000 mm2. 
A small-diameter flexible tube that plugs into the monitor manifold switch airs each cell in 
the matrix. The thickness of the deflated matrix is approximately 2-3 mm. The stated 
pressure ranges from 0 to 32.8 kPa, with a resolution of 0.13 kPa.  
A total of 63 patients participated in the study. The allocation of the mattress was 
based on convenience. The operating theatres that handled head and neck surgery mostly 
used the ROHO® or the Waffle® mattress. The Action® mattress was used for all types of 
surgery (head and neck, abdominal & thoracic and extremities). Care was taken that the TIP 
was measured in at least 20 patients on each type of the three mattresses.  
The preparation of the operating theatre table was as follows. A flannel sheet was 
put over the table. A heating blanket was positioned on top of this followed by one of the 
three mattresses under investigation. The mattress under investigation was covered with a 
sheet and a towel in the sacral area on which the patient was positioned.  
The positioning of the sensor arrays was carried out after the patient was correctly 
positioned on the mattress on the operating table and before anesthesia. The sensor array at 
the sacrum was positioned first. The patient was asked to lift the buttocks and the sensor 
array was manually positioned by the investigator over the sacral area by positioning the 
sacrum as close as possible to the center of the sensor array. The second array was placed 
under the left buttock. To do this the patient was asked to pull up the left knee as much as 
possible towards the chin and to turn approximately 300 to the left side, without moving the 
right buttock over the mattress. The investigator positioned the sensor array manually over 
the buttock such that the ischial tuberosity was felt as close as possible to the center of the 
matrix. Finally, two single sensors were placed under the left and the right heel at the point 
of the maximum pressure located at the center of the sensor.  
The two sensor arrays and two single cells were connected to the TPM III and the 
first measurement was carried out after the patient was completely anesthetized and 
paralyzed. The TPM III starts to measure the TIP at the sacrum followed by the left buttock 
and then the heels. Then the cycle starts again. Each cycle is called a frame. Each 
measurement consisted of 8-9 frames and took about 5 minutes, measured every 14 to18 
minutes. 
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The performance of the three mattresses in this study was analysed on the basis of 
the calculated Peak mean of TIP (PIP) for each sensor array (sacrum, buttock) or single 
sensor (heel). As the pressure between the patient and the operating table mattress has a 
continuous character, probably the PIP has the highest impact on the patient’s skin during 
surgery. The highest mean TIP of each sensor in the array over the 8-9 measured frames 
was considered to be the PIP. For the single sensors over the heels the mean pressure of one 
cell was considered to be the PIP. All readings of a particular sensor were excluded if one 
or more readings were 32.8 kPa. This is the highest readout of the TPM III and therefore 
the accuracy is uncertain. In most instances this was caused by a crease in the sensor array.  
Besides calculating the PIP for each anatomical site, it was also calculated for the pelvic 
area. This was defined as the highest PIP for each measurement from the two arrays 
positioned under the sacrum and the left buttock. The local institutional review board 
approved the study. 
 
Statistical analyses  
Patient demographic data between the three types of mattresses was compared using the 
chi-square test (sex) or one way ANOVA. The Pearson correlation test was used for 
analysing the relation of the PIP, versus body mass, Body Mass Index (BMI) and the age of 
the patients on the three types of mattresses. Comparison of the PIPs between the three 
types of mattresses during the observation period for each anatomical site was done using 
repeated measurements ANOVA. Comparison of the PIPs measured at the sacrum, the 
buttocks and both the heels for each type of mattress was done using the paired sample T-
test. The stability of the measurements was evaluated by calculating the coefficient of 
variation (VC) of the first eight measurements in each patient. The level of significance was 
set at p < 0.05 for all the statistical tests.  
 
 
Results 
 
Sixty-three patients participated in the study (35 males, 28 females). The mean age for both 
males and females was 45 years (SD respectively: 17, 25). There was no significant 
difference between the male/female distribution over the three mattress groups (p = 0.82). 
A summary of the characteristics of the patients who underwent surgery on each type of the 
three mattresses is shown in Table I. The time the patients spent on the Action® mattress 
was significantly less compared with the time the patients spent on the Waffle® mattress (p 
< 0.05). The length of the average measurement interval was also significantly less in the 
patients on the Action® mattress compared with that on the Waffle® mattress (p < 0.05). 
There was no correlation between the mean PIP measured at each anatomical site and the 
body mass, BMI and age within the three types of mattresses. 
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Table I.     An overview of characteristics, mean PIP values and type of surgery in 
patients who underwent surgery on the three types of operating table mattresses 
(SD) 
Characteristics  ROHO® Action® Waffle® 
Number of patients 20 21 22 
Male/female 10/10 12/9 13/9 
Age (yrs) 53 (± 17) 38 (± 24) 44 (± 18) 
Mass (kg) 76 (± 16) 74 (± 19) 76 (± 19) 
Height (m) 1.72 (± 0.1) 1.71 (±0.1) 1.75 (± 0.1) 
BMI 25 (± 4.2) 25 (± 4.0) 25 (± 4.1) 
Number of measurements 8 (± 2.5) 7 (± 1.9) 8 (± 3.0) 
Number of cycles per measurement 9.85 (± 3.7) 9.12 (± 1.7) 9.48 (± 2.3) 
Measurement interval (min) 16 (± 4.4) 14 (± 3.2) 18 (± 4.6) 
Average time on the mattress (min) 137 (± 73) 90 (± 32) 156 (± 94) 
Mean PIP values 
Mean PIP sacrum (kPa) 10.3 (± 2.9) 15.5 (± 4.2) 9.1 (± 4.9) 
Mean PIP buttock (kPa) 6.3 (± 1.5) 11.7 (± 4.6) 5.8 (± 2.1) 
Mean PIP pelvic area (kPa) 10.4 (± 2.9) 16.6 (± 3.4) 9.0 (± 4.7) 
Mean PIP left heel (kPa) 10.2 (± 3.5) 15.8 (± 4.4) 9.9 (± 6.2) 
Mean PIP right heel (kPa) 11.1 (± 4.8) 16.9 (± 4.1) 10.3 (± 4.9) 
Type of surgery 
Head and neck (%) 95 38 73 
Abdominal / thoracic (%) 5 33 14 
Extremities (%) 0 29 13 
  
Since the number of measurements depended on the duration of the surgery, it 
varied for each patient. Most surgery was completed within 2 hours, thus allowing 8 
measurements. Therefore, the first 8 measurements were used for analysing the difference 
between the mean PIPs at the 4 sites in each patient for the three types of mattresses. An 
overview of the course of the mean PIPs for each site for each mattress is shown in Figure 
1. There was a significant difference between the mean PIPs measured on the ROHO® and 
the Waffle® mattresses compared with the mean PIPs measured on the Action® mattress 
for all measurements and for each anatomical site (p < 0.01). There was no significant 
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difference (p > 0.05) between the mean PIPs on the ROHO® mattress and the Waffle® 
mattress for all sites. For an impression of the variation in the gathered data, the individual 
course of the first eight measurements at the sacrum of all patients is shown in Figure 2. It 
is evident that particularly the ROHO® and the Waffle® mattresses showed some variation 
in the PIPs. The mean VCs of the ROHO® and the Waffle® mattresses were higher than 
10% although the mean median VC was below 10 % indicating that the measurements were 
instable in only a few patients. The VCs of the PIPs at the buttock were all below 10 % and 
the VCs of the PIPs at both the heels were generally speaking higher than 10%. 
 
Figure 1. An overview of the different patterns of the mean PIP for each type of mattress 
for each site for the first 8 measurements ( ▀: ROHO® mattress, ●: Action® mattress, ▼: 
Waffle® mattress) 
 
The highest PIP for each patient in the pelvic area was mostly observed at the 
sacrum (ROHO®: 93%; Action®: 75%; Waffle® 80%). The PIP measured at the sacrum 
was for all types of mattresses was significantly higher compared with the PIP measured at 
the buttocks (p < 0.001). The PIP measured at the left and the right heel was significantly 
the different for the ROHO® and the Action® mattresses ( p = 0.018, p = 0.014 resp). The 
PIPs measured at the heels on the Waffle® mattress was not significantly different (p = 
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0.265) when compared with those on the ROHO® and Action® mattresses.  Comparing the 
PIPs at the heels with those measured at the sacrum and the buttocks showed that all PIPs 
measured at the buttocks were significantly lower than those measured at both the heels ( p 
< 0.001). The PIPs at the left heel on the Waffle® mattress and at both the heels on the 
Action® mattress were not significantly higher than those measured at the sacrum. This 
was not the case on the ROHO® mattress compared with the sacrum on the other 
mattresses. 
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Figure 2. Individual PIP measurements (maximum of eight) at the sacrum of all patients on 
the three mattresses under investigation 
Interface pressures in patients lying on different mattresses during surgery 
 
 118 
Discussion 
 
The results of this study clearly showed that patients who were operated on the ROHO® 
and the Waffle® mattresses generated lower PIPs compared with those in patients who 
were operated on an Action® mattress.  Defloor and de Schuijmer [8] investigated the 
pressure-reducing capacity of 5 OTMs ( standard-, polyether -, polyurethane-, foam- and 
gel (visco-elastic dry polymer overlay) mattresses) in patients lying in various positions. 
TIP was measured using the Ergocheck® which is a pressure mapping system consisting of 
684 pneumatic sensors. They also observed that a visco-elastic dry polymer mattress 
generated the highest TIP in the supine position (5.7 kPa) compared with the other 4 OTMs.  
We measured a maximum PIP of 16.6 kPa in the pelvic area on the Action® mattress. This 
difference can be explained by the fact that different measuring devices were used in the 
study by Defloor and de Schuijmer and this study. Moreover, in that study [8] measurements 
were done in healthy volunteers, whereas we measured in patients. Nevertheless, this 
suggested that a visco-elastic polymer mattress increased the risk for developing PUs when 
compared with the ROHO® and the Waffle® mattresses. In contrast, Nixon et al. [24] noted  
that using a visco-elastic dry polymer mattress during surgery decreased  the development 
of PUs by 50% when compared with a standard OTM. Hoshowsky and Schramm [21] 
investigated the effect of three OTMs (standard 2 inch mattress, 2 inch foam and gel 
mattress and a visco- elastic dry polymer mattress overlay)  in preventing the development 
of PUs. Their results also indicated that the visco-elastic dry polymer mattress overlay in 
combination with the standard mattress prevented the development of PUs more effectively 
than the standard mattress alone.  
The results of those two studies [21, 24] clearly indicated that a standard OTM alone 
during surgery is ineffective in preventing the development of PUs at the sacrum or the 
buttocks. Compared with the results of this study, it also indicated that the additional use of 
a Waffle ® or a ROHO® mattress reduced the TIP even more and thus reduced the risk of 
developing PUs even further. 
The fact that the TIP was measured every 14 to18 minutes during surgery made it 
possible to evaluate the variation in the measurements. It is evident from Figure 3 that some 
patients on the ROHO® and the Waffle® mattresses showed a significant variation in PIPs 
at the sacrum. This was mainly because of manipulations by the surgical team during 
surgery. This also indicated that a single measurement in each patient is not sufficient to 
obtain a correct impression of the pressure-reducing capacity of an OTM. The high 
variability at the heels can be explained by the fact that only one sensor was used to 
measure the TIP. Slight movements of the legs during the time of measurement and a slight 
change in the position between the measurements may cause this variation.  
On the average about 80 % of the highest PIPs in the pelvic area were measured at 
the sacrum. The range of the mean PIPs at the sacrum on the ROHO® and the Waffle® 
mattresses varied between 8.7 kPa and 10.7 kPa for a period of at least 2 hours. In most 
cases this value was above the diastolic blood pressure indicating a higher risk of decreased 
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tissue perfusion [30]. The PIPs measured at the sacrum and the buttocks were higher than 
those reported in other studies [8, 23, 25]. Blaylock and Gardner [25] evaluated two different 
foam mattresses and measured the TIP at the scapula, the sacrum and the heels in 20 
patients. At the sacrum they measured mean pressures of 5.1 kPa. Other investigators used 
other measuring devices for measuring the TIP that enable measurements of the interface 
pressure over a specific area instead of a specific site. Scott et al. [23] used the Force Sensing 
Array (FSA) (Vista Medical®) to measure the TIP in volunteers in two positions on four 
foam mattresses. In the supine position, the mean TIP at the sacrum varied between 8.3 kPa 
and 10.0 kPa. Defloor and de Schuijmer [8] used the Ergocheck® to measure the TIP 
generated in the supine position in healthy volunteers on 5 different mattresses. They 
observed mean TIP values of between 4 kPa and 6.7 kPa. Our mean PIP values at the 
sacrum on the Waffle® and the ROHO® mattresses were more in concordance with the 
values reported by Scott et al. [23]. Two factors that varied between the studies could have 
influenced the TIP. We measured the interface pressure in patients during surgery 
compared with measurements in healthy volunteers in the other two studies [8, 23]. Campbell 
[19] reported that in general the interface pressure increased by 27.5 % after anesthesia. 
During surgery this increased to 35 % compared with pre-anesthesia TIP values. An earlier 
study by Weststrate et al. [31] also reported a significant difference between the TIP 
measured in patients compared with healthy volunteers.   
Another factor that may influence the TIP is the number of layers of material 
between the sensor and the skin and the sensor and the mattress. In relation to the number 
of layers between the sensor and the mattress, often specific techniques for draping the 
operating tables are used whereby layers of different materials (heating blankets, flannel 
sheets, incontinence pads, towels) are placed between the sensor and the mattress. 
Campbell [19] reported that each layer of cloth or material  on top of the OTM decreased the 
pressure-reducing ability of the mattress and suggested to limit the number of layers 
between the patient and the special OTM to a maximum of four. In our investigation, a 
maximum of three layers was used as the heating blanket was positioned under the OTM. 
In relation to the number of layers between the skin and the sensor, the sensors in our study 
were positioned directly on the skin of the patient.  
The highest pressures in our study were measured on the heels of the patients. 
Although the use of the ROHO® and the Waffle® mattresses did reduce the mean PIP, the 
actual mean still exceeded the diastolic blood pressure in most cases. Other investigators [32, 
33] measured interface pressure on the heel and reported  results that are comparable with 
the results of this study. Therefore, a pressure-reducing OTM to lower the pressure on the 
heel is not sufficient. If possible, pillows supporting the lower leg and lifting the heel from 
the mattress should be used to ensure that the heel is free of pressure.  
In conclusion, the ROHO® and the Waffle® mattresses generated the lowest 
interface pressures at the sacrum, the buttocks and the heels during surgery compared with 
the Action® mattress. The mean PIP measured specifically at the sacrum and the heels on 
the ROHO® and Waffle® mattresses often exceeded the average diastolic blood pressure. 
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Therefore, the tested mattresses would not prevent pressure ulcer development in patients 
during surgical procedures.  
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8.1  Introduction 
 
Two critical aspects of the concept of pressure ulcer development as described by Defloor 
are investigated in this thesis [1]. In the first three studies (chapters 2, 3 and 4) the value of 
using a pressure ulcer (PU) risk assessment instrument which quantified the tissue tolerance 
(intrinsic factors) with regard to the applied pressure in patients was investigated. The 
manner in which TIP measurements may be relevant for clinical practice was investigated 
in the studies described in chapters 5 ,6 and 7. In this discussion the relevance of the studies 
on both aspects is dealt with separately. Suggestions on further research are also mentioned. 
Traditionally PU development is considered as a sign of “bad” nursing [2]. This 
implies that nurses are to blame when a PU develops. This also insinuates that nurses are 
the primary group of healthcare workers who should do something about it and that other 
healthcare staff have no or less significant responsibility in this matter. It is the opinion of 
the author that nowadays PU development is a multidisciplinary issue and its prevention 
can only be successful if it is viewed as a multidisciplinary problem. This implies that each 
professional who is involved in the patient rehabilitation process is responsible for 
preventing PU development through effective collaboration with other involved disciplines. 
 
 
8.2    The value of Pressure Ulcer risk assessments 
 
It is evident from chapters 2 and 3 that PU development in intensive care patients is a 
significant problem in the local and European context. In a recent national study in 
intensive care patients, Bours  et al (2002) reported almost the same prevalence (28.7%) as 
we did [3].  This indicates that PU development is an actual problem in patients in the ICU.  
In order to establish a strategy for preventing the development of PU, we investigated 
whether the Waterlow PU risk assessment scale could be used daily for identifying patients 
who had a particularly high risk of developing a PU. The investigation was not carried out 
with the aim to test its predictive accuracy as this can only be done if no preventive 
interventions (intentional or unintentional) are carried out by the medical and nursing staff 
during the time the patients are in the ICU [4]. As this is unethical and does not enhance the 
patient’s rehabilitation, testing its predictive accuracy by diagnostic testing is not the 
method of choice for evaluating a PU risk assessment instrument [5].  Therefore, it is 
debatable whether a specific pattern can be predicted for each individual patient. In relation 
to the prediction of PU development it resembles more to the application of the chaos 
theory applied in the meteorology meaning that only predicting PU development may be 
reasonably accurate in the very near future [6].  
In analyzing the collected data, we incorporated the type and the frequency of 
preventive measures that were implemented. We also wanted to use the model in 
combination with the clinical experience [4, 5]. This indicates that the nurses sometimes took 
different decisions based on the same PU risk assessment score whether or not a special 
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pressure-reducing mattress was used. The results of the studies presented in chapter 4 
showed that the developed prediction model efficiently provided the ICU nurses with this 
information on their patients. This model has been successfully used by the nurses at the 
local ICU for the last 10 years to prevent PU development because the percentage of PU 
days in the unit decreased to below 10% [7]. 
In general, the daily use of PU risk assessment scales is encouraged for preventing 
the development of PU [8, 9]. The collected data on the quality indicators at the fifth yearly 
national PU prevalence survey showed that half of the quality indicators were present in an 
average unit at a university hospital. Zooming in on the quality indicator for registering 
high risk patients with respect to PU development, the nursing notes showed this was done 
in 20% of the units in 2002  [10] and in 32%  of the units in 2003. Unfortunately, whether the 
high risk patients were identified in the medical notes was not investigated. Therefore, the 
advice in the guidelines of the European Pressure Ulcer Advisory Panel (EPUAP) and the 
Dutch institute of healthcare improvement (CBO) is neglected. The question is whether this 
explains why there was no decrease in the PU prevalence during the national PU prevalence 
survey in the Netherlands over the period 1998- 2003 [11] . Clearly, it is not enough for 
physicians and nurses to be informed and have access to the clinical guidelines to change 
their clinical practice. This raises the question why physicians and nurses are slow in 
implementing the evidence-based guidelines on the prevention of PU.  
Hunt [12] (1981) suggested five reasons why nurses neglect working according to 
the evidence-based guidelines. These were: nurses were unaware of the research findings, 
they did not understand them, they did not believe them, they did not know how to apply 
them and they were not allowed to use them. The item `they did not believe them` is still 
actual as was shown in a  recent study that 50.4% of the participating nurses (n =389) did 
not value working according to the evidence-based principles [13]. This is certainly an issue 
that needs to be addressed by hospital administrators, nurse leaders, unit managers and last 
but not least in nursing education programs. Concerning the other four items, as more than 
20 years have passed, it is expected that nurses have increased their professionalism and are 
aware of these items. Therefore, other issues in which physicians may play an important 
role as well explains for their reluctance. Five possible items are analyzed below. 
The first possible reason why nurses fail to use PU risk assessment instruments to 
identify patients with an increased risk is that they perceive PU development as a chain 
event. As patients these days visit more than one department during their stay at a hospital, 
the nurses possibly perceive PU development as caused not during the patient’s stay in their 
unit and therefore feel less responsible. Blaming other units does not stimulate taking 
responsibility. Such thinking places the healthcare staff central instead of the patient who 
needs good quality care. Adequate preventive measures can be taken in time when PU risk 
assessments are carried out daily in all patients, regardless of the unit or the department 
they are cared by. Not performing any PU risk assessment in such a situation also obscures 
the evidence of an increased risk. The studies described in chapter 4 clearly show that the 
daily PU risk assessment was very important for the patient. 
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Secondly, not every patient with an increased risk develops a PU. This decreases 
the confidence of the nurse or the physician in the instrument as an effective warning 
device. Recent developments in evaluating the predictive value of risk assessment 
instruments has sometimes  been misinterpreted by the physicians and nurses in adopting 
the view that risk assessment instruments are of no use because of their poor predictive 
value [14]. What has actually been shown is that the current PU risk assessment instruments 
are not accurate in predicting the inevitable development of a PU. It is debatable whether 
this was the initial purpose when these instruments were developed [5]. The value of using a 
PU risk assessment instrument lies more in the realm of being a warning instrument and the 
outcome must be combined with clinical assessment by experienced nurses. In doing so a 
more realistic  PU risk assessment emerges [4]. In stressing the importance of clinical 
assessment, the British Department of Health published a document which underlined that 
the use of a PU risk assessment instrument should never replace nurse’s clinical judgment 
[15].  
Using a PU risk assessment instrument may be compared with a traffic light. 
Every time a red signal is ignored does not mean that an accident is imminent, but that the 
more often you ignore it the higher is the risk of an accident. Therefore, daily assessment of 
patient’s for their risk to develop a PU makes the nurse aware of the risk a patient has for 
developing a PU and to take the appropriate preventive measures. 
Thirdly, a PU is not seen as an immediate life-threatening condition. Especially, in 
an ICU and an emergency room there are often a large number of life-threatening 
conditions that need immediate attention compared with PU preventive measures. On such 
occasions filling in a PU risk assessment instrument has no priority. Not only life-
threatening conditions have this impact, but also the involvement of the nurse and the 
physician in all sorts of organizational aspects such as meetings and management tasks 
pushes the patient from the center of attention. Braden and Bergstrom [16] speak of a sensory 
overload which reshuffles the priority list regularly as besides the direct patient care other 
demands also need to be addressed. This results in less time and the quality of total patient 
care is jeopardized.  
Addressing the mortality risk when having a PU, the Dutch Central Bureau of 
Statistics (CBS) mentioned that in 1999, 445 people died of a PU as a primary cause of 
death and 1396 patients died of PU as a secondary cause of death [17]. In the long-term, a 
PU maybe more life-threatening than one would like to think. Certain patients who often 
have an increased mortality risk in an ICU will benefit from an aggressive PU prevention 
strategy.   
Fourthly, PU development is currently not viewed as an accident or a near 
accident and therefore, is not reportable to the hospital administration. It is also not viewed 
as a serious complication for the patient’s rehabilitation process which is often discussed 
within a ward-based team.  The absence of these administrative rules decreases the 
importance of the issue both from a quality and socio-economical point of view. Besides 
the patient’s discomfort, the fact that yearly each hospital spends substantial amounts of 
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money on buying or renting special pressure-reducing mattresses should provide enough 
rationale for the hospital administrators to take a closer look at this issue. A hospital-wide 
blame-free obligation to register each PU equal to or higher than stage 2 may stimulate a 
process in which the nurses and the physicians view PU development as an unacceptable 
complication, which has a negative influence on their budgets. Ward-based analysis of the 
collected data may help them to find out that in most instances the PU development could 
have been prevented if adequate measures were taken. Regular surveillance by independent 
specially trained nurses should help to keep everyone alert on this issue. This issue is 
particularly taken seriously by the Dutch Ministry of Health which placed PU development 
at the top of the yearly reported list of critical care indicators [18]. 
A fifth reason may be that as PU development has an incubation time between a 
couple of hours and 5 days [19], the ICU nurses and the physicians are not always confronted 
with the effect of their PU prevention strategy because often the patients have already been 
transferred to another unit. On the one hand, this may provide a false impression that PUs 
do not develop in patients in ICU and therefore, the nurses do not need to use a risk 
assessment instrument. On the other hand, it can give the nurses in the other unit the 
impression that whatever they do, patients from the ICU always develop a PU and a PU risk 
assessment instrument is therefore not useful. Regular communication in this respect 
between the physicians and the nurses in various units may bring such issues to the surface. 
Collaboration between units shows the reality and stimulates taking responsibility for the 
issue involved. The same applies to the healthcare personnel in other units in which patients 
stay for a short time (e.g. emergency department, operating theatre, radiology and nuclear 
medicine department). 
In conclusion the following recommendations can be made for using PU risk 
assessment instruments.  
¾ Nurses and physicians in general and specifically in the ICU should 
follow the national guidelines on the prevention and the treatment of PU. 
This should be recorded in the medical and the nursing notes [10]. 
¾ Daily reporting of the risk a patient has to develop a PU and the condition 
of the skin at PU risk areas in the nursing notes. 
¾ Weekly measurement of the PU prevalence in a randomized fixed number 
of patients in each ward at the hospital. The outcome of such an exercise 
keeps the nurses, the physicians and the hospital administrators alert and 
can act as an objective measure of the quality of the supplied care.  
¾ Each PU development equal to or higher than stage 2 should be recorded 
blame-free in a central hospital register. Regular surveillance of the ward 
by specially trained independent nurses must ensure compliance. Monthly 
multidisciplinary reflective discussions between the physicians and the 
nurses of various units with cases of patients with PU may help to prevent 
future occurrences. Benchmarking with other similar types of units with 
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identical patient mix will also help to identify the best practice models in 
this area of care [15].  
 
Future research must be directed at the influence of using a risk assessment instrument 
on the suggested interventions with and without the clinical assessment by the nurse. This 
would clarify the role the nurse’s expertise and experience play in the process of risk 
assessment and which factors (education, experience, knowledge, attitude, etc) influence its 
accuracy [20]. 
 
 
8.3    The value of interface pressure measurements 
 
In the studies in the second part of this thesis (chapters 5, 6 and 7) the value of Tissue 
Interface Pressure (TIP) measurements performed in patients admitted to the hospital were 
investigated. When the aim of measuring the TIP is to predict PU development on the basis 
of the intensity of the pressure, the results of the study in chapter 5 showed that this was not 
a reliable parameter. The Intra-Class Correlation Coefficient (ICC) had low values, 
indicating a large variation between the two measurements. It is suspected that the primary 
cause is that patients did not need to be in the same position for each measurement. To ask 
this from patients would not reflect the reality of daily life. Patients move regularly in bed 
during the day and also change their positions according to their experienced comfort 
during the course of their hospital stay. It was calculated for this patient group that it would 
take nine measurements on nine consecutive days in order to get a reliable impression on 
the average TIP for a particular patient. With the purpose of the study in mind this is not 
practical as most PU develop within a time span of  a couple of hours to five days [19] 
depending on the intensity of the pressure and the tissue tolerance of the patient to 
withstand the pressure.  
Selecting more specific patients with an increased risk for developing a PU who 
do not move in bed would be better for investigating the reliability of this parameter. 
Therefore, patients in the ICU who are unable to move or are heavily sedated or comatose 
are probably better for answering this question.  
An alternative method to analyze the reliability of the TIP for a more mobile 
patient group is to use a different method for measuring the TIP. In chapter 5, the method 
used for measuring the TIP with a sensor array in patients on two occasions with at least an 
interval of 24 hours is described. The measurement itself took about 10 minutes after which 
the sensor array was removed. It is unknown how often the patient changed position 
between the two measurements. This can be of great importance as relief of pressure allows 
oxygen deprived tissues to get rid of their metabolic waste products and be re-oxygenated. 
A new measuring device known as the Forced Sensor Array (FSA) from Vista Medical® 
provides the opportunity to measure the TIP with a fixed interval and a remote control. 
Hereby the quality and the quantity of the patient’s movement can be detected and 
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incorporated into the analysis of the data. The FSA sensor array has 256 sensors distributed 
over an area of 6466 cm2. This makes it possible to register both the alterations in position 
more accurately and the time patients spend in a specific position. This was investigated 
earlier for the reproducibility of the TIP in wheelchair patients [21]. 
As the TIP in patients is an unreliable parameter to predict their risk of developing 
a PU, the focus of  interest shifted towards  assessing the pressure-distributing capacity of 
our hospital mattress with the TIP (chapters 6 and 7). The reason why we investigated the 
possible difference in the TIP between patients and healthy volunteers was inspired by the 
fact that most of the research in this area was carried out in healthy volunteers. This amazed 
us because most of mattresses in hospitals are used by patients with a variety of physical 
disabilities. The assumption that the mattress has the same effect on patients as compared 
with healthy volunteers was contradicted by the results of the studies that were pursued in 
chapter 6. 
Besides the TIP, there are a number of other selection criteria, which should be 
considered before purchasing a mattress. Krouskop and Van Rijswijk [22] mentioned three 
main purposes of a support surface (provide comfort, facilitate posturing and redistribute 
pressure) and developed a method to assess the nine related criteria; 1: skin moisture 
control, 2: skin temperature control, 3: redistribution of pressure, 4: patient / product 
friction, 5: life expectancy, 6: inflammability, 7: safety, 8: infection control and  9: product 
service requirements. These criteria may be divided into three categories namely product 
efficacy, product safety and product cost / benefit ratio. Manufacturers design their 
mattresses using these criteria to make the performance of the product transparent for health 
care professionals and administrators in their decision making process. The issues related to 
product efficacy should be assessed by nurses and physicians; the product safety related 
issues by technicians and the product cost / benefit by hospital administrators [23].  
Currently, there is no legal requirement for the manufacturers of mattresses to 
provide proof that the marketed mattresses are beneficial in preventing PU development in 
patients compared with a standard hospital mattress. At the moment the manufacturers only 
require a CE (Conformité Européenne) marking as a sign that the product is safe for use in 
a hospital. This CE marking has four risk classes. The manufacturer decides the risk class 
his product falls under. Most if not all mattresses fall under the risk class I, which indicates 
a low risk and only requires a technical report showing that the product is safe for use [24].  
Receiving a CE marking is no guarantee that the product is effective in what it is supposed 
to achieve. A suggestion for the near future would be that each request for a CE marking 
should be accompanied by a report from an independent agency (University hospital, 
technical universities or other technical institutions), which supplies (scientific) evidence 
that the new mattress meets the efficacy and the safety criteria satisfactorily. Such a report 
can only be demanded by the Ministry of Health supported by leading experts in this area. 
In order to compare different mattresses, a protocol detailing the research including the 
methodology, the analyses and the format of the reports should be compiled as a guideline 
for the manufacturers. The CBO may co-ordinate such a process. Only such an incentive 
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will separate the chaff from the corn and the mattresses that are marketed would adequately 
serve the needs of the patients.  
A positive (side) effect of this, which should not be underestimated, is that the 
manufacturers must collaborate with healthcare institutions for the required research. This 
would help them to focus on the needs of the patients in an early phase of product 
development. For the healthcare institutions this would be an opportunity not only to be a 
consumer but also to be a partner with responsibility for developing a product for their 
patients. Such a formal partnership would benefit the patients, the manufacturers and the 
hospitals. As mattress manufacturers place their mattresses in CE class I there is no need to 
use dummies or healthy volunteers to investigate the pressure-reducing capacity of such 
mattresses. Therefore, manufacturers have no reason for hesitating to let patients participate 
in any research project they claim their product to be safe for use in a hospital. More 
complex mattress systems should be assigned to the CE class II and up, but require further 
investigation. The comparison with drug evaluation in the laboratory may be relevant, both 
in healthy volunteers and in patients. 
Today, there are many different types of mattresses on the market and it is 
tempting to work according to a general consumer principle to get the best value for the 
lowest price. This raises the question of what is the best, as besides the TIP we can evaluate 
8 other criteria [22]. What is the best for one patient group does not need to be the best for 
another group. This dilemma is illustrated by the investigations described in chapter 7. 
Judging what is best according to the measured TIP did not result in any significant 
difference between the ROHO® and the Waffle® mattresses. This raises the question of 
whether selecting the best pressure distributing mattresses for our patients is the most 
effective strategy. Springle suggested working according to the principle of selecting the 
inappropriate mattresses based on research rather than selecting the appropriate ones based 
on their efficacy [25]. This would provide a ranking of mattresses that are effective. Such a 
ranking must be based on research. Such lists may be compiled for specific PU risk (low, 
medium and high) groups of patients. Lists may also be compiled according to the three 
clustered criteria (product safety, product efficacy and product cost / benefit). This would 
provide healthcare institutions with a choice as to the most important criteria in relation to 
the types of patients at their institution.  
Ranking the performance of the mattress in a specific patient group with a risk 
level (high, medium, low) of developing a PU binds the two halves of this thesis. Daily PU 
risk assessment is essential for determining the patient’s risk for PU development. Specific 
categories of pressure distributing mattresses can be used based on this risk level. 
Information on the anticipated efficacy that can be achieved is obtained when the pressure-
reducing capacity of each type of mattress has been evaluated in a clinical trial.  
Future research has to focus more on continuous TIP measurements in tandem 
with routine skin inspection [25]. This enables the researchers to find general TIP threshold 
valvues for particular patients or even patient groups. This would provide a strong 
evidence-based recommendation for clinical practice. For this purpose, collaborative efforts 
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by nurses, physicians, scientists and statisticians must help in designing research and 
implementation protocols. 
In general terms, the future research in the area of PU prevention must shift 
towards a new paradigm. The research over the last 50 years has highlighted much isolated 
and fragmented knowledge in a large number of healthcare disciplines. The anticipation 
that PU development would not be a clinical issue in the year 2000 has not been achieved in 
spite of the large number of research articles that have been published in this field. 
According to Kuhn, there is no scientific progress when only knowledge is accumulated 
over time, but occurs when a shift in paradigm takes place because the old paradigm is 
unable to answer the relevant clinical and research questions [26]. The new paradigm for 
preventing PU development could well be that clinically oriented research should always be 
multi-centered and carried out by a multidisciplinary team. This implies that the physicians 
and the nurses are always involved in the research, and in implementing its results. The 
multi-center aspects would also prevent the possible bias of single organization issues 
affecting the results. Although this work involves a lot of complicated planning and 
preparation, it may be anticipated that both the prevalence and the incidence of PU will 
decrease by implementing research-based PU prevention strategies. 
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Summary 
 
In the two most cited conceptual models on the development of pressure ulcers 
(PUs) the exerted pressure (influenced by extrinsic factors) and the tissue tolerance 
(influenced by intrinsic factors) are described as two critical parameters. However, 
PU will not develop if there is no pressure even when tissue tolerance is decreased. 
In contrast, when pressure is exerted, the level of tissue tolerance determines the 
timeframe in which the PU will develop. 
Qualitative measurement techniques have been adopted for both the main 
aspects. Numerous devices for measuring the pressure between the skin of the 
patient and the adjoining surface (interface pressure) have been developed over the 
last decades. PUs may develop at any site on the human body, but the favored sites 
are where a thin layer of skin covers bony prominences like the sacrum, the 
buttocks, the scapulae and the heels. Most research on measuring the interface 
pressure has been done at these sites. 
The tissue tolerance is quantified by using risk assessment instruments. The 
original purpose was to use these as risk assessment instruments in order to assess 
the individual risk a patient has in PU development. Recent research has indicated 
that flipping a coin is just as accurate in predicting PU development compared with 
using a risk assessment instrument. Not withstanding this assumption, the main 
purpose of the risk assessment instrument is to act as a warning for the physicians 
and the nurses so that the patients at a high risk for developing a PU can be 
identified early. This in combination with the clinical judgment of the nurses 
determines if and which preventive interventions are necessary.  
Three investigations in relation to the prevalence of PU and the use of risk 
assessment instruments in an intensive care setting are described in this thesis. The 
repeatability of tissue interface pressure (TIP) measurements in patients, the 
difference between the TIP measured in patients and volunteers and the evaluation 
of the pressure-reducing capacity of three operating room table mattresses in 
patients during surgery are described in the other three investigations.  
 
The clinical characteristics when pressure is applied to the skin followed by the 
current state of the art of what is known on the etiology of pressure ulcer 
development is described in chapter 1. Next a historical background on how the TIP 
measurement technique has developed over the last decades is given. Following this, 
different types of TIP sensors and their behavior in a clinical setting are discussed 
and evaluated. Subsequently, the different methods for analyzing the gathered data 
are discussed. The decision to use the Talley Pressure Monitor III (TPM III) for our 
research program was based on the outcome of the analyses of previous tests. 
The second part of this chapter deals with the use and the interpretation of 
PU risk assessment instruments. A number of risk assessment instruments that are 
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specifically related to the risk factors that intensive care patients have are discussed. 
Finally, the motivation as to why the Waterlow risk assessment scale was selected 
for assessing the risk of PU development in intensive care patients is given. 
 
The results of a frequently carried out PU point prevalence at a surgical intensive 
care unit (ICU) (short- and long-stay unit) are described in chapter 2. Besides the 
number and the stage of PU, the risk of developing a PU and the use of the 
Waterlow PU risk assessment instrument was assessed and the number of 
implemented preventive measurements was investigated. The results showed that the 
patients who stayed longer at the ICU had a higher PU prevalence compared with 
patients whose stay was shorter. The PU prevalence varied significantly over the 
days. This was mainly caused by the high turnover of patients who were admitted 
and discharged daily. The average prevalence at the short-stay unit was 13.6% and at 
the long-stay unit was 42.1%. The Waterlow risk assessment score in patients with 
PU grade 0 was statistically significant lower compared with those with grade III. 
This indicated certain sensitivity in detecting differences in PU risk assessments 
between the various PU grades in patients. There was a positive correlation between 
the number of preventive measurements and the PU grade indicating that ICU nurses 
were primarily alerted by the visual signs of PU development and not by the score of 
the risk assessment scale. It was concluded that PU development is a serious 
problem in intensive care patients and that using a risk assessment instrument like 
the Waterlow PU risk assessment scale can help intensive care nurses to identify 
high risk patients early. 
The results of a questionnaire study on PU prevention strategies at a 
number of critical care units in Europe are given in chapter 3. The questionnaire 
consisted of two parts; the first with questions related to the organizational issues 
with regard to PU prevention strategies and the second with a number of questions 
related to the individual patients present on a particular day at the unit. In total 44 
units in 4 countries (Denmark, Italy, Germany and the Netherlands) participated in 
the study. The main results were that most units used a PU prevention and treatment 
protocol and had a nurse who specialized in this area working in the ward. At about 
70% of the units, a PU risk assessment scale was used. The other 30% used their 
clinical judgment to assess the patient’s risk of developing a PU.  
In total 299 patients were evaluated in the study. The average PU 
prevalence (grade II and higher) was 27%. This varied considerably between the 
countries from 4% - 49%. The main risk factor was described as decreased mobility 
followed by decreased activity, increased sensitivity and the use of vasoactive 
medication. The use of a pressure reducing mattress in relation to the PU risk level 
of patients had varied significantly between the countries. It was concluded that 
there is a need in Europe for standardization of protocols regarding PU prevention 
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strategies in critical care patients. Organizations like EPUAP, EFCCNa and the 
ESICM can play an important role in this area. 
 
A study in which the clinical usefulness of the Waterlow PU risk assessment scale 
for intensive care patients was evaluated for creating a PU risk profile is dealt with 
in chapter 4. This prospective study was carried out at a surgical ICU. Data was 
collected from 594 patients who had stayed for longer than 24 hours at the ICU. 
Each patient was assessed daily with respect to their Waterlow PU risk score and the 
presence of a PU (grade II and higher) in the sacral region. Actuarial statistical 
methods were used to analyze the predictive value of the PU risk profile based on 
the Waterlow risk assessment scale. The PU incidence was 7.9%. There was a 
significant difference between the sex, the stay at the ICU and the Waterlow score 
between patients who did and did not develop a PU. The results showed that as long 
as patient’s Waterlow PU risk score stayed below the score of 15, they did not 
develop a PU, whereas if patients had a Waterlow PU risk score of above 25, their 
risk profile in developing a PU increased sharply. The results also demonstrated that 
the PU risk assessment of the last 24 hours is the best indicator for the development 
of a PU within the next 24 hours. Further, it was shown that relying only on the 
clinical assessment of the patient’s skin for initiating PU preventive measures did 
not prevent the PU development, but often only confined the extent of damage. It 
was concluded that the risk profile model based on the Waterlow risk assessment 
scale could be used in the ICU. However, as the risk profile model is based on the 
number and the frequency of standard PU preventive interventions, it cannot be 
translated without considering the context to other intensive care units as they may 
use other PU prevention protocols and interventions. Consequently each unit has to 
develop its own model. 
 
A study in which the reproducibility of TIP measurements is evaluated in a patient 
population is presented in chapter 5. The significance of this study is based on the 
fact that although the exerted pressure is the main cause of PU development, PU risk 
assessment instruments used in clinical practice are only based on factors that 
influence the tissue tolerance. Combining the value of the individually generated 
TIP with the value of the PU risk instrument may produce a more accurate PU risk 
profile of patients during their stay in hospital. For the use of the TIP value in this 
way, its reproducibility must be evaluated.   
The “between day” reproducibility of the TIP at the sacrum and the buttocks was 
assessed with the TPM III in 76 surgical patients who had bed rest at least for a 
period of 4 days. The reproducibility of the TIP measurements, with an interval of at 
least 24 hours, was assessed by calculating the Intra-Class Correlation Coefficient 
(ICC) of the Peak Interface Pressure (PIP) over the two measurements. The main 
results showed a low ICC (range 0.13-0.23) over the two measurements. Of all 
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extraneous variables, only the elevation of the backrest had a significant influence 
on variation of the PIP. It was concluded that TIP measurements in a patient 
population are not reproducible after a minimum time interval of 24 hours. 
Therefore, the patient’s individually generated TIP value cannot be used in creating 
an individual PU risk profile model in combination with the value of the PU risk 
assessment instrument. 
 
An investigation purpose to compare the measured TIP between patients and 
volunteers lying on the same type of mattress is described in chapter 6. The 
relevance of this study was based on the fact that the pressure-reducing capacity of 
mattresses is mostly evaluated by measuring the TIP in healthy volunteers. Patients 
can generate different TIPs compared with those generated by the volunteers due to 
pain and other uncomfortable conditions. Therefore, it is important to investigate if 
the generated TIPs in patients are in the same range compared with those generated 
by the volunteers. 
The TIP was measured with the TPM III at the sacrum and the buttocks in 
28 patients and 30 healthy volunteers. The TIP measurements in patients were 
carried out in their most preferred position. The TIP measurements in volunteers 
were carried out in the three most used positions: supine, backrest elevated to 300 
and backrest elevated to 300 with 220 Fowler’s position.  The results showed that the 
PIPs measured at the sacrum and the left buttock in the patients were significantly 
higher than those measured in the healthy volunteers in all three positions. It was 
concluded that the patients generated higher PIPs than those generated by the 
healthy volunteers. Therefore, the results of an evaluation into the pressure-reducing 
capacity of mattresses carried out in healthy volunteers should be interpreted with 
caution when the mattresses are meant for use in patients.  
 
A study in which the pressure-reducing capacity of three types of operating table 
mattresses was evaluated in 63 patients undergoing surgery is presented in chapter 
7. The purpose of the study was to evaluate which type of mattress reduced the 
exerted pressure most effectively and is suitable for use on operating tables. The 
pressure-reducing capacity was evaluated by measuring the TIP with the TPM III at 
the sacrum, the left buttock and both the heels. The TIP was measured every 15 
minutes for a period of 5 minutes, so that the stability of the measurement during the 
time of surgery could also be evaluated. The PIP within each 5 minutes of the 
measurement was the primary outcome parameter. The three types of mattresses that 
were evaluated were the Action® visco-elastic dry polymer mattress, the Waffle® 
air mattress and the ROHO® air mattress.  
The results showed that the Action® mattress produced significantly higher 
PIPs compared with the other two. There were no significant differences in PIP 
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Therefore, it was concluded that the Waffle® and the ROHO® mattresses were best 
suited for use on the operating table during surgery because they distributed the 
exerted pressure adequately in the patients. 
 
The implications of the studies described in this thesis for clinical practice are 
discussed in chapter 8. After decades of research, PU development is still a 
significant clinical complication that on the average occurs in one out of every 5 
patients admitted to hospital. This is even more frequent in ICU patients. The 
investigations described in this thesis show that this complication is an international 
problem and not only a problem for the patients in the Netherlands. Daily clinical 
assessment of the patient’s risk for developing a PU is a critical component in its 
prevention. The use of a risk profile model that can provide insight not only into the 
risk over 24 hours but also beyond can be of considerable value. Further research in 
this area should focus on the type and frequency of PU preventive measurements on 
the model. Incorporating the average measured PIP of a standard and pressure-
reducing mattress may also be of considerable value for the clinical practice.  
Evaluating the pressure-reducing capacity of mattresses is an important 
item as each year new types of mattresses come on the market. In order to separate 
the chaff from the corn measuring the generated TIPs in a patient population 
provides valuable information. Next to evaluating a number of other critical 
characteristics, a rank order can be given to the mattresses varying from good to 
poor effectiveness. By removing the inappropriate type of mattress in combination 
with providing the best possible care for the patient, the development of PUs can be 
reduced significantly in the future.  
As mentioned in the title, this thesis has been written from a nursing 
perspective. Therefore, it should also include a specific set of recommendations for 
the nurses with emphasis on the important role and the position they occupy in the 
care of the patients. The prevention of PUs is a multidisciplinary responsibility; the 
healthcare chain is as strong as its weakest link. To make sure that this is not the 
case for the nurses the following recommendations are made.   
In terms of responsibility, the nurses should at least carry out daily PU risk 
assessments in combination with a physical assessment of the patient’s skin. The 
results of this should be documented in the nursing notes. This also provides a clear 
report of the patient’s condition when there are transfers of patients between 
different units within the hospital or between different healthcare institutions. As the 
nurses in the hospital observe the patient almost continuously, they are the pre-
eminent discipline for initiating uni- and multidisciplinary collaborative 
consultations around this issue.   
In terms of knowledge, the nurses should commit themselves to continuous 
schooling in this area by being involved in clinical research.  Participation in 
reporting the incidence and the prevalence helps to face the reality of the PU 
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problem and generates relevant questions for clinical researchers. As there are still 
numerous unanswered (research) questions in this field, initiating or participating in 
new research stimulates an interest in finding answers to those questions.  
In terms of attitude, it is important that nurses commit themselves to 
following the national and international PU prevention guidelines. The use of 
process parameters as quality indicators instead of outcome criteria facilitates the 
nurses to evaluate their own performance. Combined with participating in 
benchmarking projects, the nurses are encouraged to learn from each other when 
differences are noted. 
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In de twee meest geciteerde conceptuele modellen met betrekking tot het ontstaan 
van decubitus zijn de uitgeoefende druk (beïnvloed door de combinatie van 
extrinsieke factoren) en de weefseltolerantie (beïnvloed door het totaal van 
intrinsieke factoren) beschreven als de twee kritische parameters. Alhoewel, zelfs als 
er geen druk wordt uitgeoefend en met een verlaagde weefseltolerantie zal zich er 
geen decubitus ontwikkelen. Wanneer er echter wel druk wordt uitgeoefend, zal de 
mate van weefseltolerantie de tijd bepalen waarbinnen zich de decubitus zal 
ontwikkelen. Kwantitatieve meettechnieken zijn voor beide belangrijke aspecten 
ontwikkeld. De laatste jaren zijn er verscheidene instrumenten ontwikkeld die de 
druk tussen de huid en het onderliggend matras meten (interfacedruk). Hoewel 
decubitus zich in principe op iedere locatie van het lichaam kan ontwikkelen, heeft 
het wel een aantal voorkeursplaatsen. Dit zijn met name locaties waar een dunne 
huidlaag zich over een benig uitsteeksel plooit zoals het geval is bij het sacrum, het 
zitbeen, de schouderbladen, de hielen etc. Het meeste onderzoek met betrekking tot 
meten van de interface druk vindt dan ook plaats op deze locaties. 
De weefseltolerantie wordt gekwantificeerd met behulp van 
risicobeoordeling-instrumenten. Het oorspronkelijke doel van deze instrumenten 
was om het individuele risico op het ontstaan van decubitus bij patiënten in kaart te 
brengen. In een later stadium heeft men getracht deze instrumenten te gebruiken om 
het ontstaan van decubitus te voorspellen. Recent onderzoek laat zien dat het 
opgooien van een munt hierin een net zo nauwkeurig antwoord geeft als het 
instrument. 
Het belangrijkste doel van een dergelijk instrument is om artsen en 
verpleegkundigen de mogelijkheid te geven een patiënt met een verhoogd risico op 
decubitus vroegtijdig te identificeren. Dit, in combinatie met een klinische 
beoordeling van de patiënt door de verpleegkundige, bepaalt wanneer en welke 
preventieve interventies noodzakelijk zijn. 
Drie onderzoeken in relatie met de preventie van decubitus en het gebruik 
van risicobeoordelinginstrumenten op de intensive care afdeling zijn beschreven in 
dit proefschrift. De reproduceerbaarheid van de interfacedruk gemeten in patiënten, 
het verschil in interfacedruk gemeten bij patiënten en vrijwilligers en de evaluatie 
van de drukreducerende capaciteit van drie operatietafelmatrassen bij patiënten 
tijdens een chirurgische ingreep zijn beschreven in drie andere onderzoeken. 
 
De klinische verschijnselen van druk op de huid en de huidige “state of the art” wat 
betreft de etio-pathologie van decubitus is beschreven in hoofdstuk 1. Vervolgens 
wordt een overzicht gegeven, hoe de techniek van het meten van de interfacedruk 
zich de laatste jaren heeft ontwikkeld. Hierna wordt het gebruik van verschillende 
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waarna verschillende analysemethoden van de verzamelde data worden besproken.  
Het besluit om de Talley Interfacedruk Monitor (TPM III) te gebruiken voor deze 
onderzoeken is gebaseerd op deze analyse.  
Het tweede gedeelte van het hoofdstuk beschrijft het gebruik en de interpretatie van 
decubitus risicobeoordelinginstrumenten. Een aantal van deze instrumenten waarin 
specifieke risicofactoren zijn opgenomen die relevant zijn voor de ICU patiënten 
worden hier besproken. Vervolgens wordt beargumenteerd waarom het Waterlow 
risicobeoordelinginstrument is gekozen om het risico op decubitus bij ICU patiënten 
te beoordelen. 
 
De resultaten van een frequent uitgevoerde decubitus puntprevalentie studie op een 
chirurgische intensive care unit (kort en langdurig verblijf) staat beschreven in 
hoofdstuk 2. Naast het aantal patiënten met decubitus, de gradering, het risico op 
het ontwikkelen van decubitus en het gebruik van het Waterlow decubitus 
risicobeoordelingsinstrument werd ook het aantal en type decubitus preventieve 
maatregelen onderzocht. De resultaten laten zien dat patiënten die langer op de 
intensive care verbleven een hogere prevalentie van decubitus hadden in 
vergelijking met diegenen van wie het verblijf kortdurend was. Tevens verschilde de 
prevalentie van decubitus significant tussen deze dagen dat gemeten werd. Dit werd 
met name veroorzaakt door het grote aantal patiënten dat dagelijks werd opgenomen 
en ontslagen. De gemiddelde prevalentie op de kortverblijf-unit bedroeg 13.6% en 
op de langverblijf-unit was dit 42.1%. De Waterlow decubitus risicoscore bij 
patiënten die geen tekenen van decubitus hadden was statistisch significant lager in 
vergelijking met diegenen die decubitus graad III hadden. Dit laat een zekere 
sensitiviteit zien in de verschillen van risico op decubitus  tussen patiënten met 
verschillende gradaties van decubitus. Tevens was er een positieve correlatie tussen 
het aantal uitgevoerde preventieve maatregelen  en de gradatie van decubitus wat liet 
zien dat verpleegkundigen op de ICU hoofdzakelijk door de klinische verschijnselen 
hun beleid laten bepalen en niet door de hoogte van het decubitus 
risicobeoordelinginstrument. Geconstateerd werd dat de ontwikkeling van decubitus 
bij patiënten op de intensive care een serieus probleem is en dat gebruik van een 
risicobeoordelinginstrument als de Waterlow decubitus risicoschaal 
verpleegkundigen kan helpen om patiënten met een hoog risico te identificeren. 
 
De uitkomsten van een enquête naar decubitus preventieve maatregelen op een 
aantal intensive care afdelingen in Europa staan vermeld in hoofdstuk 3. De enquête 
bestond uit twee delen. Het eerste deel bestond uit vragen met betrekking tot de 
organisatie van de afdeling in relatie tot decubitus preventieve maatregelen. Het 
tweede gedeelte bestond uit vragen die betrekking hadden op het risico op decubitus 
van de individuele patiënten die op een bepaalde dag aanwezig waren op de ICU. In 
totaal deden 44 afdelingen mee verdeeld over vier landen (Denemarken, Italië, 
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Duitsland, en Nederland). De belangrijkste resultaten waren dat de meeste 
afdelingen een decubitus preventie- en behandelprotocol gebruikten en dat er een 
verpleegkundige op de afdeling aanwezig was die gespecialiseerd was op dit gebied. 
Op ongeveer 70 % van de afdelingen werd een decubitus risico 
beoordelingsinstrument gebruikt. De resterende 30% gebruikte alleen de klinische 
blik om het risico op decubitus bij de patiënt in te schatten. 
In totaal werden 299 patiënten geëvalueerd in de studie. De gemiddelde prevalentie 
van decubitus in de studie (graad II en hoger) bedroeg 27%. Dit getal varieerde 
behoorlijk tussen de vier landen (4%-49%). De belangrijkste risicofactor werd 
omschreven als een verminderde mobiliteit gevolgd door een verminderde activiteit 
en het gebruik van vasoactieve medicatie.  Het gebruik van een drukverlagend 
matras in relatie met de decubitus risicoscore van patiënten varieerde ook sterk 
tussen de verschillende landen. Concluderend werd gesteld dat er in Europa behoefte 
is aan een zekere standaardisatie van protocollen in relatie tot decubitus preventieve 
maatregelen bij intensive care patiënten. Organisaties als de EPUAP, EFCCNa en de 
ESICM kunnen hierin een belangrijke rol spelen. 
 
Een studie waarbij de klinische bruikbaarheid van een risicoprofiel op basis van het 
Waterlow decubitus risicobeoordelinginstrument is geëvalueerd bij patiënten op de 
intensive care afdeling staat beschreven in hoofdstuk 4. Deze prospectieve studie is 
uitgevoerd op een chirurgische intensive care afdeling. Data werden verzameld van 
594 patiënten die langer dan 24 uur op de intensive care afdeling verbleven. Iedere 
patiënt werd dagelijks beoordeeld met betrekking tot de Waterlow decubitus 
risicoscore en de aanwezigheid van de decubitus (graad II of hoger) op de stuit. 
Actuariële statistische methoden zijn gebruikt om de voorspellende waarden van het 
decubitus risicoprofiel op basis van de Waterlow decubitus risicobeoordelingschaal 
te analyseren.  
De incidentie van decubitus tijdens de gehele studie was 7,9%. Er bestond 
een significant verschil tussen de patiënten die wel en geen decubitus ontwikkelden 
met betrekking tot geslacht, de verblijfsduur op de intensive care en de Waterlow 
decubitus risicoscore. De resultaten lieten zien dat, zolang een patiënt’s Waterlow 
decubitus risicoscore onder de 15 punten is deze geen decubitus ontwikkelde op de 
intensive care afdeling. Dit in tegenstelling tot patiënten met een score van 25 
punten of hoger. Hun risico op het ontwikkelen van decubitus steeg bijzonder snel. 
Tevens laten de resultaten zien dat de risicobeoordeling van decubitus over de 
laatste 24 uur de beste indicator is voor het al dan niet ontwikkelen van decubitus in 
de volgende 24 uur. Het werd duidelijk dat het inzetten van preventieve maatregelen 
alleen op basis van een klinische beoordeling van de huid de ontwikkeling van 
decubitus niet tegenging maar alleen mogelijk de omvang van de schade beperkte. 
De conclusie van het onderzoek was dat een risicoprofiel gebaseerd op het Waterlow 
decubitus risicobeoordelinginstrument effectief kan worden ingezet op de intensive 
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care afdeling. Een aantekening hierbij is dat het risicoprofiel omdat het mede 
gebaseerd is op het type en de frequentie van standaard decubitus preventieve 
maatregelen, niet zomaar op een andere intensive care afdeling gebruikt kan worden, 
omdat zij mogelijk andere decubitus preventie maatregelen en interventies 
gebruiken. De conclusie is dan ook dat iedere unit zijn eigen risicoprofiel zal moeten 
ontwikkelen. 
 
Een onderzoek waarin  reproduceerbaarheid van de interfacedruk op de huid (TIP) is 
geëvalueerd in een patiëntenpopulatie staat beschreven in hoofdstuk 5. Het belang 
van deze studie is gebaseerd op het feit dat hoewel de uitgeoefende druk de 
belangrijkste oorzaak is voor het ontstaan van decubitus de decubitus 
risicobeoordelinginstrumenten die in de praktijk worden gebruikt alleen maar 
gebaseerd zijn op factoren die de tolerantie van de huid ten aanzien van de druk 
beïnvloeden. Een combinatie van de individueel gemeten TIP gecombineerd met de 
waarde van het decubitus risicobeoordelinginstrument kan een meer nauwkeurig 
decubitus risicoprofiel van de patiënt geven gedurende zijn verblijf in het 
ziekenhuis. Om de TIP op een dusdanige manier te gebruiken moet de 
reproduceerbaarheid van de meting eerst aangetoond worden. 
De TIP op de stuit en de bil werd op twee momenten met een tijdsinterval 
van tenminste 24 uur (“tussendag” reproduceerbaarheid) gemeten met de TPM III 
bij 76 chirurgische patiënten die bedrust hadden voor een periode van tenminste vier 
dagen. De reproduceerbaarheid  van de twee TIP-metingen werd beoordeeld met 
behulp van de Intra-Class Correlation (ICC) van de Piek Interface Druk (PIP) van 
iedere meting. De belangrijkste uitkomsten laten een lage ICC zien (bereik 0,13-
0.23) over de twee metingen. Van alle andere factoren had alleen de elevatie van de 
hoofdsteun significante invloed op de variatie van de PIP. De conclusie van het 
onderzoek was dan ook dat de PIP in een patiëntenpopulatie niet reproduceerbaar is 
bij een minimum tijdsinterval van 24 uur. Hierdoor kan de individueel berekende 
PIP van de patiënt niet gebruikt worden om een individueel decubitus risicoprofiel te 
vervaardigen in combinatie met de waarde van het decubitus 
risicobeoordelinginstrument. 
 
Een onderzoek met als doel het vergelijken van de TIP tussen patiënten en gezonde 
vrijwilligers liggend op hetzelfde type matras staat beschreven in hoofdstuk 6. Het 
belang van deze studie is gebaseerd op het feit dat de drukverlagende capaciteit van 
matrassen vaak wordt geëvalueerd met behulp door de TIP te meten bij gezonde 
vrijwilligers. Ten gevolge van pijn en andere oncomfortabele omstandigheden 
kunnen patiënten andere TIP-waarden produceren. Het is dan ook van belang om te 
onderzoeken of de gemeten TIP-waarden bij patiënten in dezelfde range liggen in 
vergelijking met de TIP waarden gemeten bij vrijwilligers. De PIP werd berekend 
op basis van de gemeten TIP met de TPM III aan de stuit en bil bij 28 patiënten en 
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30 vrijwilligers. De TIP-metingen bij patiënten werden uitgevoerd in hun meest 
comfortabele positie van dat moment. De metingen bij vrijwilligers werden 
uitgevoerd in de drie meest gebruikt posities n.l. plat op bed, hoofdsteun op 300 en 
hoofdsteun op 300 gecombineerd met de positie van Fowler in 220. De resultaten 
laten zien dat de PIP aan de stuit en de linker bil bij patiënten hoger uitvalt in 
vergelijking met die bij gezonde vrijwilligers in alle drie de posities. De conclusie 
was dan ook dat patiënten een hogere PIP genereren in vergelijking met gezonde 
vrijwilligers op een zelfde type matras. Als conclusie kan dan ook worden gezegd 
dat de resultaten van een matrasevaluatie m.b.t. het drukreducerend vermogen  
vastgesteld met behulp van gezonde vrijwilligers kritisch moeten worden bestudeerd 
wanneer het matras voor een patiënten populatie gaat dienen. 
 
Een onderzoek waarin het drukreducerend vermogen van drie operatietafelmatrassen 
werd beoordeeld is beschreven in hoofdstuk 7. Het doel van de studie was om te 
bestuderen welk type matras de uitgeoefende druk het meest effectief  kon reduceren 
en geschikt was voor gebruik op de operatietafel. De drukreducerende capaciteit 
werd bestudeerd door het meten van de TIP met behulp van de TPM III aan de stuit 
en de linker bil en beide hielen. De TIP werd iedere vijftien minuten gedurende vijf 
minuten gemeten zodat tevens de stabiliteit van de meting kon worden geëvalueerd. 
De PIP over iedere 5 minuten was de primaire uitkomst variabele. De drie 
matrastypes die zijn geëvalueerd waren de Action® Visco-Elastische droge polymer 
matras, de Waffle® luchtmatras en de Roho® matras.  
De resultaten laten zien dat de Action® matras significant hogere PIP-
waarden produceerde in vergelijking met de andere twee matrassen. Er bestonden 
geen significante verschillen in PIP waarden tussen de Roho® en Waffle® matras 
op alle drie de lichaamslocaties. De conclusie van het onderzoek was dan ook dat de 
Waffle® matras en de Roho® matras het meest de druk bij patiënten reduceerde en 
hierdoor het meest geschikt waren voor gebruik op de operatietafel. 
 
De gevolgen van de onderzoeksresultaten voor de klinische praktijk worden 
besproken in hoofdstuk 8. Na tientallen jaren van onderzoek naar de ontwikkeling 
van decubitus is het nog steeds een belangrijke klinische complicatie die gemiddeld 
bij één op de vijf patiënten in het ziekenhuis voorkomt. Bij patiënten opgenomen op 
de ICU ligt dit getal zelfs hoger. De studies die in dit proefschrift staan beschreven 
en de referenties laten zien dat deze complicatie een internationaal probleem is en 
dus niet alleen bij patiënten in Nederland voorkomt. Dagelijkse klinische 
beoordelingen naar het risico op het ontstaan van decubitus bij patiënten is een 
kritische component in de preventie ervan. Het gebruik van een risicoprofielmodel 
kan niet alleen inzicht geven in de hoogte van het risico over de eerste 24 uur maar 
kan ook op langere termijn van waarde zijn. Verder onderzoek moet zich richten op 
de invloed van decubitus preventieve maatregelen op dit model. Het opnemen van 
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de gemiddelde PIP-waarde van een standaard matras en een drukreducerend matras 
kan van betekenis zijn voor de praktijk. Het evalueren van de drukreducerende 
capaciteit van matrassen is een belangrijk gegeven omdat jaarlijks tal van nieuwe 
matrassen op de markt verschijnen. Om het kaf van het koren te scheiden kan het 
meten van de TIP in een patiënten populatie waardevolle informatie opleveren. 
Naast het meten van een aantal andere kritische parameters kan dan een rangorde 
worden samengesteld variërend van geschikt tot ongeschikt voor gebruik bij 
patiënten. Door de ongeschikte matrassen te verwijderen in combinatie met het 
geven van de best mogelijke zorg aan de patiënt kan in de toekomst de aanwezigheid 
van decubitus belangrijk worden teruggedrongen. 
Zoals in de titel staat vermeld is dit proefschrift geschreven vanuit een 
verpleegkundig perspectief. Daarom ook zijn aanbevelingen ook op hun plaats die 
het belang van de rol en positie van verpleegkundigen in de zorg voor patiënten 
m.b.t. dit onderwerp benadrukken. De preventie van decubitus is een 
multidisciplinaire verantwoordelijkheid. De zorgketen hiervan is dan ook zo sterk 
als de zwakste schakel. Verpleegkundigen kunnen ervoor zorgen dat deze schakel 
tenminste niet in hun domein ligt door de volgende aanbevelingen vorm te geven in 
hun dagelijkse praktijk. 
In termen van verantwoordelijkheid zouden verpleegkundigen tenminste 
dagelijks een decubitus risicobeoordeling moeten uitvoeren in combinatie met een 
klinische inspectie van de huid. De bevindingen hiervan dienen te worden 
gedocumenteerd in het verpleegkundige dossier. Een dergelijke verslaglegging geeft 
tevens  een heldere beschrijving van de conditie van de patiënt wanneer deze wordt 
overgeplaatst naar een andere afdeling of  instelling. Aangezien verpleegkundigen 
de patiënt bijna continu observeren vormen zij de discipline bij uitstek om het 
initiatief te nemen in mono- en multidisciplinaire consultaties op dit gebied. 
In termen van kennis kunnen verpleegkundigen zich voortdurend scholen 
door betrokken te zijn bij klinisch wetenschappelijk onderzoek op het gebied van 
decubitus preventie. Deelname in het rapporteren van de incidentie en prevalentie 
helpt hen om de realiteit van het probleem onder ogen te zien. Tevens genereert dit 
het stellen van relevante vragen voor klinisch onderzoekers.  
In termen van houding is het van belang dat verpleegkundigen het gebruik 
van nationale en internationale richtlijnen voor de preventie van decubitus 
onderschrijven. Het gebruik van proces parameters of uitkomstindicatoren laat 
verpleegkundigen hun eigen gedrag evalueren. Dit gecombineerd met deelname aan 
benchmarkprojecten stimuleert het leren van elkaar met name wanneer er verschillen 
aanwezig zijn. 
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Dankwoord 
 
Aan de totstandkoming van dit proefschrift hebben veel mensen hun steentje 
bijgedragen. Als ik één ding geleerd heb tijdens dit promotieonderzoek is het wel dat 
niets waardevols tot stand komt tenzij vele wijze mannen en vrouwen hun bijdrage 
daar aan leveren. Die mensen wil ik bedanken.  
 
Allereerst mijn promotor prof. dr. H.A. Bruining. Beste Kieje, ik ervaar het als een 
voorrecht dat ik als verpleegkundige bij jou mag promoveren. Ik kan het moment 
nog herinneren dat je mij schijnbaar achteloos vroeg om te komen werken binnen de 
onderzoeksgroep. Van het een is het ander gekomen, zie hier dit boekje. Het 
vertrouwen en de steun die je aan mij gaf ontwikkelden bij mij de energie om dit 
proefschrift te realiseren. Hartelijk dank hiervoor. In de toekomst hoop ook ik in 
staat te zijn anderen zodanig te inspireren dat het ondenkbare mogelijk wordt. 
Een betere copromotor dan dr. Ed Heule had ik niet kunnen krijgen. Beste 
Ed, ik zal onze uren samen missen in de komende jaren. Je was altijd weer in staat 
om kritisch te kijken naar mijn enthousiaste verhaal en vertrouwen te geven op het 
moment dat het even niet lukte. Ik heb veel bewondering gekregen voor de 
zorgvuldigheid waarmee je naar de resultaten van mijn onderzoek keek en mij altijd 
weer uitdaagde om de zaak “nog eens kritisch te bekijken”. Je “rode pen” heeft mij 
een betere onderzoeker gemaakt. 
Ook de leden van de kleine commissie, prof. dr. S.E.R. Hovius, prof. dr. ir. 
C.J. Snijders en prof. dr. H.A.M. Neumann wil ik bedanken voor het beoordelen van 
dit proefschrift. Een bijzonder plaats in de jaren van onderzoek neemt dr. W.C.J. 
Hop in. Beste Wim, heel wat uurtjes hebben we naar onderzoeksontwerpen en 
verkregen data gekeken. Hoewel mijn ideeën niet altijd uitvoerbaar waren kwam het 
met jouw statistische expertise tot een heldere boodschap. Ik dank ook de Raad van 
Bestuur van het Erasmus MC en in het bijzonder Willem Geerlings, die het 
financieel mogelijk maakte om het onderzoek te verrichten dat tot deze promotie 
heeft geleid. Mag ik het bestuur aanmoedigen om zorgonderzoek, uitgevoerd door 
verpleegkundigen een vaste plek in dit ziekenhuis te geven? In dit verband dank ik 
ook mevrouw Ineke van Breugem en mevrouw Yvonne Rosman die respectievelijk 
als directeur patiëntenzorg en verpleegkundig manager mijn promotieaanvraag 
onderschreven. Ik dank Kees van Bezooijen voor de nuttige suggesties bij het 
schrijven van de aanvraag. 
 
Mensen van het eerste uur wil ik speciaal bedanken voor hun bijdrage. Ginie 
bedankt voor die ene zin die mij het belang van onderzoek liet zien “Weet je wel 
waarom je dit zo doet”? Dr. ir. C Ince, Can bedankt voor de discussies en de 
kritische houding. Ik heb er veel van geleerd. Verder bedank ik Karin Kofflard, 
Jannie Koeman, Linda Laukens en Jaqueline van Stratum voor de tijd dat we samen 
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in de onderzoekgroep op de heelkunde intensive care hebben gezeten en jullie 
betrokken waren bij de dataverzameling bij patiënten. Ik bedank Leo Tegelaar voor 
het onderschrijven van het belang van onderzoek door verpleegkundigen bij 
patiënten op de intensive care. Ik zie je nog de knoop doorhakken in de deurpost van 
kamer 1004. Dit proefschrift is mede door deze beslissing tot stand gekomen. Met 
jou bedank ik alle intensive care verpleegkundigen van de afdeling die betrokken 
zijn geweest bij het verzamelen van de data. Ook ben ik dank verschuldigd aan  
Coos Jabbaaij voor zijn altijd aanwezige bereidheid om acute technische problemen 
op te lossen. Steven Buijk, Karan Kanhai en Jan Pompe bedank ik voor steun en 
bereidheid om kritisch naar teksten te kijken. Tevens voor het plezier dat we als 
onderzoeksgroep met elkaar hadden.  
 
Voor het tweede gedeelte van mijn proefschrift ben ik veel dank verschuldigd aan 
dr. ir. R.H.M. Goossens. Richard, jij hebt mij ingewijd in het land der drukmetingen. 
Annemoon Timmerman bedank ik voor haar hulp bij het beschrijven van het begrip 
“druk”. Tevens wil ik in dit verband de leden van de decubituswerkgroep bedanken 
voor hun steun. Speciaal in dit verband noem ik Astrid van Dam, Rosalie Helfrich, 
Marleen van den Hurk en Debora van der Eijk. Hartelijk dank voor jullie grote inzet. 
Het was niet altijd eenvoudig om de metingen uit te voeren, maar jullie 
doorzettingsvermogen heeft een mooi resultaat neergezet. Ik hoop dat de 
betrokkenheid bij dit proefschrift jullie heeft gestimuleerd om je talenten binnen de 
verpleegkunde verder te ontwikkelen. Ook bedank ik dr. Chris Mallios die het 
mogelijk maakte om bij de patiënten op de operatiekamer te meten. Verder bedank 
ik de verpleegkundigen die betrokken zijn geweest bij het meten van de 
interfacedruk bij patiënten en de intensive care verpleegkundigen bij het matras-
onderzoek. In dit verband bedank ik ook de medewerkers van het beddenmagazijn 
voor hun logistieke medewerking. Dr. Bob Tank, jou wil ik bedanken voor de vele 
uren die je gestoken hebt in het corrigeren van de Engelse teksten en het geven van 
kritisch commentaar. Door je bijzondere vaardigheid op dit gebied is het een 
leesbaar proefschrift geworden. 
 
Voorts bedank ik de leden van de EPURIG voor hun betrokkenheid en 
bereidwilligheid om kritisch de diverse onderzoeksvoorstellen te bestuderen. 
Speciaal bedank ik Lisette Schoonhoven en Erik de Laat voor hun loyaliteit. 
Kenmerkend voor onze samenwerking is dat wij elkaar meer in het buitenland 
tegenkwamen dan in Nederland. De discussies die we daar voerden, hielpen mij 
altijd me te realiseren dat het probleem complexer was dan dat ik dacht. Tom 
Defloor, ook jij bedankt voor je buitengewone kennis op het gebied van decubitus en 
je voorbeeld in bescheidenheid. Je bent voor mij het bewijs dat inhoud superieur is 
aan politiek. Het is voor mij een eer dat je in de commissie plaatsneemt.  
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Verder wil ik een aantal mensen bedanken die tijdens mijn onderzoeksperiode op 
diverse manieren mij het leven aangenaam hebben gemaakt. Allereerst de mensen 
van de zesde etage Z gebouw. Mijke bedankt voor die zinvolle “management” 
lessen. Verder ben ik dank verschuldigd aan Wilma, Irene, Sjaan, Marijke, Marielle, 
Mathilde, Ineke, Babs, Jos, Frederiek, Eline en Maria. Jullie waren in een cruciale 
periode van mijn onderzoek een positieve omgeving voor mij. Ook jou Gerard 
Brekelmans bedank ik voor het brengen van de broodnodige relativering van mijn 
frustraties. Je beseft niet hoeveel energie deze ontmoetingen mij weer gaven. Ook 
bedank ik de mensen van de Wijnstokgemeente. Jullie blijk van betrokkenheid was 
vaak voor mij de juiste aanmoediging om het werk af te maken. Johan bedankt voor 
het maken van de frisse omslag. Mijn familie en verdere vrienden dank ik voor de 
steun die ik de afgelopen jaren van hen heb ontvangen. Jullie interesse gaf mij 
telkens weer de overtuiging dat ik met iets belangrijks bezig was. Ik dank mijn 
ouders voor het feit dat zij in mij zijn blijven geloven. Door hen heb ik ervaren dat 
voor een kind niets zo belangrijk is als trotse ouders, zelfs als je bijna 50 bent. 
Mama, je hebt gelijk, ik ben een laatbloeier. Ik hoop dat jij nog lang van deze herfst 
mag genieten. Lieve papa*, jammer dat je de finale net niet hebt kunnen meemaken. 
 
Trots ben ik op mijn kinderen Renske en Tjitze die als paranimf naast mij staan 
tijdens de verdediging. Jullie zijn een plezier in mijn leven en laten mij telkens weer 
zien waar het nu echt om draait. Ook bedank ik hiermee hun partners Daniël en 
Elsbeth. Jullie aanwezigheid op deze dag wordt bijzonder gewaardeerd. Het laatste 
woord is voor jou lieve Marian, mijn maatje voor het leven. Vaak heb je mijn 
aanwezigheid moeten ontberen. Dat het in de toekomst rustiger wordt kan ik niet 
beloven. Ik dank je voor je onvoorwaardelijke steun en het plezier dat je mij de 
afgelopen jaren hebt gegeven. 
 
*In memoriam A.Weststrate (3 februari 2005) 
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Appendix 2. Description of the various pressure sore stages as 
defined by the Dutch National Pressure Ulcer Advisory Panel  
 
Stage I  Non-blanchable erythema of intact skin; the heralding lesion of skin 
ulceration. 
 
Stage II  Partial thickness skin loss involving epidermis and/or dermis; the 
ulcer is superficial and presents clinically as an abrasion, blister, or 
shallow crater. 
 
Stage III  Full-thickness skin loss involving damage or necrosis of 
subcutaneous tissue which may extend down to, but not through, 
underlying fascial layer; the ulcer presents clinically as a deep crater 
with or without undermining of adjacent tissue. 
 
Stage IV  Full-thickness skin loss with extensive destruction, tissue necrosis, 
or damage to muscle, bone, or supporting structures (e.g. tendon, 
joint capsules, etc.) 
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Appendix 3. An overview of the 3x4 sensor array of the Talley 
Pressure Monitor III 
 
 
A: The actual sensor 
B: Connection tubes to TPM III and monitor 
 
A 
B 
